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Clostridium difficile is a Gram-positive spore-forming anaerobe and the leading cause of 
antibiotic-associated diarrheal disease in the United States. C. difficile produces two toxins, 
TcdA and TcdB, that are necessary for diarrheal disease symptoms. Colonization of the intestine 
is a necessary prerequisite to diarrheal disease symptoms. C. difficile produces flagella that aid 
not only in bacterial motility, but adherence to intestinal tissue. SigD, a flagellar alternative 
sigma factor in the early stage flagellar (flgB) operon, indirectly activates expression of the tcdA 
and tcdB genes. Both flagella and toxins are C. difficile virulence factors that synergistically 
promote diarrheal disease symptoms, pathology, and inflammation. Therefore, factors that 
regulate expression of the flgB operon affect not only motility, but toxin production and the 
virulence of C. difficile. The main objective of the research described in this dissertation was to 
identify and characterize a genetic mechanism controlling co-regulated flagellar and toxin gene 
expression in C. difficile. In Chapter 2, we identified a “flagellar switch” located upstream of the 
flgB operon, that mediates the phase variable production of flagella and toxins in C. difficile. 
Bacteria with the sequence in one orientation produced flagella, were motile and secreted the 
toxins ("flg ON"). Bacteria with the sequence in the inverse orientation were aflagellate and 
showed decreased toxin secretion ("flg OFF"). We determined that the tyrosine recombinase 
RecV is required for inversion of the flagellar switch in both directions. In Chapter 3, we found a 
single strain family, designated as “ribotype 012”, of C. difficile exhibits low frequency inversion 
! iv!
of the flagellar switch in laboratory-adapted, environmental, and clinical isolates. In Chapter 4, 
we demonstrated that Rho factor is required for flagellar phase variation in C. difficile. We 
hypothesize that Rho factor directly terminates transcription in the leader RNA of the flgB 
operon in flg OFF bacteria. Future studies will assess the virulence contribution of flagellar and 
toxin phase variation to host infection dynamics, outcome, and transmission. Phase variable 
flagellar motility and toxin production suggests that these important virulence factors have both 
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CHAPTER 1: INTRODUCTION 
Overview 
Bacillus difficilis was identified in 1935 in the feces of healthy newborns (1). As 
referenced in the species name, B. difficilis was “difficult” to culture because the bacterium 
required anaerobic conditions for growth (1). Hall and O’Toole demonstrated that injection of 
two day old cultures of B. difficilis into the peritoneum of guinea pigs and rabbits induced severe 
pathology, convulsions, and death (1). From the outcomes of the animal experiments, Hall and 
O’Toole hypothesized the bacterium produced a toxin (1). Lastly, Hall and O’Toole noted that B. 
difficilis was spore-forming and motile under the conditions tested (1). The key phenotypes 
observed by Ivan C. Hall and Elizabeth O’Toole in B. difficilis growth and virulence have stood 
the test of time and are under active investigation to date. 
 B. difficilis was renamed Clostridium difficile in the 1970s based on phenotypic similarity 
to other Clostridia (1-3). Like many Clostridia, the actively growing “vegetative” cell form of C. 
difficile is sensitive to atmospheric oxygen. Therefore, C. difficile vegetative cells reside in an 
anaerobic environment, such as the large intestine of a human host. The ability to form 
metabolically dormant spores confers the ability of C. difficile to transmit between hosts. C. 
difficile infection (CDI) manifests as a diarrheal disease that can range in severity from mild to a 
severe form known as pseudomembranous colitis. According to the Centers for Disease Control 
and Prevention, ~500,000 people are diagnosed with CDI resulting in ~30,000 deaths annually 
(4). CDI is largely considered a nosocomial infection whereby the most susceptible population 
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are patients in a hospital (5). In terms of colonization, C. difficile is not restricted to a human host 
and can colonize farm animals, such as cattle and pigs (6). The leading risk factor for CDI is 
prior antibiotic treatment for a preexisting bacterial infection.  Broad spectrum antibiotics, such 
as clindamycin and ampicillin, increase susceptibility to infection through disruption of the 
microbiota in the intestine that normally afford resistance to C. difficile (7). CDI is treated with 
either metronidazole or vancomycin, for which C. difficile rarely exhibits resistance (8). 
Recurrent infections are common due to antibiotics failing to clear metabolically dormant spores. 
The most effective therapy is an experimental treatment called fecal microbial transplantation, 
whereby feces from a healthy donor is transferred into the intestine of a CDI patient for 
reconstitution of a protective microbiota (8).  
C. difficile completes a life cycle of germination, vegetative cell growth, and sporulation 
during diarrheal disease (3, 9, 10). In a susceptible host, C. difficile spores transit the 
gastrointestinal tract and upon contact with primary bile salts and certain amino acids the spores 
germinate into vegetative cells (9, 11). Outgrowth of vegetative cells leads to the expression of 
different cell surface adhesins to promote C. difficile colonization of the colon (12, 13). Surface 
appendages include flagella (discussed later) and Type IV pili as contributing to C. difficile 
colonization (14, 15). The vegetative cells consume various host and microbial metabolites to 
grow to a high burden (16). Upon deprivation of nutrients within the intestine, the vegetative 
cells express and produce two toxins named TcdA and TcdB (10). Both toxins inactivate 
intracellular host factors responsible for assembly of the actin cytoskeleton resulting in 
disassembly of the cytoskeleton, stimulation of host immune defense genes, secretion of 
inflammatory cytokines and recruitment of neutrophils and monocytes that potentiate 
inflammation (10, 17). Nutrient deprivation and additional ill-defined signals trigger sporulation 
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of vegetative cells (9). The sporulation cascade is fairly well conserved from the model organism 
Bacillus subtilis in C. difficile (9, 18-20). Spores produce various surface proteins to restrict and 
permit passage of select molecules, adherence to host tissues, and detoxify host antimicrobials 
(9). Spores are shed into the environment where a susceptible host can become infected for the 
next cycle.  
The remaining sections of the Introduction focus on topics directly relevant to 
understanding content in Chapters 2-4: toxin structure, regulation, and function; flagellar 
structure, regulation, and function; and an overview of phase variation.   
 
Regulation & Function of the Glucosylating Toxins in Clostridium difficile 
Genetic Organization of the Pathogenicity Locus 
 The genes encoding the glucosylating toxins are located within the Pathogenicity Locus 
(PaLoc) in toxigenic C. difficile strains (21). The PaLoc is a 19.6 kb chromosomal region that is 
conserved in toxigenic C. difficile strains and can be mobilized for transfer to non-toxigenic 
strains via a conjugation-like mechanism (22). The genetic locus contains genes that encode the 
glucosylating toxins, TcdA and TcdB, as well as the transcriptional regulators of the toxin genes, 
TcdR and TcdC, and an export apparatus, TcdE. Below, I briefly review the function of TcdR, 
TcdC, and TcdE. The structure, function, and regulation of TcdA and TcdB will be discussed 
later.  
 TcdR is an alternative sigma factor that is required for expression of the toxins in C. 
difficile (23, 24). Using in vitro transcription assays, Dupuy et al. demonstrated that recombinant 
TcdR alone cannot promote transcription from promoter sequences upstream of tcdR, tcdA, and 
tcdB, but can do so only when in association with RNAP polymerase (RNAP) (23). Recent work 
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from Girinathan et al. demonstrated that TcdR not only contributes to expression of the toxins, 
but also regulates genes outside the PaLoc contributing to sporulation and germination (25). 
However, the contribution of TcdR to C. difficile virulence during host infection has yet to be 
determined.   
 TcdC is a proposed negative regulator of toxin gene expression. TcdC is proposed to 
function as an anti-sigma factor by antagonizing TcdR interaction with RNAP prior to 
transcription initiation (26). Thus, TcdC indirectly inhibits transcription of tcdA, tcdB, and tcdR 
(26).  Outside of the prescribed role in TcdR inhibition, TcdC can also interact with G-
quadraplex DNA structures containing repetitive guanine nucleotides, but the functional 
contribution of this feature has yet to be assessed in C. difficile  (27). Mutants of tcdC tell a 
different story depending on the strain background. Epidemic ribotype 027 strains contain 
nonsense mutations in tcdC, which were proposed to contribute to the hypervirulence of these 
strains.  Overexpression of functional, intact TcdC in M7404, a ribotype 027 strain with 
nonsense mutations in tcdC, was sufficient to mediate repression of toxin gene transcription and 
production relative to vector control strains (28). In addition, hamsters infected with M7404 
overexpressing TcdC succumb to infection significantly earlier than wildtype. In contrast to 
these data, Cartman et al. used allelic exchange to repair the mutations in tcdC in the R20291 
background, a ribotype 027 strain, and found no difference in toxin activity by cytotoxicity 
assays between strains with a repaired and non-functional tcdC gene (29). Similar results were 
observed in a tcdC mutant and complemented strain of 630∆erm (30).Taken together, the 
functional contribution of TcdC to C. difficile virulence has yet to be conclusively determined.   
 TcdE is a small protein suggested to contribute to toxin export. TcdE has three predicted 
transmembrane spanning domain and homology to holins (31). Holins are small membrane 
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proteins encoded in bacteriophage that insert in the membrane of bacterial cells to promote lysis 
and release of bacteriophage (32). Govind et al. generated a tcdE mutant in JIR8094 and found 
the mutant had a significant reduction in secreted TcdA and TcdB, but an increase in intracellular 
levels, relative to wildtype (31). Expression of tcdE in E. coli with an endolysin lead to bacterial 
lysis, providing in vivo evidence that TcdE can function as a holin  (31). In contrast to these 
findings, Olling et al. demonstrated that a tcdE mutant of strain 630∆erm secretes TcdA and 
TcdB to levels comparable to wildtype. TcdE function in TcdA and TcdB export is inconclusive 
based on the aforementioned reports that could be due to differences in C. difficile strains and 
assay conditions. 
 
Roles of Toxins in Disease 
 Multiple animal models have been used to assess the functional contribution of TcdA and 
TcdB to diarrheal disease. In a rabbit ileal loop model, purified TcdA caused fluid accumulation, 
mild hemorrhaging, and immune cell trafficking, so TcdA became referred to as the enterotoxin 
(33). TcdB caused very little fluid accumulation and other symptoms in animal models, but in 
cell culture experiments promoted cell rounding and reduced viability, so it became referred to as 
a cytotoxin (33). In subsequent studies using the hamster model (34), multiple low doses of 
TcdA were sufficient to elicit fluid accumulation, diarrhea, and intestinal pathology, whereas 
even high doses of TcdB resulted in no observable effect. Combination studies using low doses 
of both TcdA and TcdB resulted in lethal intoxication with significant intestinal pathology and 
diarrhea (34). These results suggested that TcdA and TcdB act synergistically to cause diarrheal 
disease symptoms and that TcdA must cause damage to host tissue for TcdB to gain a foothold.  
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 Infection studies using single or double mutants of tcdA and tcdB have provided new 
insight into the specific contributions of each toxin during infection. Early studies used JIR8094, 
a laboratory derivative of the ribotype 012 C. difficile strain 630 that was isolated from a patient 
with fulminant diarrhea in 1982 (35). In JIR8094, the tcdA and tcdB genes were mutated 
individually and in combination and then the resulting mutants were assayed for virulence in 
hamsters pretreated with the antibiotic clindamycin (36). Lyras et al. found that hamsters 
infected with the TcdB-only producing strain (A- B+) exhibited fulminant diarrheal disease and a 
mean time to death similar to hamsters infected with the parent strain (36). By contrast, infection 
with the TcdA-only producing strain (A+ B-) resulted in survival of at least 70% of the hamsters. 
These results led to the early conclusion that TcdA is dispensable for disease, and TcdB is the 
only essential toxin. However, in the subsequent year, Kuehne et al. produced conflicting data 
using strain 630Δerm, showing that both toxins individually contribute to diarrheal disease 
development and significantly reduced time to death compared to uninfected or a double toxin 
mutant (37). The primary difference between the two findings in these papers was the parental 
strain used. Both studies used derivatives of strain 630 that were serially passaged on non-
selective media to obtain an erythromycin-susceptible strain (36-39). However, whole genome 
sequencing and phenotypic analysis revealed multiple differences in the genome, including 
single nucleotide polymorphisms, inversions, and other genomic alterations (40). The JIR8094 
strain is also non-motile and produces less toxin than 630Δerm and the mutual 630 parent (41, 
42). These phenotypes, as well as the conflicting contributions of the toxins to disease in 
hamsters, could be explained by the accumulated changes in the JIR8094 genome.  
 Toxin gene mutations in C. difficile ribotype 027 strains helped resolve the contribution 
of each individual toxin to disease development and pathology. Using the hamster model of 
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infection, Kuehne et al. demonstrated the either TcdA or TcdB produced alone in R20291 (using 
tcdB or tcdA mutants, respectively) is sufficient to cause fulminant diarrheal disease and lethality 
compared to a double toxin mutant (43). The mean time to end point for hamsters infected with 
TcdB only producing strain was 2.3 days, whereas an infection with TcdA only producing strain 
was 5.9 days (43). These data are consistent with previous findings that TcdB is the more potent 
toxin, but TcdA can also lead to disease, pathology, and lethality. To comprehensively determine 
the contribution of each toxin to disease and to unify the field, Carter et al. assessed individual 
and double mutants of tcdA and tcdB in ribotype 027 strain M7404 in three different animal 
models in three different laboratories to control for differences in animal husbandry, the 
intestinal microbiota, and antibiotic treatment protocols (44). In a mouse model at Monash 
University where mice consistently develop severe diarrheal disease symptoms, all mice died 
when infected with wildtype (TcdA+ TcdB+), and 95% of mice infected with the isogenic TcdA- 
TcdB+ strain succumbed to infection by 48 hours (44). By contrast, only 20% of mice infected 
with the isogenic TcdA+TcdB- strain died by 48 hours. In addition, histopathology scores and 
weight loss for mice infected with the TcdA+ TcdB- strain more closely resembled infection 
with the toxin double mutant than the wildtype or TcdA- TcdB+ strains (44). In a Sanger 
Institute mouse model, where mice exhibit self-limiting inflammation and mild diarrhea, 
infection with the TcdA-TcdB+ strain was more lethal than infection with wildtype or any of the 
other mutants tested (44). Lastly, in the hamster model of infection at Hines VA hospital, the 
infection with TcdA+ TcdB- was significantly attenuated based on mean time to moribund state 
compared to infection with TcdA- TcdB+ or wildtype (44). Collectively, these data from 
multiple ribotype 027 strains confirm the previous findings from Kuehne et al. in that both toxins 
are sufficient for diarrheal disease development and lethality (37), but TcdA is less essential and 
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plays an adjunctive role. Recently, a TcdA+ TcdB- clinical isolate was found in a patient with 
fulminant diarrheal disease that resolved after treatment with antibiotics (45). The TcdA+ TcdB- 
only strain could not be detected by conventional diagnostic kits as they rely on TcdB activity. 
Contrary to the only TcdA+ TcdB- clinical isolate reported (45), TcdA-TcdB+ strains are 
frequently isolated from patients with diarrheal disease symptoms (46-48). Taken together, C. 
difficile produces toxins that are necessary for diarrheal disease development in humans and 
certain animal models. 
 
Structure and Mechanism of Action of the Toxins 
 C. difficile toxins TcdA and TcdB are greater than 250 kDa in size and are roughly 50% 
identical in amino acid sequence (10, 49, 50). Both toxins have four functional domains 
designated as ACDB. The Active domain (A) contains the glucosyltransferase domain that 
modifies host substrates. The Cutting domain (C) becomes activated in the host cell cytosol to 
mediate autoprocessing and release of the A domain. The Delivery domain (D) mediates uptake 
and trafficking of the toxin through an endocytic pathway. The Binding domain (B) recognizes 
and binds a host cell surface receptor for subsequent intoxication. Briefly reviewed below are 
important domains, functional characterization, and additional details for each domain.  
 
Step 1: Receptor Binding 
 The Combined Repetitive Oligopeptides (CROPS) domain is the C-terminal tail of the 
toxin and represents the Binding domain. The CROPS domain consists of short amino acid 
repeat sequences regularly interspersed between large amino acid repeat sequences. Protein 
crystallography and molecular modeling studies indicate that the CROPS domain forms a 
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cylindrical coil, or solenoid, built from the short and long repeat sequences at the junctions (51, 
52).  
Evidence for the CROPS domain functioning as the host cell receptor-binding domain 
came from studies evaluating the interaction of TcdA CROPS domain and glycan motifs present 
on rabbit erythrocytes (53), and various blood group glycans present in humans (54). In terms of 
protein receptors, TcdA can bind to gp96, a heat shock protein ER chaperone that is 
posttranslationally modified with carbohydrate sequences (55). Depletion and inhibition of gp96 
expression and activity only partially protected cells from TcdA cytopathicity and intoxication, 
suggesting an additional set of receptors for TcdA (55). A mutant of TcdA lacking the CROPS 
domain remained capable of exerting cytopathic effect on various mammalian cells lines, 
suggesting alternative domains upstream of the CROPS that mediate receptor recognition (56).  
Antibodies targeting the CROPS domain of TcdB reduces disease, suggesting that this 
domain contributes to intoxication (57). Three host cell receptors for TcdB have been identified. 
Yaan et al. identified Chondroitan Sulfate Proteoglycan 4 (CSPG4) as a receptor for TcdB using 
a knockdown system in HeLa cells and screening for resistant clones (58). CSPG4 interacts with 
TcdB via the CROPS domain based on pull down, blocking, and mutant experiments (58). 
However, loss of CSPG4 in mice does not completely protect against TcdB by intraperitoneal 
challenge, suggesting an additional receptor. Moreover, high concentrations of TcdB can kill 
CSPG4 deficient cells, again suggesting another receptor (58). In 2015, LaFrance et al. identified 
nectin-3 (or poliovirus receptor-like protein 3) as a TcdB receptor by screening cells with a 
spectrum of gene knockdown constructs with high concentrations of TcdB and evaluating cell 
viability (59). Knockdown and competitive inhibition of nectin-3 protected cells from TcdB 
destruction (59). CROPS-less TcdB could still infect host cells, suggesting that, like in TcdA, a 
! 10!
domain outside of the CROPS facilitates TcdB interaction with nectin-3 (59). Lastly in 2016, 
Tao et al. identified the Wnt receptor frizzled protein receptor family (1, 2 & 7) as cellular 
receptors for TcdB (60). TcdB bound frizzled proteins independent of the CROPS domain, and 
combined knockdown and knockout of essential and non-essential frizzled genes, respectively, 
mediates cellular resistance to TcdB (60). Mice deficient in non-essential frizzled proteins were 
less susceptible to TcdB pathology (60). If and how TcdB engages all three protein receptors 
during host infection remains to be determined. 
 
Step 2: Toxin Uptake & Translocation 
 TcdA and TcdB bind their respective receptors, and subsequent uptake and translocation 
is dependent on the Delivery domain. The GTPase dynamin mediates toxin endocytosis (61). 
Dynamin is responsible for the scission of vesicles. Clathrin proteins mark the budding vesicles 
to specify the destination. TcdB depends on clathrin for uptake (61), whereas TcdA uses a 
clathrin-independent pathway mediated by PACSIN2 (62).  
 Upon entry, the toxin-containing vesicles are trafficked through endosomes to an 
acidified compartment. Both toxins undergo pH-dependent conformational changes, which 
promotes insertion into the membrane (52). Pharmacological agents that target the vesicular 
ATPase attenuate toxin activity, suggesting a requirement for low pH (63, 64).  
 
Step 3: Activation 
 The Cutting domain of TcdA and TcdB mediates the activation and release of the Active 
domain into the cytosol. Cytosolic inositol hexakisphosphate (InsP6) induces an autocatalytic 
cleavage through binding to the autoprocessing domain (APD) (65, 66), which undergoes a 
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significant conformational change to release the A domain. Three essential residues – cysteine, 
histidine, and aspartate – coordinate a zinc ion for auto processing (67, 68).  
 
Step 4: Target Modification 
 The Active domain of TcdA and TcdB contains the enzymatic domain for host substrate 
modification. The A domain is a glucosyltransferase (GTD) domain. The GTD uses uridine 
diphosphate (UDP)-glucose in the host cell cytosol for host substrate modification (69, 70). The 
GTD targets Rho family proteins, the GTP binding Ras superfamily that regulates the 
cytoskeleton, but also indirectly affects cell cycle progression and apoptosis. The GTD attaches 
the UDP-glucose to a threonine residue in the switch I region of Rho proteins (71). The switch I 
region is essential for GTP binding and interaction with downstream effectors. Modification with 
UDP-glucose prevents switch I from undergoing the conformational changes necessary for GTP 
binding, which is necessary for activity and keeps the protein inactive (71). Glucosylation of the 
Rho proteins is irreversible since humans do not possess glycosidases in the cytosol that can 
cleave the glucose-threonine bond. Both TcdA and TcdB target RhoA, RhoB, RhoC, Cdc42, and 
Rac1, and individually affect other minor substrates (10).  
 
Functional Consequence of Toxin Activity 
TcdA and TcdB indirectly disrupt the actin cytoskeleton, which ultimately activates a 
variety of host cell death pathways. In polarized and confluent cell lines, toxin activity 
compromises tight junctions and results in increased paracellular permeability (72-75). In terms 
of cell death, apoptosis in epithelial cells is dependent on GTD activity and characterized by 
DNA fragmentation, cell shrinkage, and caspase activation (76, 77). The toxins also activate the 
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inflammasome and induce pyroptosis. Inflammasome activation occurs via Pyrin sensing of the 
modification of RhoA, which eventually leads to cleavage of caspase-1 (78). Caspase 1 cleaves 
both pro-interleukin 1ß and interleukin-18, which are released from cells via gasdermin pores 
and the cell lyses from a disrupted concentration and ion gradient (79). Uniquely, TcdB can 
induce necrosis in epithelial cells, independent of the GTD, at high concentrations by activating 
the epithelial NADPH oxidase to make reactive oxygen species (80, 81).  
 
Regulation of Toxin Production 
The glucosylating toxins are subject to diverse regulatory mechanisms beyond TcdR and 
TcdC. How nutrition, sporulation, and quorum sensing control toxin production are reviewed 
below. 
 
A.! Nutritional Control  
 Nutrient limitation during stationary phase in vitro growth conditions of C. difficile are 
optimal for expression and production of the toxins. Early studies found that tcdA, tcdB, tcdR, 
and tcdE are transcribed at low levels in exponential phase, but highly induced upon entry into 
and during stationary phase, whereas tcdC has the inverse expression pattern (82). The addition 
of different nutrient sources to the media was found to activate or repress toxin gene expression 
and production (83). Glucose, fructose, and mannitol repress toxin gene expression during 
exponential and stationary phase (83). Glucose repression of toxin gene expression and 
production was observed for several C. difficile strains and therefore represents a generalizable 
phenomenon.  
! 13!
Carbon catabolite repression allows bacteria to inhibit expression of genes encoding 
machinery necessary for transport and utilization of non-preferred sugars when a preferred one is 
present (84). The process is mediated by the transcriptional regulator CcpA, the carbon catabolite 
control protein A. Bacteria can transport different carbon sources into the cell via the 
phosphoenolpyruvate-dependent carbohydrate: phosphotransferase system. In a ccpA mutant of 
C. difficile, toxin gene expression was constitutive and no longer responsive to glucose (85). In 
addition, mutations in genes encoding different components of the PTS made C. difficile 
unresponsive to glucose-mediated repression of toxin gene expression (85). CcpA was found to 
bind non-specifically to sites upstream of tcdA and tcdB, and two consensus binding sites for 
CcpA were found upstream of tcdR (85). Thus, carbon catabolite repression affects not only 
nutrient utilization, but also virulence factor production in C. difficile like many other pathogens 
(84). 
Branched chain amino acids and GTP levels inversely correlate with toxin production in 
C. difficile (84). In low-GC Gram positive bacteria, the transcriptional regulator CodY directly 
senses GTP and branched amino acids (isoleucine, leucine, and valine) via the N-terminus, and 
the helix-turn-helix DNA binding domain in the C-terminus mediates repression of gene 
transcription during nutritional abundance (86). During nutrient deprivation, or conditions that 
mimic stationary phase where GTP and amino acid pools become limited, CodY becomes 
inactivated, resulting in derepression of genes that promote amino acids availability. A codY 
mutant in C. difficile showed increased expression of the toxin genes (87). In Chip-Seq and 
DNase I protection assays, CodY was found to bind to three regions upstream of tcdR – two 
regions in the tcdR-dependent promoter and one downstream in a !A- dependent promoter region 
(88, 89). In addition, CodY regulation of toxin production is conserved among ribotypes (90). 
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Thus, CodY activity and regulation are conserved in C. difficile as in other Gram-positive 
bacterial pathogens (84). 
 
B.! Sporulation  
 Nutrient limitation is a cue for certain bacteria to undergo sporulation, a process 
involving the formation of metabolically dormant cells that can persist until favorable growth 
conditions resume (91). Genes that are required for or contribute to initiation of sporulation in C. 
difficile also regulate toxin production (92). In B. subtilis, a phosphorelay involving multiple 
sensor kinases activates the master regulator of sporulation Spo0A to activate genes necessary 
for sporulation (91). In tandem, an alternative sigma factor, SigH, is required for expression of 
spo0A (93). In C. difficile, a sigH mutant showed increased toxin gene expression and toxin 
production, indicating that SigH represses toxin production (94). No SigH consensus sequence 
was found in the PaLoc, so the mechanism is undetermined and likely indirect. Mutation of 
spo0A in C. difficile resulted in an increase or decrease in toxin production depending on the 
ribotype and strain lineage (95-97). No Spo0A consensus sequence was found in the PaLoc, 
suggesting an indirect mechanism of regulation. Outside of sporulation initiation, toxin gene 
expression was unaffected in sporulation-specific sigma factor mutants (18, 20). These data 
suggest that the initiation process of sporulation serves as a cue, depending on the strain 
background, to promote toxin production, but upon commitment to the sporulation 
developmental program, toxin gene transcription remains unchanged. In agreement with this 
hypothesis, Edwards et al. found a new regulator of sporulation and toxin production, RstA, that 
represses toxin production and activates sporulation (98). Moreover, recent work from 
Girinathan et al.  sought to determine the role of the sin locus in C. difficile (99). In B. subtilis, 
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SinR is a DNA-binding protein that negatively regulates sporulation and SinR activity is directly 
antagonized by SinI (91, 100). In C. difficile, mutation of sinR reduced expression of spo0A, 
which resulted in an asporogenous phenotype, as well as a significant reduction in production of 
TcdA and TcdB (99). In C. difficile, the SinI orthologue appears more like SinR paralogue and 
was named SinR’ (99). A sinR’ mutant produced significantly more toxin, yet the sinR’ mutant 
still produces SinR (99). The mechanism identified by which SinR and SinR’ control toxin 
production is through c-di-GMP and SigD (discussed later). 
 
C.! Quorum Sensing 
 Quorum sensing (QS) is a process by which bacteria coordinate group behaviors, and QS 
involves the detection, sensing, and transduction of a secreted molecule or peptide based on cell-
density (101).  C. difficile strains possess genes for synthesis of both a peptide based quorum 
sensing system called the accessory gene regulator (Agr) and a second class of small molecule 
called autoinducer-2 involved in interspecies interactions. Mutation of  genes necessary for 
peptide quorum sensing attenuates toxin production and C. difficile virulence likely by 
modulating expression of the flagellar alternative sigma factor, SigD (discussed later) (102, 103). 
The contribution of autoinducer-2 to toxin production is inconclusive due to conflicting reports 
(104, 105). Nonetheless, the contribution of peptide-based QS to C. difficile virulence is 
consistent with studies done in other Gram-positive bacterial pathogens (101). 
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Flagellar Function & Regulation in Clostridium difficile 
 
Conservation and Genetic Organization of Flagellar Genes 
 The flagellar genes are organized into three distinct loci in most C. difficile ribotype 
strains (106). The early stage flagellar biosynthesis locus, based on gene conservation and 
similarity to flagellar gene organization in B. subtilis (107), is the F3 or flgB operon. The flgB 
operon encodes proteins necessary for assembly of the flagellar basal body, rod, motor proteins, 
and the alternative sigma factor SigD (FliA or !28 in Gram negative bacteria). Expression of the 
flgB operon is driven by a single promoter with consensus sequences that match the !A 
housekeeping sigma factor (108). The basal body serves as a structural anchor located in the 
cytoplasmic membrane and through the peptidoglycan. The basal body functions as a conduit for 
the secretion of flagellar proteins involved in late stage assembly of the hook and filaments, and 
also as a rotor for torque generation by the motor proteins. The rod serves as a drive shaft. The 
hook has a curved architecture, is located outside of the basal body, and functions as the joint 
between the basal body and filament. The SigD alternative sigma factor encoded within the flgB 
operon controls transcription of flagellar genes in the late stage F1 and F2 loci (41, 109). The F1 
locus contains genes encoding the flagellar filament, chaperones, the flagellar cap, and a 
glycosyltransferase (106, 110). Regulation of the F1 locus is hypothesized to be restricted until 
hook-basal body completion by the anti-sigma factor FlgM as in B. subtilis (111). The F2 locus 
encodes flagellar glycosylation and other posttranslational modification proteins and is located 
between the F3 and F1 loci. The F2 locus consists of four genes in C. difficile 630, but six genes 
in ribotype 027 strains CD196 and R20291 (110).  
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Glycosylation and Posttranslational Modification of Flagella 
 Flagella can be subject to glycosylation and other modifications to alter function in 
numerous Gram-negative and -positive bacterial pathogens (112). Glycosylation is predicted to 
shield binding sites of flagellin from host immune receptor and antibody recognition, in addition 
to autoagglutination, flagellar assembly, and various other roles (112, 113). In 2009, Twine et al. 
showed using mass spectroscopy that flagellin from C. difficile 630 is glycosylated with a N-
acetyl hexosamime (HexNAc) residue (114). Addition of the HexNAc residue was dependent on 
the glucosyltransferase encoded within the F1 locus. Mutation of the glucosyltransferase gene 
rendered the flagellin protein smaller and unmodified, and the corresponding mutant bacteria 
produced significantly fewer flagellar filaments and were non-motile (114). Analysis of flagellin 
glycan modification in other C. difficile isolates suggested greater complexity in flagellin 
modifications. Faulds-Pain et al. determined that the HexNAc modification was misidentified 
and, based on NMR analysis, was actually a ß-O-linked N-acetylglucosamine (GlcNAc) attached 
to either serine or threonine in the flagellin protein (115). The O-linked GlcNAc addition was 
further modified with a methylated phospho-threonine (115). Mutations of the genes involved in 
posttranslational modification of flagellin led to autoagglutination, increased binding to abiotic 
surfaces, and reduced colonization in a relapsing model of C. difficile infection (115). All of the 
aforementioned studies were done using C. difficile strains harboring 4 genes in the glycosylation 
F1 locus. A recent study from Valiente et al. evaluated the contribution of five out of seven 
genes predicted to contribute to flagellin glycosylation and PTM in ribotype 027 strains(116) . 
Mutation of three predicted glycosyltransferase genes were shown to contribute to the sequential 
addition of ß-O-linked GlcNac, two rhamnoses, and a novel sulfonated peptidyl-amido sugar 
moiety (116). Select F1 loci gene mutants in R20291 were attenuated for motility, had increased 
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biofilm formation and autoagglutination (116). Lastly, all of the F1 mutants tested could 
stimulate host Toll-like Receptor 5 (TLR5), an immune receptor for flagellin recognition, to 
secrete interleukin-8 at levels comparable to the wildtype strain demonstrating that glycosylation 
does not hinder recognition by TLR5 (116). Taken together, glycosylation and PTM of flagellin 
plays variable roles in C. difficile flagellar motility, adherence, and host infection.   
 
Roles of Flagella 
A.!Motility  
Flagella contribute to C. difficile swimming and swarming motility, but the degree of 
motility is ribotype-specific. Stabler et al. found that ribotype 027 strains were more motile than 
ribotype 012 strains (110). However, Valiente et al. revealed heterogeneity in the degree of 
motility even among strains of the 027 ribotype (117). Lastly, as predicted, mutations in 
individual structural and regulatory genes necessary for flagellar biosynthesis abrogated 
flagellum production and impair motility irrespective of ribotype (118-121).   
 
B.! Autoagglutination 
 Surface structures in bacteria can alter their ability to autoagglutinate, or the ability to 
clump together or with host cells. Among clinical isolates, Valiente et al. observed heterogeneity 
in autoagglutination among C. difficile ribotype 027, 176, 198, and 244 strains (117).  Stabler et 
al. found that R20291, which has additional genes in the F2 locus, was attenuated for 
autoagglutination compared to the historical 027 ribotype strains CD196 and BI-1 and ribotype 
012 strain 630 (110). The differences in flagellin posttranslational modification could contribute 
to these autoagglutination differences (115, 116). Many other cell surface factors may contribute 
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to autoagglutination independent of flagella because strain M120, which lacks the flgB operon 
locus, autoagglutinates to a significantly higher degree than all of the other strains tested (110). 
Nonetheless, autoagglutination by flagella could contribute to C. difficile virulence during host 
infection.  
 
C.! Adherence and Colonization 
 The flagellum structure and flagellar-driven motility contribute to bacterial adherence or 
colonization to host epithelial cells in many bacterial pathogens, such as the enteric pathogens 
Campylobacter jejuni and Listeria monocytogenes (113). Flagellar filaments are long structures 
that extend up to 20 micrometers beyond the bacterial cell and can thus probe the host cell 
surface for initial contact. Flagellar-dependent motility can drive filament interaction with great 
force onto the host cell surface (113). Beyond TLR5 (122), there are no reports of a specific 
flagellin or flagellar receptor for bacterial binding. Most of the features that promote flagellar-
dependent adhesion are polymeric protein, glycans, and lipids (113).  
 Flagella contribute to C. difficile adherence to epithelial cells in vitro and host 
colonization in a ribotype-dependent manner. An early study from Tasteyre et al. showed 
recombinant flagellin FliC, the flagellar cap protein FliD, and crude flagella can bind to and 
interact with cecal mucus purified from axenic mice, but not with porcine mucus (123). To 
determine whether flagella contribute to colonization and adherence to mucus in the cecum, 
axenic mice were infected with flagellated or aflagellate C. difficile strains from the same 
serogroup, the mice were sacrified, and cecum removed in an anaerobic chamber to plate for 
colony forming units. With two different serogroup strains, Tasteyre et al. found that flagella 
contribute to adherence to the cecum in axenic mice during infection (123). However, these 
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studies predated tools for targeted genetic modification of C. difficile and relied on comparisons 
of non-isogenic strains. Later work from Dingle et al. using 630∆erm, an erythromycin sensitive 
derivative for gene inactivation using an erm resistance cassette marker, showed that mutation of 
fliC or fliD enhances bacterial adherence to epithelial cells compared to wildtype (118). In 
addition, both mutants colonized the lumen and tissue of the hamster cecum to wildtype levels, 
indicating that flagellar assembly is dispensable in the hamster model of infection. Surprisingly, 
hamsters infected with either the fliC or fliD mutant reached a moribund state sooner than 
wildtype (118). In agreement, Aubry et al. used 630∆erm to generate mutants and observed a 
similar trend in which mutations that inactivate early stage flagellar genes result in attenuated 
virulence in the hamster model, whereas late stage mutants (fliC, fliD) were more virulent and 
animals reached a moribund state sooner (119).  Results from both Dingle et al. (118) and Aubry 
et al. (119) suggested that mutation of late stage genes altered the immunogenicity of C. difficile. 
Both aforementioned studies revealed an increase in toxin production for late stage flagellar gene 
mutants (118, 119), but Aubry et al. noted toxin gene expression and production were attenuated 
for early stage mutants. How are flagellar gene expression and toxin production connected? The 
flagellar alternative sigma factor SigD was demonstrated to control expression and production of 
TcdA and TcdB by activating expression of tcdR (41, 109, 119). Thus, the mutations 5’ of sigD 
in the flgB operon can exert a polar effect on sigD expression resulting in a decrease in toxin 
expression, production, and attenuated virulence of C. difficile during host infection (119). 
Phenotypic characterization of flagellar mutants in R20291 yielded different results. 
Baban et al. found that flagellar gene mutants of R20291, in both early and late stage genes, were 
attenuated for adherence to Caco-2 cells. Allelic exchange was used to generate a paralyzed 
flagellar mutant through mutation of motB, a motor protein, in R20291 (29, 121). The paralyzed 
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flagellar mutant produced wildtype levels of flagellar filaments, but were unable to engage in 
swimming motility due to an inactive motor (121). Survival curves between mice infected with a 
paralyzed flagellar mutant and wildtype were comparable (121). However, wildtype R20291 was 
attenuated for colonization based on bacterial burden relative to the paralyzed flagellar mutant 
suggesting that motility-driven colonization is dispensable and instead the flagellar filaments 
serves as a scaffold to promote mucus and host cell interactions. To support the filament-
colonization hypothesis,  axenic mice were co-infected with the paralyzed flagellar mutant and a 
fliC mutant and the paralyzed flagellar mutant outcompeted the fliC mutant for colonization in 
the cecum (121). Notably, studies from this paper should be interpreted with caution, since their 
R20291 strain produced a single flagellum (121), which has never been observed in our R20291 
isolate, any other published ribotype 027 strains, or clinical isolates of C. difficile.  
 
Regulation of Flagellar Gene Expression 
Prior to our studies, a single cis-acting regulatory element was identified to control 
flagellar gene expression in C. difficile. The nucleotide second messenger cyclic diguanylate (c-
di-GMP) is synthesized from two GTP molecules by diguanylate cyclases (DGC) and 
hydrolyzed into pGpG by phosphodiesterases (PDE) (124). Cyclic diguanylate regulation 
contributes to numerous phenotypes in bacteria, to include motility, biofilm formation, and 
virulence factor production (124). Cyclic diguanylate binds directly to the Cd1 riboswitch in the 
leader RNA of the flgB operon, resulting in an altered conformation of the mRNA leader that 
controls downstream gene expression. (125). In the absence, or in low-levels, of c-di-GMP, 
transcriptional elongation through Cd1 is uninterrupted and the downstream genes are 
transcribed. In the presence of higher concentrations of c-di-GMP, the nucleotide binds to the 
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riboswitch, alters RNA base pairing in a manner that results in the formation of an intrinsic 
transcription terminator. Thus, c-di-GMP triggers premature transcription termination within the 
flgB leader sequence, precluding transcription of the downstream genes (108, 125). Consistent 
with this, artificially increasing intracellular c-di-GMP in C. difficile through the ectopic 
expression a DGC inhibited flagellar gene expression and impeded motility (108, 126).  
Numerous transcriptional regulators control flagellar gene expression and motility in C. 
difficile. Activators of flagellar motility include AgrA (102), Hfq (127), and SinR (99) (Figure 
1.1). As previously mentioned, AgrA is a quorum-sensing regulated transcription factor. An 
agrA mutant was shown to be attenuated in transcription of flagellar genes by RNA-seq and 
production of flagella by electron microscopy (102). The mechanism of flagellar gene regulation 
by Agr QS could be through the Cd1 riboswitch since several PDEs were differentially regulated 
in the agr mutant  (102). An additional regulator, Hfq, was demonstrated by Boudry et al. to 
control flagellum production in C. difficile (128). Hfq is an RNA chaperone that promotes base-
pairing of regulatory RNAs, specifically trans-acting that have limited sequence 
complementarity, to target messenger RNAs (129). Boudry et al. were unable to generate a 
mutation in hfq and thus relied on antisense RNA-mediated depletion of target RNA and protein 
synthesis (127). Data (not shown in the manuscript) suggested that depletion of Hfq results in 
reduced motility and the loss of flagella (127). RNA-seq experiments identified a variety of 
differentially expressed genes, however, no changes in flagellar gene expression were observed 
(127). Interestingly, depletion of Hfq resulted in a significant increase in expression of both sinR 
and a DGC gene, but a decrease in the expression of a PDE gene (127). Based on the Hfq 
depletion RNA-seq results, Hfq could possibly control flagellar motility through altering c-di-
GMP metabolism genes that either transcriptionally, post-transcriptionally, or post-
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translationally control flagellar motility. Lastly, SinR was recently described to serve as an 
activator of flagellar motility through repression of a DGC gene, dccA (99, 126). By HPLC 
analysis, the sinR mutant had an over three-fold increase in the intracellular concentration of c-
di-GMP relative to the wildtype strain (99). Taken together, Agr QS, Hfq, and SinR appear to 
activate flagellar gene expression through modulation of genes that would reduce the 
intracellular concentration of c-di-GMP, which could promote transcriptional readthrough at the 
Cd1 riboswitch. 
Repressors of flagellar motility and gene expression include RstA (98), SinR’ (99), and 
SigH (94) (Figure 1.1).  All three aforementioned regulators have been demonstrated to control 
toxin gene expression and production in C. difficile by regulation of sigD expression or activity. 
Briefly, Edwards et al. demonstrated that RstA affects transcription of sigD and fliC, suggesting 
RstA regulates transcription of the flgB operon either directly or indirectly (98). The Helix-Turn-
Helix (HTH) domain of RstA was deemed essential for regulation of motility since 
complementation of the rstA mutant with RstA∆-HTH failed to restores fliC expression (98). An 
additional repressor, SinR’, was found by Girinathan et al. to negatively regulate flagellar 
motility by directly antagonizing the activity of SinR, a positive regulator of flagellar gene 
expression (99). Lastly, mutation of the alternative sigma factor, SigH, in C. difficile was found 
to have increased expression of fliC and sigD in stationary phase relative to wildtype (94). The 
regulatory mechanisms by which SigH and RstA in C. difficile repress flagellar gene expression 
have yet to be determined. Nonetheless, many of the positive (i.e., Agr QS and SinR) and 
negative (RstA, SinR’, and SigH) regulators of flagellar motility also affect toxin production 
through sigD expression or activity, which highlights the intimate link between both virulence 
factors in C. difficile.  
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Host Immune Response to Flagella 
 C. difficile expresses flagellar genes during host infection that result in an antibody 
response. Early studies from Pechin et al. found that sera from patients diagnosed with CDI had 
antibodies targeting different components of the flagellum, including the flagellin FliC and the 
flagellar cap protein FliD (130). An antibody response to FliC and FliD was observed during 
stages of CDI with fulminant diarrheal disease symptoms highlighting the link between flagella 
and toxin production (130).  
A role for innate immune recognition of C. difficile flagellin has been largely 
inconclusive until recently. Host TLR5 can recognize bacterial FliC through specific interactions 
with a conserved domain of FliC as long as certain amino acids are conserved (122, 131). To 
date, all sequenced strains of C. difficile retain the conserved amino acids necessary for 
recognition by TLR5. However, Jarchum et al. found that TLR5 deficient mice were no more 
susceptible to infection than wildtype, suggesting that TLR5 does not play a role in recognition 
of C. difficile flagella during infection to mount a protective (or detrimental) immune response 
(132). Data from subsequent studies challenged the hypothesis that C. difficile flagellin fails to 
stimulate TLR5 during host infection. Yoshino et al. demonstrated in cell culture experiments 
with intestinal epithelial cells that recombinant FliC from C. difficile was sufficient to activate 
both NFkB and p38 MAPK signaling via TLR5 (133). In addition, recombinant FliC induced 
secretion of chemokines IL-8 and CCL20, which function in recruitment of neutrophils to the 
site of infection (133). More significantly, authors found that pretreatment of cell monolayers 
with TcdB to disrupt tight junction between epithelial cells further enhanced the host response to 
FliC (133). TLR5 is largely restricted to the basolateral face of intestinal epithelial cells and 
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damage to tight junctions enhances TLR5 engagement with FliC (134, 135). Work from Batah et 
al.(136)  also corroborated findings from Yoshino et al. (133). The aforementioned studies were 
done in cell culture, but what about the host response to C. difficile FliC during infection? Later 
work from Batah et al. showed that a fliC mutant of R20291 failed to elicit diarrheal disease 
symptoms or clinical manifestation, with very little pathology observed compared to infections 
with the wildtype parent (137). In addition, a fliC mutant  failed to activate NFkB signaling 
during infection (137), which corroborates previous cell culture phenotypes (136).  Batah et al. 
further evaluated a paralyzed flagellar mutant during host infection and found the mutant elicited 
symptoms and pathology comparable to infection with the wildtype parent. In TLR5 deficient 
mice, very little pathology was observed in cecal tissue in terms of inflammation, and no animals 
developed symptoms of disease. When the cell culture and host infection studies are taken 
together (133, 136, 137), TLR5 activation in intestinal epithelial cells by C. difficile FliC 
stimulates a detrimental host response (Figure 1.2). TLR5 deficient mice were resistant to 
damage mediated by FliC stimulation in synergy with toxin activity (137). The aforementioned 
studies are contradictory to previous findings from Jarchum et al (132). The differences among 
the studies may be attributable to the C. difficile strains used. The Jarchum et al. paper used C. 
difficile strain VPI10463, which overproduces the toxins relative to clinical or laboratory strains 
(138). The increased toxin production by VPI10463 may severely damage intestinal epithelial 
cells prior to engaging C. difficile FliC via TLR5, although this is conjecture. Nonetheless, C. 
difficile flagellin, in combination with the toxins, stimulates a detrimental host response during 
infection that leads to severe pathology and death.    
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Phase Variation of Virulence Factors in Bacteria 
 
Definition and Genetic Mechanisms of Phase Variation 
Phenotypic diversity in a clonal population of bacteria can be generated through a process 
known as phase variation (139-141). Phase variation involves the stochastic or regulated 
production of secreted or cell surface proteins in an ON/OFF manner. The overarching 
hypothesis is that phase variation contributes to host immune evasion during infection to 
promote bacterial persistence and transmission. Secreted and cell surface gene products in 
bacteria are often immunostimulatory, thus finely tuned expression and production of these 
antigens could prevent detection and clearance by the host immune system. 
A variety of genetic mechanisms can generate phase variation of bacterial gene products 
in a population (139, 140, 142). An essential requirement is that the nucleotide identity in a DNA 
sequence remain unchanged relative to the parental clone, in contrast to a missense mutation. In 
addition, phase variation occurs at a frequency higher than that of a standard mutation. The 
ON/OFF expression of the bacterial gene product is heritable, meaning the daughter cells inherit 
the expression phase of the parent. Although seemingly contradictory, the expression is 
reversible, meaning that under select conditions expression of the gene product can switch to the 
opposite phase. In addition, the fitness benefit conferred to a population is a bet hedging strategy. 
If and when the population encounters conditions that favor one phase over another a small 
subpopulation can persist and continue to divide. Briefly, we review three genetic mechanisms of 
phase variation, to include slip strand mispairing, gene conversion, and conservative-site specific 
recombination, and provide a well-studied example in a bacterial pathogen. 
A.! Slip Strand Mispairing (SSM) 
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 Single or short repeat sequences of 1 to 7 nucleotides can expand or contrac during DNA 
replication between the template and daughter strands in a process called slip strand mispairing 
(SSM) (143). The increase or decrease in the size of repeat elements in the operator, promoter, 
leader, or coding sequence of a gene can affect expression. In Campylobacter jejuni, flagellar 
motility is phase variable due to slip strand mispairing in the coding sequence for both the sensor 
histidine kinase and response regulator of the FlgSR two component system (144, 145). FlgSR 
activates transcription of genes with promoters that are !54-dependent, such as the flagellar basal 
body, rod, and hook genes. Flagella are essential for C. jejuni commensal colonization of chicks 
(146), and non-motile phase variants of C. jejuni are attenuated for chick colonization (144, 145). 
SSM is one mechanism present in bacteria that can generate phenotypic diversity (143).  
B.! Gene Conversion  
 Gene conversion involves the homologous recombination of a silent allele with the 
expression allele of a gene to generate diversity in gene products (139, 147). Gene conversion 
requires proteins involved in DNA repair, such as RecA, and recombination is unidirectional. 
Gene conversion occurs at a much higher frequency than general homologous recombination in 
that it requires less sequence identity to recombine and involves accessory factors. The best 
described example in the literature involves the type IV pilin pilE gene from Neisseria 
gonorrheae, which contribute to DNA transformation and host cell attachment (148). The pilin 
protein has a region of functionality reserved to the N-terminus (~2/3), whereas the C-terminus is 
variable and surface exposed. The gonococcal genome encodes up to 19 silent alleles of pilE 
known as pilS, which consist of full-length or truncated versions of pilE with limited homology 
(148). Type IV pilus biogenesis is phase variable in that select silent alleles encode frameshift or 
nonsense mutations that result in pilus OFF bacteria that evade host antibodies targeting pilin 
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proteins. Given the diversity of pilS in a gonococcal genome, gene conversion allows pilus ON 
bacteria to evade host antibodies targeting antigenically distinct pilin proteins (149)  
C.! Conservative Site-specific Recombination 
 Conservative site-specific recombination involves recombination of a short region of 
DNA with limited homology (139, 147). A serine or tyrosine recombinase can mediate inversion, 
insertion, or excision of a DNA element based on the limited homology (150-152). DNA 
inversion can occur in the regulatory or coding sequence of a gene to affect expression or 
activity. The best studied system for DNA inversion has been the fimbrial switch (fimS) that 
controls the Type I fimbrial operon (fimA) in E. coli. FimS consists of a 296 bp DNA element 
flanked by 9 bp inverted repeats (153). The switch contains a promoter that in an orientation-
dependent manner facilitates transcription of the fimA operon and either fimbriae are produced or 
not on the bacterial surface. Two recombinase genes located upstream of fimS recognize and 
catalyze DNA inversion. FimB can perform inversion in both orientations whereas FimE 
functions exclusively in recombination from the ON to OFF orientation (154). Functionally, 
Type I fimbriae contribute to E. coli adherence and invasion of epithelial cells in the bladder. 
Genetically phase locked fimS ON bacteria outcompete fimS OFF bacteria in colonization of the 
bladder during mouse infection (155). Many other bacterial pathogens, including Salmonella 
enterica serovar Typhimurium and Streptococcus pneumoniae (139, 156-158), use DNA 
inversion elements to control production of surface proteins and molecules that contribute to 
colonization, biofilm formation, and virulence during host infection.   
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Phase Variation in Clostridium difficile 
 Prior to our research, Cell wall protein Variable (CwpV) was the only gene product 
characterized to undergo phase variation in C. difficile (159). CwpV is a cell surface anchored 
protein with a unique C-terminal domain consisting of serine-glycine rich repeat elements (159). 
The amino acid composition and number of repeat elements in the C-terminus of CwpV was 
shown to be consistent within, but varies among, ribotypes (159, 160). Emerson et al. 
demonstrated that CwpV production was restricted to ~5%  of bacterial cells in a population 
using flow cytometry and indirect immunoflurorescence (159). Sequencing of the region 
upstream of cwpV lead to the identification of a genetic switch (159). A 195 bp element, termed 
the cwpV switch, was flanked by imperfect 21 bp inverted repeats (159). Emerson et al. 
identified a !A –dependent promoter upstream of the cwpV switch and found that the switch 
regulates cwpV post-transcription initiation. In the cwpV ON orientation, transcription initiates 
from the !A –dependent promoter and elongation proceeds uninterrupted into the cwpV coding 
sequence for expression (159) (Figure 1.3). In the cwpV OFF orientation, transcriptional 
initiation is unchanged, but the mRNA at the junction of the distal inverted repeat and the switch 
adopts the stem-loop structure an intrinsic terminator to prematurely terminate cwpV expression 
(Figure 1.3). Furthermore, a single tyrosine recombinase was identified to be necessary and 
sufficient for inversion at the cwpV switch and renamed recombinase variable (RecV) (159, 160). 
 Phase variable production of CwpV in C. difficile has been shown to contribute to 
bacterial aggregation and bacteriophage resistance (159, 160). Reynolds et al. demonstrated that 
CwpV overexpression, specifically the repeat elements in the C-terminus, promotes bacterial 
aggregation in vitro (159, 160). Based on this phenotype, Reynolds et al. hypothesized that 
CwpV promotes bacterial colonization during host infection. In a tangentially related study, 
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Sekulovic et al. found that lysogenic conversion of C. difficile strain R20291 with CD38 phage 
resulted in all cwpV phase ON cells (161). Based on these findings, Sekulovic et al. hypothesized 
that CwpV is a remnant of a prophage that prevents phage superinfection by blocking additional 
phage from binding to the cell surface (161). In subsequent work, Sekulovic et al. tested this 
hypothesis and demonstrated that CwpV mediates evasion to bacteriophage (162). Specifically, 
CwpV was found to reduce phage adsorption (partially) and through an unknown mechanism 
prevent phage tail spike DNA injection (162) (Figure 1.3). Beyond characterization of CwpV 
and RecV, to date, no other genetic switches had been characterized.  
Stabler et al. identified two additional DNA inversion sites by comparing C. difficile 
genomes and named them C. difficile inversion sites 2 and 3 (110). Cdi1 was the cwpV genetic 
switch (110, 159). Cdi2 and Cdi3 were found upstream of c-di-GMP phosphodiesterases (163, 
164). However, Cdi2 and Cdi3 have not been demonstrated to control expression of the 
phosphodiesterases.  Nonetheless, phase variation by DNA inversion may be one understudied 
mechanism by which C. difficile generates phenotypic diversity.   
 
Summary 
Flagella contribute to C. difficile adherence and inflammation during infection (14). The 
majority of human-specific C. difficile strains contain genes for hierarchical assembly of flagella 
(106, 110). C. difficile produces flagella that aid in motility and adherence to the intestinal 
epithelium (114, 118, 119, 121). We and others demonstrated that SigD, the flagellar alternative 
sigma factor that activates late flagellar genes, indirectly activates the toxin genes, tcdA and tcdB 
(41, 109, 119). Both toxins inactivate substrates that regulate the actin cytoskeleton in epithelial 
cells to disrupt intestinal barrier function (10, 50, 69, 70). These events can lead to detection of 
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flagellin, the primary structural component of flagellum, by TLR5 on the basolateral epithelial 
surface (133). The synergy of C. difficile toxin activity and flagellin detection by TLR5 leads to 
the secretion of inflammatory cytokines and chemokines by epithelial cells and greater pathology 
during mouse infection (133, 136, 137). Yet clinical isolates of C. difficile exhibit phenotypic 
variability in flagellum production (114, 123, 165), and likely toxin production, that could 
contribute to evasion of host immune detection given their respective immunostimulatory 
profiles. What contributes to phenotypic heterogeneity in C. difficile flagella and toxin 
production, and the impact of this regulation on virulence are largely unknown.   
We identified a new cis-acting regulator of flagellar gene expression in C. difficile. The 
leader RNA of the flgB operon is an unusual 498 nt compared to the average of 50 nt in E. coli 
(108). Previous work identified a c-di-GMP sensing riboswitch in the leader RNA, but this cis-
acting regulatory element terminates transcription elongation in the 5’ most 160 nt (108, 125). 
This begs the question, is there an additional cis-acting regulatory element present in the 
remaining 338 bp to control flagellar gene expression? Using bioinformatics tools, we identified 
a putative flagellar switch consisting of a 154 bp sequence, whose orientation varied among 
strains, flanked by 21 bp inverted repeats. We hypothesized that the flagellar switch enables 
phase variable production of flagella and toxins by DNA inversion in C. difficile. Phase variation 
involves the stochastic production of surface proteins in a bacterial population to generate 
phenotypic diversity for optimal fitness in diverse conditions (139). The rationale supporting our 
hypothesis is based on previous work showing phase variation of fimbriae in E. coli (153), 
flagella in Salmonella enterica serovar Typhimurium (156, 157), and a bacteriophage defense 
protein in C. difficile (159, 162) all by DNA inversion.  
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In our research, we have found that phase variation by DNA inversion controls 
production of flagella and toxins in C. difficile strain R20291 at a high frequency (Chapter 2). A 
single strain family designated as “ribotype 012” of C. difficile exhibits low frequency inversion 
of the flagellar switch in laboratory-adapted, environmental, and clinical isolates (Chapter 3). 
The gene regulatory mechanism by which the flagellar switch controls downstream flagellar 
gene expression involves the transcription terminator Rho factor (Chapter 4). And in the final 
section (Chapter 5), we further speculate on these published and unpublished studies in the 






Figure 1.1. Positive and negative regulators of flagellar gene expression. A simplified 
schematic of the flgB operon with SigD regulation of the PaLoC. Negative regulators of flagellar 
gene expression include c-di-GMP, RstA, SinR’, and SigH. Positive regulators of flagellar gene 
expression include Agr QS, Hfq, and SinR. The mechanisms by which many of these regulators 
control flagellar gene expression (promoter, leader, or post-translation) are largely unknown  
except for c-di-GMP through the Cd1 riboswitch (not shown). In addition, SigD can associate  
with RNAP to activate expression of late stage flagellar genes like fliN, flgM, and fliC. Lastly, 



















Figure 1.2. Synergy of flagellin and toxin activity in the host intestine. C. difficile (depicted 
in green) engaging in swimming motility interacts with mucus (yellow) in the intestine and a 
subpopulation penetrates to adhere to intestinal epithelial cells (light brown). Under certain 
conditions, C. difficile produces TcdA and TcdB (orange and blue structures) that intoxicate host 
cells leading to disruption of the actin cytoskeleton and epithelial tight junctions. Flagellin 
monomers (black sticks) can interact with TLR5 on the basolateral surface after toxins have 
destroyed barrier function. TLR5 ligation stimulates signaling pathways that further potentiate 
inflammation and lead to the recruitment of neutrophils to the site of infection (purple circles). 





Figure 1.3. The cwpV switch affects C. difficile interaction with bacteriophage. (A) The 
cwpV switch is in the ON orientation and transcription elongation proceeds unhindered. CwpV is 
attached to the cell wall and resists predation by a bacteriophage. (B) The cwpV switch is in the 
OFF orientation and transcription elongation is interrupted by an intrinsic terminator resulting in 
premature termination and a failure to express cwpV. Lacking CwpV in the cell wall, C. difficile 
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CHAPTER 2: A GENETIC SWITCH CONTROLS THE PRODUCTION OF FLAGELLA 
AND TOXINS IN CLOSTRIDIUM DIFFICILE1 
Summary 
Clostridium difficile is a bacterial pathogen that causes antibiotic associated diarrheal 
disease. Colonization of host tissues is a prerequisite step to disease development during 
bacterial infection. C. difficile produces flagella, which are proteinaceous structures on the 
bacterial surface that confer motility and participate in adherence to the host intestine. SigD, a 
regulator that coordinates flagellar gene expression, also activates expression of the toxin genes 
in C. difficile. Therefore, mechanisms controlling expression of flagellar genes, including sigD, 
will likely impact the severity of C. difficile infection given the impact on toxin production. In 
this body of work, we identified a genetic ON/OFF switch, which we term the “flagellar switch”, 
encoded upstream of the flagellar genes. The orientation of the flagellar switch determines 
whether or not C. difficile produce flagella, engage in swimming motility, and secrete toxins. We 
identified the enzyme that catalyzes inversion of the flagellar switch. Inactivation of the 
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corresponding gene resulted in bacteria with the flagellar switch locked in the either the ON or 
OFF orientation, with concomitant effects on flagellum and toxin biosynthesis. The flagellar 
switch may represent a new regulatory strategy to coordinately control virulence determinants 
independent of previously described regulators. 
 
Introduction 
Clostridium difficile, a Gram-positive, spore-forming obligate anaerobe, is the leading 
cause of nosocomial disease in North America, Europe and Australia (1, 2). The Centers for 
Disease Control and Prevention list C. difficile infections (CDI) as an urgent threat related to the 
use of antibiotics (3). Antibiotic use perturbs the gastrointestinal microbiota that normally 
protects against CDI (1, 4). The rates of recurrence and mortality associated with CDI have 
increased in part due to the emergence of epidemic-associated strains with enhanced sporulation 
rates and toxin production (1, 5, 6). The C. difficile PCR ribotype 027 group is associated with 
greater odds of diarrheal disease severity, outcome, and death compared to many other PCR 
ribotypes (7). Therefore, an understanding of bacterial physiology and genetics in different 
strains of C. difficile ribotype 027 could reveal unique therapeutic or diagnostic targets to 
ameliorate severe CDI.  
C. difficile is primarily transmitted as metabolically dormant spores, which germinate 
into actively growing vegetative cells in response to amino acids and bile salts such as glycine-
conjugated taurocholate (8-10). CDI ranges in severity from mild self-limiting diarrhea to 
fulminant colitis characterized by neutrophil infiltration into the lamina propria, erosion of crypts 
and goblet cells, and extensive epithelial tissue damage. Diarrheal disease is associated with 
strains that produce the glucosylating toxins TcdA and/or TcdB (11, 12). Both TcdA and TcdB 
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glucosylate Rho and Rac GTPases in host cells to promote actin depolymerization, destruction of 
tight junctions at the mucosal barrier, and inflammation (13-16). The glucosylating toxins are 
necessary for diarrheal disease in both the mouse and hamster models of infection, with TcdB 
playing a more prominent role (11, 12, 17).  
Colonization is a requisite step to diarrheal disease, and the bacterial surface structures, 
such as flagella, that participate in colonization are an active area of study. The flagellar 
apparatus confers motility and contributes to adherence, colonization, and disease in C. difficile 
(18-20). Flagellum biosynthesis genes are conserved in most sequenced C. difficile strains (19, 
21). As in other bacterial species, flagellar gene transcription occurs in a hierarchical order to 
ensure proper protein assembly and to conserve energy. The early stage flagellar operon contains 
genes for assembly of the basal body. SigD (σD), the flagellar alternative sigma factor, is 
encoded in the early stage flagellar operon and activates the transcription of the late stage 
operons (22, 23). At least four operons contain late stage flagellar genes involved in assembly of 
the flagellar hook, filament, and cap, and for post-translational modification of the flagellar 
filament (18, 22, 24-26). Flagellar arrangement is peritrichous in most strains (18, 27-31).  
The flagellar apparatus contributes to C. difficile fitness during gastrointestinal infection 
in a ribotype-dependent manner (20). In C. difficile 630Δerm (ribotype 012), flagella are 
dispensable for adherence to cultured epithelial cells and colonization in the murine model (31, 
32). In contrast, in the epidemic-associated C. difficile strain R20291 (ribotype 027), flagellar 
filaments promote adherence and colonization in vitro and during infection of mice (31). 
Flagellar motility is not required for adherence in this strain, as a MotB mutant that produces 
flagellar filaments with a nonfunctional motor displays wild type adherence (31). Interestingly, 
mice infected with the R20291 fliC mutant succumb to infection, whereas mice infected with the 
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parental strain do not (31). The R20291 fliC mutant has altered expression of genes involved in 
motility, membrane transport, sporulation, and metabolism in vitro (33), which may explain the 
enhanced virulence in mice. Post-translational modification of flagella also contributes to 
colonization kinetics in a mouse relapse model of infection in M68, an 017 ribotype strain (24). 
In the hamster model, C. difficile 630Δerm strains with a mutation in several early stage flagellar 
genes showed reduced virulence, whereas mutations in the late stage flagellar genes fliC and fliD 
generally showed increased virulence (22, 32). Several groups have observed that a 630Δerm 
fliC mutant produces more toxin, which may contribute to the increased virulence of the mutant 
(22, 31, 32). The animal model-dependent differences in virulence phenotypes of the flagellar 
gene mutants may be attributed to the greater sensitivity of hamsters to the glucosylating toxins 
(34), and to higher spore germination rates of C. difficile spores in hamsters than in mice (35).  
Notably, the expression of the glucosylating toxin genes is linked to flagellar gene 
expression in C. difficile (20, 36). TcdA and TcdB are encoded on a Pathogenicity Locus 
(PaLoc) along with the TcdR sigma factor that positively regulates tcdA and tcdB (37), the anti-
sigma factor TcdC suggested to inhibit TcdR function (38-41), and the TcdE holin-like protein 
suggested to be involved in toxin export (42, 43). Preliminary studies suggested that σD affects 
the expression of the glucosylating toxin genes (22). Subsequent work identified a σD consensus 
sequence in the tcdR promoter (23, 44). Overexpression of sigD in C. difficile increases toxin 
production in a TcdR-dependent manner (44), and recombinant σD with RNA polymerase 
directly binds the tcdR promoter (23). Taken together, these studies highlight a regulatory link 
between virulence factors critical to host colonization and to disease symptom development in C. 
difficile, similar to other diarrheal bacterial pathogens, such as Vibrio cholerae and 
Campylobacter jejuni (45, 46). 
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C. difficile flagellin and the glucosylating toxins stimulate pathogen recognition receptors 
(47-49), which promote pathogen clearance mechanisms, and therefore their production must be 
subject to precise regulation to avoid host recognition. In addition to σD, several transcriptional 
regulators modulate toxin production in C. difficile, potentially via regulation of flagellar gene 
expression. Spo0A, SigH, and RstA inhibit expression of the flagellar and toxin genes (50-53), 
while Agr quorum sensing and Hfq are positive regulators (29, 54). The exact mechanisms by 
which these regulators control flagellar and toxin gene expression are largely unknown.  
Cyclic diguanylate (c-di-GMP) is a nucleotide second messenger that controls a 
multitude of bacterial processes, such as flagellar motility, biofilm formation, and virulence 
factor expression (55-58). In C. difficile, c-di-GMP regulates swimming motility, cytopathicity, 
Type IV-pilus dependent surface motility and biofilm formation (30, 44, 59, 60). Specifically, 
elevated c-di-GMP inhibits flagellar gene expression and swimming motility (59), and also 
negatively regulates toxin gene expression as a result of reduced sigD transcription (44). 
Flagellar gene regulation occurs via a c-di-GMP sensing riboswitch, Cd1, located in the 5’ 
untranslated region of the early stage flagellar operon (61). c-di-GMP binding to Cd1 causes 
premature transcription termination, resulting in a truncated transcript of 160 nt of the 5’ 
untranslated region (62).  
Here, we describe the identification and characterization of an additional cis-acting 
regulatory element that mediates phase variable expression of flagellar genes and, consequently, 
the toxin genes. We identified a flagellar switch consisting of 154 bp flanked by 21 bp imperfect 
inverted repeats, between the Cd1 riboswitch and the first open reading frame in the early stage 
flagellar operon. The orientation of the flagellar switch controls downstream flagellar gene 
expression, including sigD, and therefore production of flagella and swimming motility. 
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Furthermore, the flagellar switch affects transcription of the toxin genes by way of σD, impacting 
the production of the glucosylating toxins and the cytotoxicity of C. difficile. We provide 
evidence that regulation through the flagellar switch occurs post-transcription initiation. Lastly, 
we identified RecV, which also controls phase variation of the cell wall protein CwpV, as the 
recombinase responsible for inversion at the flagellar switch in both directions.  Together these 
findings indicate that flagellar motility and toxin production are subject to phase variation in C. 
difficile, thus identifying an additional level of regulation of these linked processes. Flagellar and 
toxin phase variation in C. difficile may confer an advantage to the bacterium during infection of 
the gastrointestinal tract as a bet hedging strategy to either promote colonization and 
inflammation at certain tissue sites or persist and evade host immune stimulation.  
 
Results 
In silico identification of a flagellar switch upstream of the early flagellar biosynthesis operon 
Soutourina, et. al., identified a single transcriptional start site (TSS) for the early flagellar 
operon in C. difficile strain 630Δerm, located nearly 500 nucleotides (nt) upstream of the start 
codon for flgB, the first gene in this operon (62). The flgB operon is also termed the “F3 locus” 
elsewhere (21). The promoter for the flgB operon contains a σA consensus sequence (62). The 
first 160 nt of the 5’ untranslated region (UTR) of the flgB operon contains a class I (GEMM) c-
di-GMP riboswitch, previously named Cd1 (61). Binding of c-di-GMP to Cd1 causes premature 
transcription termination, preventing flagellar gene transcription and inhibiting swimming 
motility (59, 61, 62). Notably, an additional 338 nt lie between the Cd1 termination site and the 
start codon of flgB. We speculated that the remaining 338 nt of the 5’ UTR contains an additional 
regulatory element that controls expression of the flgB operon. To explore this possibility, we 
! 56!
used Clustal Omega (63) to generate multiple sequence alignments and examine the 5’ UTR of 
the flgB operon for regions of reduced sequence identity. Assuming the TSS is conserved in all 
strains, we found that all C. difficile genome sequences currently available through NCBI contain 
a 498 nt 5’ UTR, except 630 which has a 496 nt 5’ UTR. Strains of the 027 ribotype, which is 
associated with epidemics of CDI, were used for further analysis: CD196 (NCBI Accession No. 
FN538970.1), R20291 (FN545816.1), 2007855 (FN665654.1), and BI1 (FN668941.1) (19, 64, 
65). The 5’ UTRs of three strains exhibited 100% sequence identity, but BI1 had only 66.2% 
identity in a 154 bp region (Fig. 2.1A). Upon further scrutiny of the region, we identified near 
perfect 21 bp inverted repeats flanking the 154 bp region: 5’- 
AAGTT(A/G)CTAT(A/T)TTACAAAAAA-3’ (Left inverted repeat). The presence of a 
sequence flanked by inverted repeats located upstream of genes encoding an immunostimulatory 
surface structure suggested a regulatory mechanism involving phase variation by site specific 
DNA recombination. These features reflect a regulatory mechanism employed by numerous 
mucosal bacterial pathogens to stochastically control the expression of cell surface structures that 
may be immunostimulatory, therefore promoting immune evasion and persistence in a host (66). 
We reasoned that the reduced sequence identity for BI1 at the 154 bp region could be due to 
DNA inversion between the inverted repeats. To test this, we repeated the multiple sequence 
alignment using the antiparallel, “inverse” sequence for the 154 bp sequence for BI1 and 
observed restoration of 100% identity to the other ribotype 027 sequences (Fig. 2.1A). Based on 
these in silico findings, we hypothesized that the 154 bp sequence undergoes inversion via site-
specific recombination, and we term this the “flagellar switch” herein.  
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The flagellar switch undergoes DNA inversion 
If the 154 bp sequence is capable of undergoing DNA inversion, we expect to detect the 
flagellar switch in both of the orientations in C. difficile, at least under some growth conditions. 
To test this, we used an orientation-specific PCR assay to detect and differentiate between the 
two orientations of the putative flagellar switch in multiple C. difficile strains grown in liquid 
medium (Fig. 2.1B) (67, 68). We use “published orientation” to refer to the sequence present in 
the indicated published genome for the given strain, and “inverse orientation” to refer to a 
sequence with an inversion between the inverted repeats. A common reverse primer, Rv, 
complementary to the flgB coding sequence was used in all PCRs (Fig. 2.1B, black). To detect 
the flagellar switch in the published orientation, we used a ribotype-specific forward primer F1 
that anneals immediately 3’ of the left inverted repeat (LIR) (Fig. 2.1B, green). To detect the 
flagellar switch in the inverse orientation, we used a forward primer F2 that anneals immediately 
5’ of the right inverted repeat (RIR) (Fig. 2.1B, red). Primers F1 and F2 are reverse-
complementary. The primer pairs yield different products of different sizes depending on the 
orientation of the template sequence, and the sizes vary somewhat depending on the strain. We 
detected PCR products for both the published and inverse orientations for R20291 (FN545816.1) 
and ATCC 43598 (017 ribotype, sequence read archive SRX656590) (Fig. 2.1C). DNA 
sequencing of the PCR products confirmed the orientation of the template sequences. 
Furthermore, DNA sequencing suggests that DNA strand exchange for recombination would 
have to occur at or after position 12 of the IRs, because the 6th and 11th nucleotides that are not 
conserved do not change. We were unable to detect a PCR product for the inverse orientation for 
630Δerm (Fig. 2.1C), a commonly used laboratory-adapted strain. Unlike the other published C. 
difficile genomes, 630Δerm and its parental strain, 630, have shorter 20 bp IRs with an adenosine 
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absent from the 3’ end of the LIR and a thymidine absent from the 5’ end of the RIR. The length 
of IRs can impact DNA inversion (68), which may explain the lack of an inverse product for 
630Δerm. Collectively, these data indicate that at least some C. difficile strains grow in broth 
culture as a heterogeneous population of bacteria with the flagellar switch in the published or 
inverse orientation, supporting our hypothesis that the flagellar switch undergoes site-specific 
recombination. Based on the previously identified inversion sites in the C. difficile genomes (69), 
we designate the flagellar switch site as Cdi4. 
 
Quantifying the frequency of flagellar switch orientation in enriched flagellar phase variant 
populations 
We optimized an unbiased asymmetric PCR-digestion assay to distinguish the orientation 
of the switch and determine the relative proportions of each in the population (Fig. 2.2A) (67, 68, 
70). One pair of primers that flank the flagellar switch amplify a region encompassing the 5’ 
UTR flgB coding sequence of the flgB operon, yielding a 665 bp product that was subjected to 
digestion with the restriction enzyme SwaI. The presence of a single SwaI restriction site in the 
154 bp flagellar switch resulted in two fragments of different sizes depending on the orientation 
of the sequence (Fig. 2.2A). If the flagellar switch is in the published orientation, we expect 
fragments of 312 and 353 bp; if the switch is in the inverse orientation, we expect fragments of 
418 and 247 bp. All four products are expected for a mixed population.  
Spore preparations of C. difficile R20291, which contain a mix of bacteria with respect to 
flagellar switch orientation (Fig. 2.3), were plated on BHIS agar supplemented with the 
germinant taurocholate. Germinated colonies were collected and spotted onto standard BHIS 
agar. We observed that over 96 hours, the R20291 colony morphology changed from smooth and 
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circular to a spreading, filamentous colony (Fig. 2.2B). Genomic DNA was isolated from 
replicate colonies every 24 hours, and the asymmetric PCR-digestion assay was performed after 
all samples were processed. Over time, the abundance of the SwaI digested products indicating 
the inverse orientation increased (Fig. 2.2C). The proportions of bacteria with the switch in the 
two orientations were quantified by measuring the pixel intensities of the bands, normalized to a 
standard curve generated with titrated amounts of SwaI-digested DNA template for the published 
and inverse orientations (71). The proportion of the bacteria with the flagellar switch in the 
inverse orientation significantly increased after 48 hours (median of 33.8%, P < 0.005), 72 hours 
(39.0%, P < 0.05), and 96 hours (67.4%, P < 0.05) compared to 24 hours (26.4%) (Fig. 2.2D). 
These data provide evidence of DNA inversion and suggest that growth on a solid agar surface 
favors the accumulation of C. difficile with the flagellar switch in the inverse orientation.  
Single colonies derived from this growth (24-96 hours on BHIS agar) were subjected to 
the asymmetric PCR-digestion assay to determine the orientation of the flagellar switch. 
Individual colonies were enriched for one orientation of the flagellar switch. All colonies tested 
yielded either 312 and 353 bp fragments indicating the switch in the published orientation (Fig. 
2.4A) or 418 and 247 bp fragments indicating the switch in the inverse orientation (Fig. 2.4B). 
However, the asymmetric PCR-digestion has limited sensitivity for detection of low abundance 
targets. Thus, we used quantitative PCR (qPCR) of genomic DNA to quantify the frequency of 
bacteria with the flagellar switch in each orientation. In isolated colonies that showed fragments 
indicating the switch is in the published orientation by asymmetric PCR-digestion (Fig. 2.4A), 
89.5% (+/- 6.6% SD) of the population had the switch in that orientation by qPCR (Fig. 2.4C). 
Similarly, in colonies with the switch predominantly in the inverse orientation by asymmetric 
PCR-digestion (Fig. 2.4B), 96.3% (+/- 2.2% SD) of the population has the switch in that 
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orientation by qPCR (Fig. 2.4C). These data indicate that asymmetric PCR-digestion 
successfully identifies colonies that are enriched for the flagellar switch in a single orientation. 
Furthermore, the orientation of the flagellar switch remains stable during growth on an agar 
surface for at least 24 hours and switch orientation did not affect growth (Fig. 2.5).  
We note that during these experiments, we observed two distinct colony morphologies 
based on colony texture and edge– a smooth, circular (SC) morphotype, and a rough, filamentous 
(RF) morphotype (Fig. 2.6). The percentage of RF colonies increased, and the percentage of SC 
colonies decreased over time (Fig. 2.6). Bacteria from SC and RF colonies maintained their 
respective characteristic morphologies after passaging (Fig. 2.6). Colony morphology was not 
attributable to the orientation of the flagellar switch, as 72% of bacteria in the SC colonies had 
the flagellar switch in the published orientation, and 64% of bacteria in the RF colonies had the 
flagellar switch in the inverse orientation (Fig. 2.6). 
 
The orientation of the flagellar switch controls downstream flagellar gene expression 
The enrichment of two populations based on the orientation of the flagellar switch 
allowed us to determine the impact of switch orientation on downstream gene expression. We 
purified colonies with the flagellar switch in the published and inverse orientations (Fig. 2.7A) to 
assess gene expression. The abundances of early and late stage flagellar gene transcripts in the 
isolates were compared by quantitative reverse transcriptase PCR (qRT-PCR). Bacteria with the 
flagellar switch in the inverse orientation exhibited significantly reduced abundance of early 
stage flagellar gene transcripts, such as flgB and sigD/fliA, compared to bacteria with the 
flagellar switch in the published orientation (Fig. 2.7B) (23, 44). Accordingly, the abundances of 
the σD-dependent, late stage flagellar gene transcripts CDR20291_0227 (autolysin), flgM 
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(flagellar anti-sigma factor), and fliC (flagellin) (Fig. 2.7B) were also significantly decreased in 
bacteria with the flagellar switch in the inverse orientation. Consistent with this, transmission 
electron microscopy showed that the majority of bacteria from colonies with the flagellar switch 
in the published orientation displayed flagella (72% flagellated, n = 144), whereas bacteria from 
colonies with the switch in the inverse orientation were largely non-flagellated (98% non- 
flagellated, n = 163) (Fig. 2.7C). We also note that C. difficile strain R20291 was previously 
reported to produce a single flagellum (31), but we observed peritrichous flagella on our R20291 
isolate.  
In addition, we generated a transcriptional fusion of mCherryOpt, encoding a Red 
Fluorescent Protein-derivative (RFP) optimized for translation in C. difficile (72, 73), to the flgM 
promoter. The flgM gene was previously determined to be positively regulated by σD (23, 44). As 
σD is encoded in the flgB operon, it is indirectly phase variable and serves as an indicator of the 
status of the flagellar switch. This plasmid-borne reporter (PflgM::mCherryOpt) was introduced 
into C. difficile R20291 isolates with the switch in the published or inverse orientation. In the 
isolate with the switch in the published orientation, the majority of bacteria were mCherryOpt 
positive: 76.7% (+/- 9.8% SD). In the isolate with the switch in the inverse orientation, few 
bacteria were mCherryOpt positive: 2.4% (+/- 2.2% SD) (Fig. 2.7D). These values are consistent 
with those obtained using qPCR to directly evaluate the switch orientation in these populations 
(Fig. 2.4C). Differences in the frequency of the switch orientation in enriched flg ON populations 
could be due to additional flagellar gene regulators that function independently of the flg switch, 
such as c-di-GMP (59, 62). Negative controls bearing promoterless mCherryOpt (::mCherryOpt) 
lacked fluorescence (Fig. 2.8); positive controls with inducible mCherryOpt (Ptet::mCherryOpt) 
showed more uniform red fluorescence (Fig. 2.8). We additionally constructed a sigD mutant in 
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R20291 by Targetron insertional mutagenesis as a negative control (Fig. 2.9). The sigD mutant 
containing the PflgM::mCherryOpt reporter lacked mCherryOpt fluorescence, indicating that flgM 
promoter activity is dependent on σD, and therefore on the flagellar switch (Fig. 2.7C). 
Taken together, these data indicate that the orientation of the flagellar switch controls 
flagellar gene expression and are consistent with phase variable gene expression. Thus, bacteria 
with the flagellar switch in the published orientation express flagellar genes and produce flagella 
and are thus flagellar phase ON (“flg ON” hereafter); bacteria with the switch in the inverse 
orientation show decreased flagellar gene expression and flagellum biosynthesis and are 
comparatively flagellar phase OFF (“flg OFF” hereafter). 
 
Motility medium spatially segregates flagellar phase variant populations 
 Given that flg OFF bacteria were deficient in flagellum biosynthesis (Fig. 2.7), we 
predicted that flg OFF bacteria would be non-motile compared to motile flg ON bacteria. To test 
this, enriched flg ON and OFF isolates were examined for the ability to swim through BHIS-
0.3% agar (59). The R20291 sigD mutant was used as a non-motile control. The flg OFF bacteria 
appeared motile (Fig. 2.10A), though they displayed a modest but statistically significant 
reduction in swimming diameter at 24 and 48 hours post-inoculation compared to flg ON isolates 
(Fig. 2.10B).  
We reasoned that the enriched flg OFF inoculum would result in spatial restriction of 
non-motile bacteria to the inoculation site. In contrast, the small fraction of flg ON bacteria 
(detectable by qPCR and fluorescent reporters but below the limitation of detection by 
asymmetric PCR digestion assay) would be capable of motility and chemotaxis and therefore 
expand from the inoculation site, spatially segregating from flg OFF bacteria. To test this, for flg 
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ON and OFF isolates cultured in motility agar, we sampled bacteria from the inoculation site 
(center) and from the leading edge at 24, 48, and 72 hours and determined the orientation of the 
switch using the asymmetric PCR-digestion assay. As expected, flg ON maintained the flagellar 
switch in the ON orientation at all time points at both the center and edge (Fig. 2.10C, top). In 
contrast, flg OFF bacteria from the center contained the switch primarily in the OFF 
configuration, but bacteria at the leading edge had the switch to the ON orientation by 24 hours 
(Fig. 2.10C, bottom). The flg ON orientation was subsequently preserved along the leading edge 
at 48 and 72 hours (Fig. 2.10C, bottom). These results indicate that growth in motility medium 
introduced a selection barrier that restricted flg OFF bacteria to the inoculation site and allowed 
the expansion of a low frequency population of flg ON bacteria.  
 
The orientation of the flagellar switch controls production of the glucosylating toxins 
The flagellar alternative sigma factor, σD, controls transcription of genes within the 
Pathogenicity Locus (PaLoc) in addition to late stage flagellar genes in C. difficile (22, 23, 44). 
Therefore, we predicted that the flagellar switch, which impacts the expression of sigD (Fig. 
2.7B), also indirectly controls the expression of the toxin genes tcdA and tcdB by activating the 
expression of the toxin sigma factor gene tcdR. We compared the expression of tcdA, tcdB and 
tcdR in flgB ON and OFF isolates using qRT-PCR. The abundances of the tcdR, tcdA and tcdB 
transcripts were significantly reduced in flg OFF bacteria compared to flg ON (Fig. 2.11A). 
Consistent with these results, TcdA protein level was also decreased in cell lysates of flg OFF 
bacteria compared to lysates of flg ON bacteria (Fig. 2.11B). TcdB levels were below the limit of 
detection by western blot.  
! 64!
TcdA and TcdB are exported protein toxins that inactivate host cell Rho and Rac 
GTPases through glucosylation, resulting in actin depolymerization and reduced host cell 
viability (13-16). To determine the effect of the flagellar switch on C. difficile cytotoxicity, filter-
sterilized supernatants from flg ON and OFF isolates were tested in a cell viability assay with 
Vero cells. Flg ON isolates were significantly more cytotoxic compared to flg OFF isolates and a 
sigD control (Fig. 2.11C). Taken together, these data demonstrate that the flagellar switch 
orientation controls toxin production in addition to flagellum biosynthesis and swimming 
motility, indicating that these major virulence factors are coordinately phase variable in C. 
difficile.  
 
The flagellar switch mediates regulation post-transcription initiation 
Multiple mechanisms driving phase variable gene expression have been described: 
general homologous recombination, conservative site-specific recombination, short sequence 
repeat and slip strand mispairing, and DNA methylation (66, 74, 75). Classically, an invertible 
DNA element that undergoes site-specific recombination contains a promoter as the regulatory 
feature, and the orientation of the invertible DNA element (and promoter) determines whether 
the downstream genes are expressed. For example, in E. coli the orientation of the fimS switch, 
which contains a promoter, controls type I fimbrial gene expression (76). In contrast, in C. 
difficile, the genetic switch that regulates expression of cwpV operates after transcription 
initiation (68). In cwpV phase ON bacteria, transcriptional read-through of the 5’ UTR and the 
cwpV coding sequence occurs. In cwpV phase OFF bacteria, the inversion of a DNA sequence in 
the 5’ UTR leads to formation of a Rho-independent transcriptional terminator and results in 
premature transcription termination preventing expression of cwpV.  
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To begin to define the mechanism by which the flagellar switch controls gene expression, 
we generated a series of alkaline phosphatase (AP) transcriptional reporters (Fig. 2.12A) (77). 
First, the phoZ reporter gene was placed downstream of flgB (first gene of the flgB operon), 
under the control of the native flgB promoter and the full 498 bp 5’ UTR with the flagellar switch 
(FS) in either the phase ON or OFF orientation (PflgB-5’UTR(FSON/OFF)-flgB::phoZ, Fig. 2.12A, 
#3 & 4). To determine if the flagellar switch contains a promoter, a truncated 307 bp 5’ UTR 
retaining the flagellar switch (either phase ON or OFF orientation) but lacking the Cd1 
riboswitch and native flgB promoter was placed upstream of flgB::phoZ (FSON/OFF-flgB::phoZ, 
Fig. 2.12A, #5 & 6). A transcriptional fusion of phoZ to the flgB promoter (PflgB::phoZ, Fig. 
2.12A, #2) served as a positive control for the assay, and a promoterless construct (::phoZ, Fig. 
2.12A, #1) was included as a negative control. All reporter fusions were integrated onto the 
chromosome of an R20291 flg ON isolate, and AP activity was assessed. In parallel with every 
AP assay, an asymmetric PCR-digestion assay was performed to ensure that the flagellar 
switches were in the expected orientation for both the native locus and the reporter fusion (Fig. 
2.13). As anticipated, the promoterless control showed no AP activity, and the presence of the 
flgB promoter significantly increased activity (Fig. 2.12B). The PflgB-5’UTR(FSOFF)-flgB::phoZ 
reporter strain had significantly reduced activity compared to the PflgB-5’UTR(FSON)-flgB::phoZ 
reporter strain (Fig. 2.12B), consistent with previous results (Fig. 2.7). No AP activity was 
detected in strains bearing the FSON/OFF-flgB::phoZ fusions (Fig. 2.12B). Similar results were 
obtained using the same six reporter fusions integrated onto the chromosome of a R20291 with 
the native flagellar switch in the OFF orientation, although AP activity was lower overall (Fig. 
2.14). These results suggest that the flagellar switch does not contain a promoter to initiate 
transcription independently of the flgB promoter.  
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We considered alternative mechanisms by which expression could be inhibited in 
bacteria with the switch in the OFF orientation: (1) the formation of a Rho-independent 
transcriptional terminator, (2) the requirement for a trans-acting element such as an RNA 
binding protein or small non-coding RNA that selectively inhibits transcription, or (3) a Rho-
dependent terminator. To examine these possibilities, we evaluated the activity of the phoZ 
reporters in a heterologous bacterium, B. subtilis, in which C. difficile-specific factors will be 
absent, but features inherent to the flagellar switch will be preserved. The reporter fusions (Fig. 
2.12A) were integrated into the B. subtilis BS49 chromosome, and the orientation of the flagellar 
switch was monitored by orientation-specific PCR (Fig. 2.13). As in C. difficile, the positive 
control strain with the PflgB::phoZ fusion showed high AP activity, but no activity was observed 
for the ::phoZ negative control (Fig. 2.12B). Also consistent with C. difficile, B. subtilis with the 
FSON/OFF-flgB::phoZ fusions  produced negligible AP activity, indicating the absence of a 
promoter in the flagellar switch (Fig. 2.12C). In contrast to the C. difficile results, we observed 
comparable AP activity in B. subtilis with PflgB-5’UTR(FSON/OFF)-flgB::phoZ reporters (Fig. 
2.12C).Thus, reduced gene expression as a result of the flagellar switch in the OFF orientation is 
specific to C. difficile, indicating that the regulatory feature is not inherent to the sequence, 
instead supporting the role of a trans-acting factor that is specific to C. difficile.  
When considered along with the qRT-PCR data from Fig. 2.7B and 2.11A, these results 
suggest regulation post-transcription initiation from the flgB operon promoter and implicates 
changes in RNA stability or premature termination. Therefore, we used northern blot analysis to 
determine if transcription terminates prematurely or if the transcript is destabilized when the 
flagellar switch is in the OFF orientation. We were unable to detect the full-length transcript for 
the flgB operon (~ 23 kb) using a probe specific to the Cd1 region of the 5’ UTR, so we used 
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strains with the PflgB-5’UTR(FSON/OFF)-flgB::phoZ reporters in the R20291 flg ON background to 
evaluate premature transcription termination. We observed an RNA corresponding to a full-
length transcript of ~2400 nt for the PflgB-5’UTR(FSON)-flgB::phoZ reporter but reduced 
transcript for the PflgB-5’UTR(FSOFF)-flgB::phoZ reporter (Fig. 2.12D). Furthermore, we did not 
detect a smaller transcript species other than termination through the Cd1 riboswitch, which 
eliminates the possibility of Rho-dependent or -independent termination unless the transcript is 
degraded faster than we can detect by northern blot. Collectively, the reporter assays in C. 
difficile flg ON and OFF and in B. subtilis with northern blot analysis suggest that regulation via 
the flagellar switch occurs post-transcription initiation and involves an unidentified trans-acting 
element that destabilizes the mRNA to reduce gene expression in flg OFF bacteria. 
 
RecV, a tyrosine recombinase, catalyzes recombination at the flagellar switch in both 
orientations 
Serine and tyrosine recombinases catalyze site-specific recombination to mediate DNA 
inversion at phase variable genetic switches in a RecA-independent manner (78, 79). In E. coli, 
two recombinases catalyze inversion at the fimbrial switch; FimB can catalyze both orientations, 
whereas FimE is restricted to ON to OFF inversion events (80, 81). A conserved tyrosine 
recombinase called RecV catalyzes strand exchange in both orientations at the cwpV switch in C. 
difficile (68, 82-84). We postulated that the recombinase(s), which catalyze inversion at the flg 
switch, would be present in all published C. difficile genomes with intact flagellum biosynthesis 
genes. We identified eight conserved serine or tyrosine recombinases, including RecV 
(CDR20291_1004), and used a two-plasmid system in a heterologous bacterium to identify the 
flagellar switch recombinase(s) (68). One plasmid contains one of the eight recombinase genes 
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cloned downstream of an anhydrotetracycline (ATc) inducible promoter (85), and the second 
plasmid contains one of the PflgB-5’UTR(FSON/OFF)-flgB::phoZ reporters (Fig. 2.12A, #3 & 4). 
The plasmids were transformed into E. coli, induced with ATc, and orientation-specific PCR was 
used on purified plasmids to determine if inversion occurred. We found that RecV was sufficient 
to catalyze recombination of the flagellar switch from the ON to OFF (Fig. 2.15A) and OFF to 
ON (Fig. 2.15B) orientations in E. coli; the other seven were unable to promote recombination. 
These data indicate that the RecV recombinase is sufficient to catalyze inversion in both 
orientations at both the flagellar and cwpV switches in a heterologous organism. These data do 
not rule out the possibility of an additional recombinase that requires a trans-acting element, 
such as a recombination directionality factor (86), to catalyze inversion at the flagellar switch.  
To determine whether RecV is involved in inversion of the flagellar switch in C. difficile, 
we first overexpressed recV in the backgrounds of R20291 flg ON and OFF using the 
anhydrotetracycline (ATc)-inducible expression vector to determine whether RecV would 
promote inversion to the opposite orientation (87). We found that overexpression of recV in the 
flg ON and OFF backgrounds leads to a mixed population of both orientations compared to 
empty vector, regardless of the presence of ATc (Fig. 2.16, panel A). Transcription of recV in the 
ATc-inducible expression vector was leaky in the absence of inducer (Fig. 2.16, panel B), which 
is in line with previous work (87, 88). 
 
RecV mutants are phase-locked for flagellum and toxin production 
The C. difficile R20291 recV mutants were previously shown to be phase-locked for 
CwpV production (83, 84). The identification of RecV as the recombinase mediating flagellar 
switch inversion suggests that mutation of recV would similarly result in phase-locked 
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phenotypes with respect to flagellum and toxin production. To evaluate the requirement of RecV 
for flagellar phase variation in C. difficile, we obtained two C. difficile R20291 mutants with 
ClosTron insertions in recV (kind gift from Dr. Louis-Charles Fortier). One mutant contains the 
cwpV switch locked in the ON orientation, and the other, the OFF orientation (82, 83). Both 
mutants contain the flagellar switch in the OFF orientation (herein, “flg OFF*”), as determined 
using orientation-specific PCR (Fig. 2.1B, Fig. 2.15C).  
To obtain a recV mutant in which the flagellar switch is locked in the ON orientation, 
recV was expressed from a plasmid to allow inversion of the flagellar switch (Fig. 2.16C). This 
complemented strain was then passaged in the absence of antibiotic selection to allow loss of the 
plasmid. Thiamphenicol-sensitive clones were screened for flagellar switch orientation to 
identify recV mutants that are flg ON (herein, “flg ON*”) (Fig. 2.17).  
The recV flg ON* and OFF* mutants, each bearing vector or recV under the control of 
the Ptet ATc-inducible promoter, were assayed for swimming motility in BHIS-0.3% agar. A 
non-motile sigD mutant and enriched flg ON and OFF isolates were included as controls. Unlike 
the enriched flg OFF isolate that appeared motile due to a small frequency of flg ON bacteria, the 
recV flg OFF* mutant was non-motile at 24 hours incubation (Fig. 2.18A,B). This phase-locked 
phenotype was dependent on RecV, as complementation with recV in trans restored motility. In 
contrast, the recV flg ON* mutant showed motility, and providing recV in trans had no 
measurable effect in this assay. We note that extended incubation (greater than 24 hours) of the 
recV flg OFF* mutant results in motile progeny (Fig. 2.18). These motile bacteria retain the 
flagellar switch in the OFF orientation based on orientation-specific PCR and DNA sequencing 
results (Fig. 2.19), so the motile phenotype is due to suppressor mutations.  
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We next evaluated toxin production by the recV flg ON* and OFF* mutants by 
measuring TcdA production by western blot. As shown above, the enriched flg OFF isolate 
produced less TcdA than the enriched flg ON isolate (Fig. 2.18C, lanes 1,2). TcdA levels were 
greater in the recV flg ON* mutant compared to the enriched flg ON isolate. The difference is 
likely attributable to the presence of ~10.5% or 23.2% of bacteria with the flagellar switch in the 
OFF orientation remaining in the enriched flg ON isolate based on qPCR and fluorescence 
microscopy estimates, respectively (Fig. 2.4C, 2.7D). TcdA abundance in the recV flg OFF* 
mutant was comparable to that in the sigD mutant, which was below the limit of detection. 
Provision of recV in trans in either the recV flg ON* or OFF* mutant, which results in 
heterogeneity in the orientation of the flagellar switch (Fig. 2.15D), resulted in intermediate 
TcdA levels (Fig. 2.18C, lanes 5,7). The observed differences in TcdA levels among the strains 
appear to depend on the proportion of flg ON and OFF bacteria in the population. These results 
indicate that RecV mediates flagellum and toxin phase variation, in addition to CwpV phase 
variation, in C. difficile. 
 
Discussion 
Colonization is a prerequisite step to diarrheal disease development in C. difficile 
infection. The identification of colonization factors and the mechanisms controlling their 
production is an active area of study. Transcriptional regulators (51-53), a peptide-based quorum 
sensing system (29), and an RNA chaperone (54) activate or repress flagellar gene expression, 
albeit the exact regulatory mechanisms remain undetermined. Prior to this study, Cd1, a class I c-
di-GMP sensing riboswitch, was the only identified cis-acting regulatory element to control 
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flagellar gene expression (59, 61, 62). Here, we report an additional cis-acting regulatory 
element, a “flagellar switch,” present upstream of the early stage flagellar operon.  
The flagellar switch is the fourth identified C. difficile inversion site (Cdi4) and consists 
of a 154 bp sequence flanked by 21 bp imperfect inverted repeats (69). The flagellar switch is 
functional, undergoing site-specific recombination in at least two different C. difficile ribotypes, 
027 and 017. The flagellar switch inverted repeats are conserved in all sequenced C. difficile 
genomes that contain the flagellum biosynthesis genes, except the 630 genome has shortened 20 
bp inverted repeats (Fig. 2.20). The flagellar switch appears locked ON in C. difficile 630, which 
may be due to the shortened inverted repeats. Alternatively, the 630 genome (012 ribotype) may 
differ in RecV transcription, production, or activity compared to the 027 and 017 ribotype 
strains, although there are no obvious differences in the recV promoter or open reading frame 
sequences to indicate that this is the case. Genetic evidence suggests that reduced inverted repeat 
length can impair recombination at the cwpV switch in C. difficile (68). The cwpV switch (Cdi1) 
controls the production of a large cell wall protein that promotes bacterial aggregation in vitro 
and is postulated to promote intestinal colonization (68, 82). CwpV may also contribute to C. 
difficile survival in the host by conferring resistance to predation by bacteriophages (84). 
Deposition of CwpV on the surface of C. difficile reduces phage adsorption and specifically 
prevents the injection of phage DNA into the bacterial cell (84). The other two identified 
inversion sites in C. difficile, although not yet demonstrated to be functional switches, are under 
active investigation.  
Unlike the cwpV switch that controls the expression of a single structural gene, the 
flagellar switch controls the expression of both structural and regulatory genes, including sigD. 
Flagellar phase ON bacteria, as well as a recV mutant with the flagellar switch locked in the ON 
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orientation, display peritrichous flagella, engage in swimming motility, and produce the 
glucosylating toxins. Flagellar phase OFF bacteria and recV mutants with the flagellar switch 
locked in the OFF orientation are attenuated for transcription of flagellar genes, and therefore 
grow as aflagellate, non-motile bacteria also attenuated for toxin production. Thus, the flagellar 
switch coordinately controls the production of a colonization factor and essential virulence 
determinants by impacting sigD expression. Moreover, the flagellar switch orientation is 
expected to affect additional genes in the σD regulon, such as metabolic pathways, multiple cell 
wall proteins, metabolic transporters for amino acids and divalent cations, and several 
transcriptional regulators (23). 
Classically, genetic switches that toggle between two orientations and facilitate phase 
variable expression of downstream genes contain a promoter to alter transcription initiation (66). 
Transcriptional reporter data excluded the presence of a promoter within the flagellar switch, 
indicating that the switch controls downstream gene expression after transcription initiation from 
the flgB operon promoter has occurred. Indeed, the switch is within the previously defined 5’ 
UTR of the flgB (F3) operon, downstream of the c-di-GMP riboswitch (62). This arrangement of 
regulatory elements suggests that flagellar phase variation is only relevant when c-di-GMP levels 
are sufficiently low to permit transcriptional read-through beyond the riboswitch and into the 
flagellar switch. Regulation post-transcription initiation by genetic switches has been described 
previously. The cwpV switch in C. difficile also lacks promoter activity and instead regulates 
cwpV expression post-transcriptionally (68). When the switch is in the cwpV phase OFF 
orientation, the mRNA adopts a structure containing a Rho-independent terminator resulting in 
premature transcription termination (68). In E. coli, the fimE mRNA is subject to regulation post 
transcription initiation. FimE is encoded immediately 5’ of fimS, and when fimS is in the OFF 
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orientation, the fimE mRNA forms a Rho-dependent terminator that reduces transcript stability 
(89). If the flagellar switch in C. difficile contained a Rho-independent terminator, we would 
expect no AP activity in B. subtilis when the flagellar switch was in the OFF orientation. 
However, AP activity was indistinguishable between the flg ON and OFF reporters in B. subtilis, 
suggesting a trans-acting regulatory element that is expressed only in C. difficile. We note that 
AP activity from the reporters was substantially higher in B. subtilis compared to C. difficile; it is 
possible that a regulatory factor in B. subtilis masked the unidentified trans-acting regulatory 
factor. Moreover, northern blot analysis suggests a mechanism independent of both Rho-
dependent and independent termination since we were unable to detect a truncated transcript 
from the phase OFF condition. Collectively, our results suggest that the early stage flagellar 
operon mRNA is destabilized or degraded when the flagellar switch DNA is in the OFF 
orientation. We speculate that a constitutively-expressed C. difficile-specific regulatory factor, 
either an RNA binding protein or small, non-coding RNA, binds to the leader sequence of the 
mRNA to directly or indirectly degrade or destabilize the mRNA. Thus, the flagellar switch in C. 
difficile represents a novel system that requires an unknown additional regulatory factor to 
function as an ON/OFF switch.  
In many mucosal pathogens, phase variation is a regulatory feature that modulates the 
expression of an immunostimulatory cell surface structure (66). Flagellar phase variation occurs 
in Clostridium chauvoei (90), Salmonella enterica serovar enterica Typhimurium (91, 92), 
Helicobacter pylori (93), and Campylobacter jejuni (94). Wild strains of B. subtilis grown under 
planktonic conditions bifurcate into two distinct populations: flagellated, motile single bacteria 
and aflagellate, non-motile chains of bacteria (95). Expression and activity of σD determines 
whether these populations arise in B. subtilis. Expression of swrA, which encodes a master 
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regulator of swarming motility, is subject to phase variation by slip strand mispairing in the 
coding sequence (95-97). SwrA controls transcription of the flagellar and chemotaxis (fla/che) 
operon by regulating the activity of the transcriptional regulator DegU (98). SigD, encoded 
within the fla/che operon, also positively regulates swrA transcription (98). Thus, a feedforward 
loop resulting from swrA expression introduces a bias for σD ON bacteria that are flagellated and 
motile. These and other data present a model in which flagellar gene expression in B. subtilis is 
bistable (97). Although additional work is needed to determine if C. difficile flagellar gene 
expression meets the criteria of bistability (99-101), inversion of the C. difficile flagellar switch 
similarly results in phenotypic heterogeneity that would confer an advantage in an environment 
that selects for one phenotype over the other (99-101). Thus, B. subtilis and C. difficile may use 
distinct mechanisms to accomplish the same outcome. 
We identified RecV as necessary and sufficient for inversion of the flagellar switch in 
both orientations, by over-expression of recV in C. difficile and in E. coli bearing the flagellar 
switch sequence, and by mutation of recV in C. difficile R20291. Notably, RecV was previously 
reported to control inversion of the cwpV switch in C. difficile (68, 82). The use of a single 
recombinase to control inversion of multiple genetic switches has been described previously. In 
Bacteroides fragilis, the Mpi recombinase controls inversion of at least 13 genetic switches, 
including seven switches that control expression of different capsular polysaccharide loci (102). 
These switches are scattered through the genome and contain inverted repeats that harbor a 10 bp 
core consensus sequence (102). In contrast, the inverted repeats and the flanking half sites for the 
cwpV and flagellar switches lack recognizable sequence identity, although the identification of 
additional RecV-controlled genetic switches might reveal a core consensus sequence. RecV may 
bind the recognition sequences with different affinities, allowing hierarchical inversion of 
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switches bearing disparate inverted repeats. Regulation of recV transcription and/or RecV 
activity could therefore differentially affect inversion of the cwpV and flagellar switches. 
Hierarchical binding could be achieved solely by RecV, or via additional proteins that direct 
RecV to specific target sequences. The need for these binding partners may have been bypassed 
in E. coli due to over-expression of recV. It is also possible that trans-acting DNA binding 
proteins, such as a histone-like protein or recombination directionality factor (RDF) (86, 103), 
influence DNA bending to affect the recombination reaction at RecV-controlled genetic 
switches. Such DNA binding proteins can integrate environmental signals to bias switch 
orientation and generate genetic variants that have a fitness advantage in that environment. For 
example, leucine-responsive regulatory protein and H-NS affect the recombination reaction at 
fimS in E. coli (104, 105). The existence of factors influencing RecV activity in C. difficile is 
supported by the observation that C. difficile R20291 carrying the prophage ϕCD38-2 has the 
cwpV switch biased to the ON orientation; recV transcription is unaltered (83). Prophage 
infection of a recV mutant with the cwpV switch in the OFF orientation remains locked, 
suggesting that the phage does not encode a recombinase to promote inversion, but that instead a 
phage gene product modulates RecV activity (83). ϕCD38-2 did not affect flagellum or toxin 
gene transcription in R20291, but C. difficile may produce another factor that similarly 
influences recombination within the flagellar (and cwpV) switch. Recent evidence demonstrates a 
role for RDFs in C. difficile physiology: an RDF pairs with a serine recombinase to excise a 
prophage-like element from a sporulation-specific sigma factor gene (106). Future studies will 
explore how RecV can control multiple genetic switches with divergent inverted repeat 
sequences. 
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Ultimately, iterative combinations of cwpV and flg ON and OFF phenotypes may 
influence C. difficile fitness in the host intestinal environment. A dual cwpV and flg ON 
phenotype could facilitate penetration of the bacteriophage-rich colonic mucus (107), and/or 
increase bacterial attachment to and colonization of the intestinal mucosa. Conversion of one or 
both phenotypes to phase OFF might reduce the probability of the host simultaneously 
developing an antibody response to these immunostimulatory surface structures. The role of 
flagellum and toxin phase variation in C. difficile pathogenesis remains to be determined, though 
it stands to reason that both the phase ON and OFF phenotypes confer advantages during the 
course of an infection. The flg ON bacteria would be competent for efficient intestinal 
colonization for R20291 (31). Yet purified flagellin from multiple C. difficile strains can activate 
host Toll-like receptor 5 (TLR5) and stimulate p38 MAPK activation and IL-8 secretion in vitro 
(47, 108, 109). Although TLR5 is dispensable in a mouse model of CDI (49), recombinant C. 
difficile FliC is immunogenic and protective in a mouse model of CDI (110). In addition, the C. 
difficile glucosylating toxins have been implicated in activation of the NLRP3 and Pyrin 
inflammasomes, which could promote pathogen clearance (48, 111). C. difficile flg OFF bacteria 
could thus evade TLR5 recognition and inflammasome stimulation, enhancing bacterial 
colonization and persistence within the host. Future studies will determine the contribution of 
flagellum and toxin phase variation to C. difficile virulence. 
 
Materials and Methods 
Growth and Maintenance of Bacterial Strains 
The strains and plasmids used in this study are listed in Table 2.1, and details on their 
construction are described later in the methods. C. difficile was maintained in an anaerobic 
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chamber (Coy Laboratories) at an atmosphere of 90% N2, 5% CO2, and 5% H2 and grown in 
Brain Heart Infusion medium (Becton Dickinson) supplemented with 5% yeast extract (Becton 
Dickinson) (BHIS) at 37°C. Bacteria were also cultured in Tryptone Yeast (TY) broth media 
where indicated. All C. difficile broth cultures were grown statically. Escherichia coli DH5α, 
BL21, and HB101(pRK24) were cultured at 37°C in Luria-Bertani (LB) medium with the 
indicated antibiotics for plasmid selection. Bacillus subtilis strain BS49 was grown in BHIS with 
the appropriate antibiotics. Antibiotics were used at the following concentrations: 
chloramphenicol, 10 µg/ml; thiamphenicol, 10 µg/ml; kanamycin, 100 µg/ml; ampicillin, 100 
µg/ml; erythromycin, 5.0 µg/ml, lincomycin 20.0 µg/ml. 
 
Orientation-Specific PCR Assay 
Spores of C. difficile strains 630Δerm, R20291, and ATCC 43598 were plated on BHIS 
supplemented with 0.1% sodium taurocholate (Sigma) (BHIS+TA). After 24 hours, individual 
colonies were grown in BHIS at 37°C. Overnight cultures were diluted 1:50 in fresh BHIS and 
grown to early stationary phase. An aliquot of each culture was diluted 1:5 into 10 mM Tris-HCl, 
pH 7.5, 1 mM EDTA (TE) buffer. Boiled lysates served as templates in PCR using primers 
designed for each strain based the genome sequences for strains 630 (Accession No. 
AM180355.1) and R20291 (Accession No. FN545816.1). The ribotype 017 strain ATCC 43598 
has not been sequenced, so we used M68 (Accession No. FN688375.1) as a representative 
ribotype 017 strain to design primers for the flagellar switch. Primer sequences are listed in 
Table 2.2. Primers R1614 (published/ON orientation) and R1615 (inverse/OFF orientation) were 
used for R20291. Primers R1622 (published/ON orientation) and R1623 (inverse/OFF 
orientation) were used for ATCC 43598. Primers R1751 (published/ON orientation) and R1752 
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(inverse/OFF orientation) were used for 630Δerm. All reactions used R857 as the reverse primer 
given the sequence identity between strains for the first gene in the early flagellar operon, flgB. 
The results shown are representative of three independent experiments each with at least two 
biological replicates for each strain.  
 
Asymmetric PCR-Digestion Assay 
To amplify the flagellar switch, chromosomal DNA purified from C. difficile R20291, as 
previously described (112), served as the template in PCRs with primers R591 and R857, 
yielding a product of 665bp. The PCR products (500 ng) were digested with SwaI (NEB), which 
results in different products depending on the orientation of the flagellar switch: 312 bp and 353 
bp for the published orientation, and 418 bp and 247 bp for the inverse orientation (Fig. 2.2). A 
mixture of bacteria with the flagellar switch in the published and inverse orientation results in 
four bands at varying intensities. SwaI reaction products were separated in 2.5% agarose gels, 
which were stained with ethidium bromide (EtBr) for imaging with a G:BOX Chemi Imaging 
system. For all experiments with purified phase variant populations, three or four biological 
replicates of R20291 flg ON and OFF were assessed by the asymmetric PCR-digest assay to 
ensure a homogeneous population. We used ImageJ to perform a densitometry analysis of the 
digested bands to determine the relative proportions of bacteria with flagellar switch in the 
published/ON (312, 353 bp) and inverse/OFF (418, 247 bp) orientations. The pixel intensities of 
published/ON or inverse/OFF bands were divided by the total pixel intensity for that sample. 
These values were normalized to a standard curve generated by mixing known quantities of flg 
ON and OFF plasmid template and subjecting them to the asymmetric PCR-digestion assay, 
giving the percentage of bacteria in a sample with the switch in a given orientation. 
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To evaluate the effect of surface growth on the flagellar switch, C. difficile R20291 
spores were plated on BHIS-TA to induce germination. After 24 hours, individual colonies were 
suspended and spotted onto four BHIS plates. Every 24 hours for four days, one plate was used 
for recovery of bacteria from colony for chromosomal DNA extraction. Once chromosomal 
DNA was collected, the orientation of the flagellar switch was determined using the asymmetric 
PCR-digestion assay. Densitometry analysis was performed using ImageJ software as described 
above. Values for bands corresponding to the published/ON and inverse/OFF orientations were 
compared to a standard curve. The data were combined from three independent experiments, 
each with two to four biological replicates. 
 
Purification of Flagellar Phase Variant Populations 
 C. difficile R20291 spores were plated on BHIS+TA. After 24 hours, six to ten individual 
colonies were suspended in BHIS, spotted onto individual BHIS plates, and grown 24-96 hours 
as indicated. Single colonies were derived from this growth (24-96 hours) by passaging onto 
BHIS plates and individually screened for the flagellar switch orientation by the asymmetric 
PCR digestion assay. A higher frequency of colonies with the flagellar switch in the OFF 
orientation was observed at later time points (96 hours). For all experiments using enriched 
flagellar phase variant populations, except the phoZ reporters, mCherryOpt reporters, and cell 
viability assay, glycerol stocks were not made to ensure robust reproducibility of the phenotypes 
between independent experiments and reproducibility of the enrichment protocol. At least two to 




Quantitative PCR Analysis of the Flagellar Switch Orientation 
 In all reactions, SYBR Green Real-Time qPCR reagents (Thermo Fisher) were used, with 
primers at a final concentration of 500 nM and an annealing temperature of 55°C. Titrated 
amounts of genomic DNA from recV flg ON* and flg OFF* were used to determine the amount 
of template necessary for the reactions and the primer efficiency. Primers for detection of the ON 
orientation (R2175 and R2177) had a PCR efficiency of 88.5% for the recV flg ON* DNA, and 
the primers for detection of the OFF orientation (R2176 and R2177) had a PCR efficiency of 
84.5% for the recV flg OFF* DNA. To determine the frequency of the flg ON and OFF 
orientations in populations of enriched C. difficile R20291 flg ON and OFF isolates, three 
biological replicates of each were grown in BHIS medium to an OD600 of ~1.0, and 
chromosomal DNA was extracted as previously described (112). Quantitative PCR was done 
using 4 ng of DNA from flg ON and OFF isolates. DNA copy number was calculated using the 
ΔΔCt method, with the rpoC gene as the indicated reference gene for DNA copy number.  
 
RNA Extraction, cDNA Synthesis, and Quantitative Reverse Transcriptase PCR 
 Isolated C. difficile flg ON and OFF variants were grown overnight in BHIS medium, 
1:50 in 3mL of BHIS medium and grown to stationary phase (OD600 of 1.8 - 2.0). RNA was 
isolated as described previously (59, 112). Briefly, cells were collected by centrifugation and 
lysed by bead beating in cold TriSURE (Bioline). Nucleic acid was extracted with chloroform 
(Sigma), precipitated from the aqueous phase with isopropanol, washed with ethanol, and 
suspended in RNase-free water. To remove contaminating genomic DNA, RNA was treated with 
TURBO DNase (Thermo Fisher) according to the manufacturer’s protocol. Synthesis of cDNA 
was done using a Tetro cDNA Synthesis kit (Bioline) and random hexamers according to the 
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manufacturer’s instructions and including a no-reverse transcriptase control. Real-time PCRs 
were done using 2 ng of cDNA and SYBR Green Real-Time qPCR reagents (Thermo Fisher). 
Transcript abundance was calculated using the ΔΔCt method, with rpoC as the control gene and 
the indicated reference condition/strain (59).  
 
Swimming Motility Assay 
C. difficile R20291, flg ON and OFF isolates, and recV mutants were assayed for flagellar 
motility as previously described (59). An R20291 sigD mutant was included as a non-motile 
control in all experiments. Details regarding the generation of the sigD mutant are in S1 Methods 
and S5 Fig. Autoclaved 0.5 X BHIS with 0.3% agar (30 mL) was poured into 100 mm Petri 
dishes allowed to solidify overnight. These soft agar plates were kept in the anaerobic chamber 
for at least 4 hours prior to the experiment. Bacteria were grown in BHIS medium overnight, 
diluted 1:50 in fresh BHIS broth the next day, and grown to an OD600 of 1.0. Two microliters of 
flg ON, flg OFF, and sigD were inoculated into the agar, then incubated at 37oC. The diameter of 
growth was measured after 24, 48, and 72 hours; two perpendicular measurements were made for 
each swim site and averaged for each replicate. Three to four biological replicates were 
evaluated, each in technical duplicate (values averaged), in two independent experiments. Images 
were taken using the G:BOX Chemi imaging system with the Upper White Light illuminator. A 
Student’s t-test was used to determine statistical significance. 
 
Alkaline Phosphatase Assay 
 C. difficile phoZ reporter strains were grown from glycerol stocks on BHIS plates and 
incubated at 37°C. After 24 hours, 2-3 colonies of each reporter strains were grown overnight in 
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TY medium and diluted 1:50 into BHIS medium. Late exponential phase cells (OD600 ≈ 1.5, 1.5 
mL) were collected by centrifugation, the supernatant was discarded, and pellets were stored at -
20°C overnight. Frozen pellets were thawed on ice and the alkaline phosphatase (AP) assay was 
performed as previously described (77). Bacillus subtilis BS49 phoZ reporter strains were grown 
from glycerol stocks on BHIS-Erm plates under aerobic conditions, and the assay was done as 
above. Construction of AP reporters is described in S1 Methods. 
 
Detection of RNA by Northern Blot 
 C. difficile phoZ reporter strains were grown in 4mL of BHIS medium to OD600 1.5. 
Bacteria were collected by centrifugation, and RNA was extracted as described above with the 
following exceptions. Four rounds of bead beating were done, and the purified RNA was 
rigorously treated with DNase I to ensure removal of contaminating DNA. Digoxigenin (DIG)-
labeled DNA probes for the northern blot were generated by PCR using genomic DNA from 
R20291 as template for the Cd1 probe and a 5S rRNA (CDR20291_ r03) probe, a DIG High 
Prime kit was used (Roche) (Table 2.2). Reagents from the NorthernMax-Gly Kit (Thermo 
Fisher) were used for electrophoresis and hybridization. RNA samples (15ug for mRNA probe 
and 500ng for rRNA probe) were briefly thawed on ice, mixed 1:1 with Glyoxal Load Dye, 
incubated at 50°C for 30 minutes, and electrophoresed in a 1% agarose gel made with 1X Gel 
Prep/Running Buffer. The agarose gel was imaged using the G:BOX Chemi Imaging system to 
confirm RNA integrity. The gel was briefly soaked in 20X SSC (3M NaCl and 300mM sodium 
citrate), then RNA was transferred via capillary action onto a nylon membrane (Amersham 
Hybond-N+) overnight in 20X SSC for 16 hours. RNA was crosslinked to the membrane using a 
UV Stratalinker 1800 (Stratagene). After prehybridization with ULTRAhyb buffer at 42°C for 1 
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hr, 4 µL of a DIG-labeled DNA probe specific to the Cd1 riboswitch or the 5S rRNA loading 
control gene was added. After 16 hours, the membrane washed in low and high stringency 
buffers sequentially (NorthernMax-Gly Kit). To detect the DIG-labeled probes on the membrane, 
we used the buffers and followed the manufacturer’s instructions in the DIG High Prime DNA 
Labeling and Detection Starter Kit II (Roche) and the chemiluminescent substrate CDP-Star 
(Roche). Membranes were exposed to film, which was then imaged using a developer. 
 
Detection of TcdA by Western Blot 
 C. difficile was grown as patches on BHIS agar for 24 hours. The patches were 
thoroughly suspended in BHIS, and cell densities were normalized to an OD600 1.0 – 1.5. The 
cells were again pelleted by centrifugation and then suspended in 1X SDS-PAGE sample buffer 
(113) and heated at 95°C for 10 minutes. The lysates were separated on an 8% SDS-
polyacrylamide gel then transferred to a nitrocellulose membrane (Bio-Rad). TcdA was detected 
using a mouse α-TcdA primary antibody (Novus Biologicals) and goat anti-mouse IgG 
conjugated with IR800 (Thermo Fisher) as described previously (44). Detection was done using 
a LI-COR Odyssey Imager (LI-COR Biosciences). Three independent experiments were done, 
each with three to four biological replicates of flg ON and OFF isolates.  
 
Cell Viability Assay 
Vero cells were seeded in 96 well plates at 8,000 cells per well in DMEM (Life 
Technologies) supplemented with 10% Fetal Bovine Serum (Sigma) (DMEM-FBS) and 1X 
Penicillin/Streptomycin (Life Technologies) for 16 hours. C. difficile R20291 flg ON and OFF 
isolates, and a sigD mutant control, were grown on BHIS plates for 16-24 hours. Four colonies 
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of each isolate/strain were grown in TY medium overnight, then diluted 1:50 into fresh TY and 
grown to stationary phase (OD600 ≈ 2.0). Cultures were normalized to the same OD600. Bacteria 
were removed by centrifugation, and supernatants were collected, filter sterilized (0.45 micron), 
and serially diluted in TY medium. For each well with Vero cells, the cell culture medium was 
replaced with fresh DMEM-FBS. Supernatants were added in the following dilutions with cell 
culture media: 1:4, 1:40, 1:80, 1:400, and 1:800. As a negative control, Vero cells were treated 
with TY medium at a 1:4 dilution in DMEM-FBS. After 24 hours at 37°C, the medium was 
carefully removed by aspiration, and 100 µL each of cell culture medium and Promega CellTiter 
Glo reagent were added to each well. After 10 minutes at room temperature on a shaker, Vero 
cell lysates were transferred to opaque-walled 96 well plates. Luminescence was measured using 
a Synergy H1 Hybrid plate reader with Gen5 software (BioTek). Data were combined from two 
independent experiments each with four biological replicates of each isolate/strain. 
 
Identification of the Recombinase That Catalyzes Inversion of the Flagellar Switch  
 Relevant E. coli strains are listed in Table 2.1. Bacteria were passaged onto LB plates 
with ampicillin 50 µg/mL and kanamycin 50 µg/mL and grown overnight for single colonies. 
Bacteria were inoculated into LB with the above-mentioned antibiotics to grow overnight at 
30°C, diluted 1:50 into fresh medium in duplicates, and grown to an OD600 0.4. 
Anhydrotetracycline (ATc) was added to a biological replicate for each flagellar 
switch/recombinase pair at a final concentration of 200 ng/mL, grown until OD600 1.0, and 
plasmids were purified using the GeneJET Plasmid Miniprep Kit (Thermo Fisher). Purified 
plasmids were used as template in an orientation-specific PCR assay to identify the recombinase 




For transmission electron microscopy, C. difficile flg ON and OFF populations were 
isolated on BHIS agar plates as described above and briefly washed in Dulbecco’s PBS (Sigma) 
prior to suspension in PBS-4 % paraformaldehyde for fixation for 1 hour in the anaerobic 
chamber. Cell suspensions were adsorbed onto Formvar/copper grids, washed in water, and 
stained for 30 seconds in two sequential drops of 1.5% aqueous uranyl acetate. Cells were 
observed on a LEO EM 910 Transmission Electron Microscope (Carl Zeiss Microscopy, LLC, 
Thornword, NY) and recorded with a Gatan Orius SC1000 digital camera with Digital 
Micrograph 3.11.0 software (Gatan, Inc., Pleaston, CA). To image bacterial colony morphology, 
we used a Zeiss Stereo Discovery V8 dissecting microscope with a glass stage for illumination of 
bacterial colonies with light from the top and bottom.  
For fluorescence microscopy, C. difficile enriched flg ON and OFF isolates and the sigD 
mutant bearing mCherryOpt reporter fusions (Table 2.1) were cultured overnight in BHIS 
medium, diluted 1:50 in fresh BHIS medium, and grown to an OD600 of ~0.5. For strains with the 
ATc-inducible mCherryOpt reporter (pDSW1728), 15 ng/mL of ATc was added to the culture at 
OD600 ~0.3 to induce transcription of the mCherryOpt gene. One milliliter of each culture was 
briefly pelleted in the anaerobic chamber, washed and suspended in phosphate buffered saline 
(PBS), and fixed according to published methods in PBS and paraformaldehyde (73). After 3 
hours in fixative in the dark at 4°C, bacterial pellets were washed three times in PBS and 
suspended in 0.5 mL PBS with 3 µg/mL 4′,6-diamidino-2-phenylindole (DAPI) to label DNA. 
After overnight incubation at 4°C in the dark, samples were pelleted and suspended in 1 mL of 
PBS. Bacteria were immobilized on agar pads as previously described (73) and covered with 1.5 
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thickness glass cover slips (ThermoFisher) for fluorescence microscopy. The Olympus BX61 
Upright Wide Field Microscope with a 60X/1.42 Oil PlanApo N objective lens was used for 
imaging samples, and Volocity 6.3 software was used for image acquisition. Multiple fields were 
taken for each sample in a coordinated fashion to ensure no repeated sections. Three images were 
automatically taken for each field in the differential contrast (DIC) channel, DAPI channel 
(Excitation: 377 nm (+/- 25 nm), Emission: 447 nm (+/-  30nm)), and Texas Red/RFP channel 
(Excitation: 562 nm (+/- 20 nm), Emission: 642 nm (+/- 20 nm)) with consistent settings for 
side-by-side comparison. Images were processed using the FIJI version of ImageJ (114), and 
bacteria were visually enumerated for +/- mCherryOpt fluorescence, with DAPI staining and 
DIC channels allowing imaging of all bacteria. 
 
Generation of standard curve using known quantities of flg ON and OFF DNA 
The region spanning the promoter of the flgB operon, the 5’ UTR, and the flgB coding 
sequence was amplified by PCR from genomic DNA of C. difficile R20291 flg ON and OFF 
isolates using primers R1512 and R1611. The resulting 1063 bp products, PflgB-
5’UTR(FSON/OFF)-flgB, were digested with BamHI and EcoRI. The phoZ gene was PCR 
amplified from pMC358 template using primers R1609 and R1610. The 1473 bp product was 
digested with EcoRI and SphI. The digested PflgB-5’UTR(FSON/OFF)-flgB and phoZ fragments 
were ligated into BamHI- and SphI-digested pMC123 to generate flg ON (pRT1323) and OFF 
(pRT1324) reporter plasmids for the standard curve. Preparations of these plasmids were mixed 
in known ratios of OFF/ON plasmids (0:100, 10:90, 20:80, 30:70, 40:60, 50:50, 60:40, 70:30, 
80:20, 90:10, 100:0) for the asymmetric PCR-digestion assay. The mixtures were used as 
templates in PCR reactions with R591 and R857 to amplify the flagellar switch region. The PCR 
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products were column purified, digested with the restriction enzyme SwaI, and electrophoresed 
in a 2.5% agarose gel. Images of the EtBr-stained gels were collected under UV using the 
G:BOX Chemi Imaging system, and band intensities in each lane were determined using Image 
J, as previously described (71). 
 
Construction of alkaline phosphatase reporters for use in B. subtilis and C. difficile 
The slpA transcriptional terminator sequence was amplified from pRPF185 with R1848 
and R1849, resulting in a 161 bp product that was digested with BamHI and HindIII and ligated 
into similarly digested pSMB47 to generate pRT1532. Alkaline phosphatase reporter fusions 
were subsequently cloned into this vector, 5’ of the transcriptional terminator. The full length 
reporters (PflgB-5’UTR(FSON/OFF)-flgB::phoZ) were amplified from plasmids RT1323 and 
RT1324 with primers R1512 and R1610. The resulting 2530 bp product was digested with SphI 
and BamHI, and ligated into similarly digested pRT1532. The promoterless phoZ construct was 
made by PCR amplifying phoZ from pMC358 with primers R1632 and R1610, digesting the 
1479 bp product with SphI and BamHI, and ligating into similarly digested pRT1532. The 
PflgB::phoZ reporter was made by PCR amplifying the flgB operon promoter region from C. 
difficile R20291 genomic DNA with primers R1512 and R1608 (250 bp product digested with 
SphI and EcoRI) and phoZ from pMC358 with primers R1609 and R1610 (1476 bp product 
digested with EcoRI and BamHI). Digested products for PflgB and phoZ were ligated into BamHI- 
and SphI-digested pRT1532. To generate fusions of the flagellar switch only (FSON/OFF) to phoZ, 
the region downstream of the Cd1 riboswitch was amplified by PCR with primers R1673 and 
R1610 using pRT1323 and pRT1324 as templates for the flg ON and OFF orientations, 
respectively. The 2109 bp PCR products were digested with SphI and BamHI and ligated into 
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similarly digested pRT1532. Purified plasmids for each reporter were transformed into Bacillus 
subtilis BS49, as previously described (71, 112), and are listed in Table 2.1. Transformants with 
a flagellar switch were screened by orientation-specific PCR with R1614/1615 and R1706 to 
ensure that the expected orientation of ON or OFF was present and maintained. BS49 strains 
were conjugated with C. difficile R20291, and transformants were selected for lincomycin and 
tetracycline resistance, as previously described (112). C. difficile transformants were screened for 
the Tn916 AP reporter by PCR and for the orientation of the native flagellar switch and the 
Tn916 AP reporter flagellar switch using the asymmetric PCR-digestion assay.  
 
Cloning of the putative recombinase genes for expression in E. coli and C. difficile 
The genes for the eight recombinases conserved in the C. difficile genomes are listed with 
the R20291 locus tag: CDR20291_1004 (recV), CDR20291_1060, CDR20291_1068, 
CDR20291_1174, CDR20291_1826, CDR20291_1855, CDR20291_1973, and 
CDR20291_3416. The genes were amplified from C. difficile R20291 genomic DNA with 
primers named according to the pattern “locus tag F” and “locus tag R” (Table 2.2). PCR 
products were digested with KpnI and HindIII, except PCR products for CDR20291_1826 and 
CDR20291_1973 were digested with KpnI and BamHI. All PCR products were ligated into 
similarly digested pMWO-074 and transformed into E. coli DH5α. Sequence integrity was 
confirmed by sequencing the insertion in each resulting plasmid. Plasmids were purified from 
DH5α and co-transformed with either PflgB-5’UTR(FSON)-flgB::phoZ (RT1323) or PflgB-
5’UTR(FSOFF)-flgB::phoZ (RT1324) into E. coli DH5α to generate strains with a plasmid 
encoding one conserved recombinase and with a plasmid containing the flagellar switch in the 
ON or OFF orientation (Table 2.1).  
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To express recV in C. difficile, the C. difficile R20291 recV gene was PCR amplified 
from pRT1164 using primers R1853 and R1854. The 628 bp PCR product was digested with 
SacI and BamHI, ligated into similarly digested pRPF185, and transformed into E. coli DH5α, 
yielding strain pRT1529. The purified plasmid was transformed into E. coli HB101(pRK24) to 
allow transfer by conjugation of the recV expression plasmid into C. difficile R20291 flg ON and 
OFF isolates. Thiamphenicol and kanamycin resistant C. difficile transconjugants were selected 
for evaluation (112). A control plasmid of the ATc-inducible expression vector was generated by 
removing the gusA gene from pRPF185 by digestion with SacI and BamHI and religating the 
vector backbone following treatment with Klenow. The vector was introduced into C. difficile 
R20291 flg ON and OFF isolates via conjugation with E. coli HB101(pRK24), and 
thiamphenicol and kanamycin resistance colonies were selected (112). The presence of plasmids 
in C. difficile was confirmed by PCR with plasmid-specific primers flanking the multiple cloning 
site. 
 
Generation of the C. difficile R20291 sigD mutant  
 To generate the sigD mutant in R20291, we used the previously generated retargeting 
plasmid pBL100::sigD (pRT1073), which inserts the Group II intron targeting sequence into 
sigD after nucleotide position 228 (60). pRT1073 was transformed into E. coli HB101(pRK24) 
to allow its transfer into C. difficile R20291 via conjugation. Thiamphenicol- and kanamycin-
resistant transconjugants were selected and passaged on BHIS-agar with lincomycin to identify 
clones with an insertion of the Group II intron. Candidate mutants were screened by PCR with 
primers for the sigD gene and for the Group II intron as described in Fig 2.9.  
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Construction of mCherryOpt reporter fusions and introduction into C. difficile 
 The pDSW1728 plasmid with the mCherryOpt gene under the transcriptional control of 
an anhydrotetracycline-inducible promoter (gifted by Dr. Craig Ellermeier) served as the base for 
reporter construction (72, 73). To generate pPflgM::mCherryOpt, PflgM was PCR amplified from 
R20291 genomic DNA using primers R2117 and R2046 and digested with NheI and SacI to 
generate a 51 bp product. The NheI and SacI digested PflgM was ligated into similarly digested 
pRPF144. The mCherryOpt gene was digested from pDSW1728 with SacI and BamHI. The 739 
bp product was ligated into similarly digested pRPF144 with PflgM , yielding pRT1676. To 
generate the promoterless vector control plasmid (p::mCherryOpt), pPflgM::mCherryOpt  was 
digested with NheI and SacI to remove the PflgM, and the vector backbone was treated with 
Klenow before being religated to yield pRT1685. The plasmids were confirmed by PCR and 
sequencing of the insertions, then transformed into E. coli HB101(pRK24) to allow conjugation 
with C. difficile R20291 enriched flg ON and flg OFF, and sigD::ermB as appropriate. 
Thiamphenicol- and kanamycin-resistant colonies were selected, and plasmids were detected by 
PCR with vector specific primers. 
 
Generation of C. difficile recV mutant derivatives 
 The C. difficile R20291 recV::ermB (recV) cwpV ON* and OFF* (* locked) were 
obtained from Dr. Louis-Charles Fortier (84). Orientation-specific PCR (Fig 1A) was performed 
to determine the orientation of the flagellar switch using primers R1614 and R857 for the ON 
orientation (375 bp) and R1615 and R857 for the OFF orientation (281 bp). Both recV isolates 
were found to be flg OFF* (Fig 2.15). To obtain a recV flg ON* isolate, we took advantage of the 
facts that pRPF185::recV (pRT1529) has leaky transcription in the absence of inducer, and that 
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low levels of RecV are sufficient to promote a mixed population of flg ON and OFF bacteria (Fig 
2.17). The C. difficile R20291 recV cwpV OFF* and flg OFF* isolate (RT1693) was conjugated 
with E. coli HB101(pRK24) transformed with pRT1529 to obtain thiamphenicol and kanamycin 
resistant transconjugant RT1697. RT1697 was passaged in TY broth medium, diluting every 24 
hours for 4 days in the absence of thiamphenicol selection to allow plasmid loss and to obtain a 
mixture of genetic switch orientations. Broth cultures were sampled on the 4th day and cultured 
on plain BHIS agar to obtain single colonies. Eight single colonies were replica plated on BHIS 
+/- thiamphenicol plates. Colonies that were sensitive to thiamphenicol (indicating plasmid loss) 
were evaluated for the orientations of the flagellar and cwpV switches by orientation-specific 
PCR. The cwpV switch orientation was determined to identify a cwpV OFF* isolate, to prevent 
implication of cwpV in any phenotypes attributed to the flagellar switch. Primers R1920 and 
R1050 were used to detect the cwpV switch in the OFF orientation (493 bp product), while 
primers R1921 and R1050 were used to detect the cwpV ON orientation (346 bp product). Two 
recV flg ON*/cwpV OFF* clones were obtained, RT1702 and RT1703. Complementation of the 
recV flg ON* mutant was achieved by conjugation with E. coli HB101(pRK24) transformed with 
pRPF185::recV (pRT1529) and isolateion of thiamphenicol and kanamycin resistant 
transconjugants.  
 
Construction of C. difficile strains for swimming motility assay and western blot 
 E. coli (pRK24) transformed with pRT1611 (reporterless derivative of pRPF185) was 
conjugated with the following C. difficile R20291 strains: enriched flg ON, enriched flg OFF, 
sigD, recV flg ON* (cwpV OFF*), and recV flg OFF* (cwpV OFF*). Thiamphenicol and 
kanamycin resistant C. difficile transconjugants were selected for evaluation. These strains are 
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listed in the Table 2.1 and were used in the swimming motility assay and western blot for TcdA 
in Figure 2.18 with recV mutants complemented with recV on as plasmid.  
 
Evaluation of the flgB operon regulatory region from recV flg OFF* motile suppressors 
 The region upstream of the flgB operon consisting of the promoter and 5’UTR was 
amplified by PCR using primers R1512 and R1611 to generate a 1066 bp product from the 
following C. difficile R20291 recV strains: flg ON*, flg OFF*, and the eight flg OFF* motile 
suppressor mutants. The 1066 bp product was cloned into the pCR4-TOPO vector 
(ThermoFisher), as described by the manufacturer’s instructions, transformed into E. coli DH5α, 
and selected on agar medium for ampicillin resistance and loss of 5-bromo-4-chloro-3-indolyl-β-
D-galactopyranoside (X-Gal) activity. White colonies were screened by colony lysis PCR for 
insertion of the 1066 bp into the vector using vector specific primers. Plasmid was purified from 
positive transformants and used as template in orientation-specific PCR to evaluate the 
orientation of the flagellar switch. PCR products were resolved in a 2.5% agarose gel and stained 
with EtBr for visualization. The region of interest was also sequenced using plasmid specific 
primers that flank the 1066 bp regulatory region and flgB gene. Sequencing results for the 1066 
bp region from the eight recV flg OFF* suppressor mutants showed neither single nucleotide 





Figure 2.1. Evidence for DNA inversion at the flagellar switch. (A) Nucleotide sequences 
corresponding to the 5’ UTR of the flgB operon from genome sequences available for PCR 
ribotype 027 strains were aligned using Clustal Omega. Shown are the regions corresponding to 
the putative flagellar switch and flanking imperfect inverted repeats. For strain BI1 “inverse”, the 
alignment was repeated after replacing the putative switch with its reverse complement. Identical 
nucleotides are indicated with blue shading. (B) Diagram of the PCR strategy used to detect the 
putative flagellar switch orientation. The primer names and sequences used for each strain are 
listed in the Table 2.2. The predicted product sizes are based on R20291 sequence. (C) 
Orientation-specific PCR products for the flagellar switch from three C. difficile strains 
representing three ribotypes (R20291, 027, NCBI Accession No FN545816.1; ATCC43598, 017, 
NCBI sequence read archive SRX656590 (115); 630Δerm, 012, NCBI Accession No. 
EMBL:LN614756 (116)).
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Figure 2.2. Enrichment for flagellar phase variant populations. (A) Diagram of the 
asymmetric PCR-digestion method used to determine the proportions of bacteria in the 
population with the putative flagellar switch in each orientation. (B) Representative images of C. 
difficile R20291 colonies after 24 hours of growth, which are circular with smooth edges (left), 
and after 72 hours of growth, which are rough with filamentous edges (right). (C) Asymmetric 
PCR-digestion assay showing the proportions of bacteria with the flagellar switch in each 
orientation within colonies collected every 24 hours for four days. Below each lane is the 
percentage of the colony population in which the flagellar switch is in the inverse orientation, 
calculated by comparing relevant band intensities to the total normalized to a standard curve. (D) 
Quantitative measurements of the percentage of bacteria in each colony with the switch in the 
inverse orientation over the course of four days, with relevant band intensities normalized to a 
standard curve. Each circle represents one of eight biological replicates monitored over time. * p 
< 0.05, ** p < 0.01 by one-way ANOVA and Dunnett’s multiple comparisons test.  
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Figure 2.3. Spore stocks of C. difficile R20291 contain both flg ON and OFF bacteria. 
Boiled lysates of C. difficile R20291 spores served as the templates in an asymmetric PCR-
digestion assay with primers R591 and R857 and the restriction enzyme SwaI. Shown are the 
results for two independent spore preparations.  
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Figure 2.4. Assessing the purity of enriched populations. (A, B) Asymmetric PCR-digestion 
assay of genomic DNA to determine the orientation of the flagellar switch in individual colonies. 
Bacteria from individual colonies contain the switch predominantly in the published orientation 
(A) or the inverse orientation (B). Two representatives of each are shown. (C) Quantitative PCR 
results of the flagellar switch orientation in enriched phase variant populations (published, n=9; 
inverse, n=10). The ΔΔCt method was used to determine the relative DNA copies of the flagellar 
switch orientation in enriched populations relative to the rpoC gene. 
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Figure 2.5. Stability of the flagellar switch during growth in liquid and solid media. (A) 
Asymmetric PCR-digestion assay with template from enriched C. difficile R20291 flg ON and 
OFF isolates grown on an agar surface for 24 hours and 48 hours. T0 represents the cultures used 
to inoculate the agar plates. (B) Asymmetric PCR-digestion assay of C. difficile R20291 flg ON 
and OFF isolates grown in BHIS medium collected at T0, two exponential phase time points 
(EXP, OD600 0.5 and 1.0), and two stationary phase time points (STAT, OD600 1.8 and overnight, 
O/N). Images are representative from two independent experiments with four replicates of each 
flg phase. (C) Growth curve of C. difficile R20291 flg ON and OFF isolates in BHIS medium. 
Data are combined from two independent experiments each with two replicates of each flg phase, 
and means and standard deviations are shown.  
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Figure 2.6. Appearance of smooth, circular (SC) and rough, filamentous (RF) colony 
morphotypes. C. difficile R20291 spores were plated on BHIS agar supplemented with 
taurocholate to obtain single colonies. After 24 hours, individual colonies were suspended in 
media and spotted onto fresh BHIS plates. Every 24 hours for four days, colony spots were 
suspended, serially diluted, and plated on BHIS to enumerate colonies based on their 
morphologies. (A) We observed two distinct colony morphologies based on colony texture and 
edge– a smooth, circular (SC) morphotype, and a rough, filamentous (RF) morphotype. (B) The 
percentage of RF colonies increased, and the percentage of SC colonies decreased over time. 
Using the asymmetric PCR-digestion assay to determine the orientation of the flagellar switch in 
SC and RF colonies after 96 hours, colony morphology and switch orientation were determined 
to be unlinked. 72% of bacteria in the SC colonies had the flagellar switch in the published 
orientation, and 64% in the RF colonies had the switch in the inverse orientation. (C,D) Bacteria 
from SC and RF colony morphology maintained their respective characteristic morphologies 




      
Figure 2.7. The orientation of the flagellar switch impacts the expression of the 
downstream flagellar genes. (A) Asymmetric PCR-digestion assay performed on C. difficile 
R20291 isolates with the flagellar switch in the published and inverse orientations respectively. 
(B) qRT-PCR was used to determine the abundance of representative flagellar gene transcripts in 
isolates with the flagellar switch in the published and inverse orientation. Four independent 
isolates were tested, and Ct values for each flagellar gene and the codY gene (non-regulated 
control) were normalized to those of the housekeeping gene rpoC; the published orientation 
samples were arbitrarily chosen as the reference condition. Shown are the means and standard 
deviations. * p < 0.05 by t-tests comparing mean transcript abundances between published and 
inverse samples, n = 4. (C) Visualization of flagella by transmission electron microscopy at 
25,000X magnification. Size bars = 1 micron. Representative images of bacterial flagellar switch 
isolates are shown. Arrowheads indicate flagella. (D) Micrographs of enriched flg ON, flg OFF, 
and a sigD mutant transformed with the pPflgM::mCherryOpt reporter. Channels used are 
indicated for each column; the fourth column images are a merge of the DIC, DAPI, and RFP. 
RFP positive and negative bacteria were visually enumerated relative to the DIC and DAPI 





Figure 2.8.  Quantification and controls for fluorescence microscopy studies in Fig 2.7. (A) 
Frequency of RFP (mCherryOpt)-positive and -negative bacteria for strains evaluated in Fig. 
2.7D. Number of bacteria counted per group transformed with PflgM::mCherryOpt: flg ON 
(n=3321 bacteria; 7 biological replicates), flg OFF (n=3720 bacteria; 6 biological replicates), and 
sigD (n=1348, 3 biological replicates).  (B) Frequency of RFP (mCherryOpt)-positive and -
negative bacteria of strains in panel C. Number of bacteria counted per group transformed with 
PTet::mCherryOpt: flg ON (n=662 bacteria; 3 biological replicates) and flg OFF (n=401 bacteria; 
3 biological replicates). Number of bacteria counted per group transformed with promoterless 
::mCherryOpt: flg ON (n=964 bacteria; 3 biological replicates), flg OFF (n=772 bacteria; 3 
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biological replicates), and sigD (n=670, 3 biological replicates).  (C) Representative fluorescence 
micrographs for the indicated strains containing fusions of mCherryOpt to the Ptet promoter 
(grown with ATc, positive control) or promoterless mCherryOpt (negative controls). White bar = 




Figure 2.9. Construction and confirmation of the sigD mutation in C. difficile R20291. (A). 
Schematic diagram of the Group II intron disruption of sigD in C. difficile R20291 
(CDR20291_0270). The Targetron construct was designed previously to insert at nucleotide 
position 228 of the sigD gene in the sense orientation (60). The sigD gene is 702 bp. The forward 
and reverse primers, R1887 (red arrow) and R1888 (green arrow), partially flank sigD and 
produce a PCR product of 716 bp. Insertion of the Group II intron into sigD (sigD::ermB) results 
in a PCR product of ~2500 bp. A second PCR reaction was used to confirm sigD by using R991, 
a Group II intron specific primer called EBS Universal. A PCR reaction with the R1887 and 
R991 yields a product of ~450 bp if the Group II intron is in sigD. (B). Image of an EtBr stained 
agarose gel with PCR products for the different reactions detailed in (A). Lane 1: Wildtype 
R20291 used as template with primers R1887 and R1888. Lane 2: The putative R20291 sigD 
mutant used as template with primers R1887 and R1888. Lane 3: The putative R20291 sigD 
mutant used as template with primers R1887 and R991. 
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Figure 2.10. Motility medium spatially segregates flagellar phase variant populations. (A) 
The motility of C. difficile R20291 flg ON and OFF isolates was evaluated in soft agar medium. 
A non-motile R20291 sigD mutant was included as a control. (B) The motility of flg ON and 
OFF isolates was quantified by measuring the diameters every 24 hours for 3 days, and means 
and standard deviations are shown. * p < 0.05 by t-tests comparing values at each time point. The 
data are combined from two independent experiments with four biological replicates of each flg 
phase. (C) At 24, 48 and 72 hours, bacteria were sampled from the center and edges of the 
growth in the motility assays for flg ON and OFF isolates (top and bottom panels, respectively) 
and subjected to asymmetric PCR-digestion assays. Black arrows indicate products for the ON 
orientation; open arrows, the OFF orientation. Shown are representative images from 2 





Figure 2.11. The orientation of the flagellar switch impacts toxin production. (A) qRT-PCR 
was used to determine the abundance of the indicated transcripts in flg ON and OFF isolates of 
C. difficile R20291. Four independent isolates were tested, and Ct values for each gene were 
normalized to those of the housekeeping gene rpoC; the flg ON samples were arbitrarily chosen 
as the reference condition. Shown are means and standard deviations. * p < 0.05 by t-tests 
comparing mean transcript abundances between flg ON and OFF samples, n = 4. (B) TcdA 
protein levels in cell lysates of flg ON and OFF isolates were evaluated by western blot. Shown 
is a representative image for three independent experiments each with at least three replicates of 
each flg phase. (C) The flg ON and OFF isolates, as well as the sigD mutant control, were grown 
to stationary phase in TY medium. The supernatants were serially diluted and applied to Vero 
cells for 24 hours. Cell viability was assessed using the CellTiter Glo assay. Data are combined 
from two independent experiments each with four replicates of sigD mutant and flg phase 
variants, and means and standard deviations are shown. ** p < 0.01, *** p < 0.001 by one-way 




            
Figure 2.12. The orientation of the flagellar switch controls flagellar gene expression post-
transcription initiation. (A) Diagram of the reporter gene fusions. The known flgB operon 
promoter, the Cd1 c-di-GMP riboswitch, and the orientation of the flagellar switch are indicated, 
if present. (B,C) The fusions in A were integrated into the C. difficile R20291 chromosome (left) 
or the B. subtilis BS49 chromosome via Tn916 (112). Alkaline phosphatase (AP) activity was 
measured as described previously (77). Means and standard deviations are shown. *** p < 0.001 
by one-way ANOVA and Bonferroni’s multiple comparisons test, n = 8. n.s. = not significant. 
(D) Northern blot detection of the phoZ-containing transcripts from C. difficile R20291 bearing 
fusions 3 or 4. The full length (FL) transcript of ~2400 nt is indicated. 5S RNA served as the 





Figure 2.13. Confirmation of flagellar switch orientation accompanying alkaline 
phosphatase assays in C. difficile and B. subtilis. (A, B) Asymmetric PCR-digestion assay to 
determine the orientation of the flagellar switch. For the native locus, we used primers R1705 
and R1704 in PCR reactions. R1705 (forward primer) anneals 3’ of the Cd1 riboswitch DNA 
sequence, and R1704 (reverse primer) anneals to the second gene in the flgB operon, flgC 
(CDR20291_0249). For the reporter locus (B), we used R1705 and R1706, a reverse primer that 
anneals to the alkaline phosphatase gene, phoZ, for PCR amplification. Biological replicates for 
each AP reporter in C. difficile R20291 were combined and genomic DNA was extracted, based 
on published methods, to simultaneously determine the orientation of the native flagellar switch 
in each. The numerical designations for each reporter are shown in parentheses and correspond 
to Fig. 2.12A. We confirmed that both the native and reporter flagellar switches for each AP 
reporter strain were in their expected orientations. (C) Orientation-specific PCR assay of AP 
reporters #3-6 in B. subtilis showing that the AP reporter flagellar switches maintained their 
orientations.  
  
No Pr (1) Reporter: 
Native flg: ON    OFF ON   OFF ON   OFF ON   OFF ON    OFF ON    OFF 
Pr only (2) Full ON (3) Full OFF (4) FS ON (5) FS OFF (6) 




ON   OFF Native flg: ON   OFF ON   OFF ON   OFF 
Full ON (3) Full OFF (4) FS ON (5) FS OFF (6) 
ON    ON ON    ON OFF  OFF OFF  OFF 




C B. subtilis: Reporter flagellar switch: 
Full ON (3) Full OFF (4) Reporter: FS ON (5) FS OFF (6) 
ON    OFF ON    OFF ON    OFF ON   OFF Primer: 






Figure 2.14. Alkaline phosphatase activity of the phoZ gene reporters in C. difficile flg OFF. 
Activity was assessed as described in the main text in tandem with the same reporters in the 
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Figure 2.15. Identification of the recombinase that mediates inversion of the flagellar 
switch. (A,B) Orientation-specific PCR (Fig 1B) assays to identify the conserved recombinase 
that catalyzes inversion at the flagellar switch from ON to OFF (A) and OFF to ON (B). The 
gene name or R20291 locus tag numbers for the eight conserved recombinases are shown. A 375 
bp product indicates the ON orientation; a 281 bp product indicates the OFF orientation. (C) 
Orientation-specific PCR for the flagellar switch to determine whether the recV cwpV locked ON 
and OFF mutants were locked for the flagellar switch. (D) Orientation-specific PCR for the 





Figure 2.16. Expression of recV in C. difficile flg ON and flg OFF isolates stimulates 
inversion of the flagellar switch. (A) Asymmetric PCR-digestion assay of products from C. 
difficile R20291 flg ON and OFF isolates transformed with pRT1611 (V, vector), or pRT1529 
(pRPF185::recV), grown with or without 10 ng/ml ATc (Table 2.1). (B) Increased transcription 
of recV occurs in C. difficile with pRT1529 in the absence of ATc induction. qRT-PCR 
measuring transcript abundance of recV and codY control gene in R20291 flg ON and OFF, each 
with pRT1611 (vector) and RT1529 (recV). Data were normalized to the rpoC gene and 























flg ON + pRPF185:EV
flg ON + pRPF185:recV
flg OFF + pRPF185:EV
flg OFF + pRPF185:recV
flg N + pRT 611 
flg N + pRT 529 
flg FF + pRT 611 












Figure 2.17. Identification of C. difficile R20291 recV flg ON* mutants. C. difficile R20291 
recV flg OFF* strain was transformed with a plasmid for expression of recV to allow flagellar 
switch inversion. The strain was then passaged without antibiotics to allow plasmid loss. Five 
thiamphenicol-sensitive colonies were identified and screened by PCR as in Fig. 2.1B for the 
orientation of the cwpV and flagellar switches. Shown: orientation-specific PCR assay of five 
isolates, two of which (#1, #3) have the flagellar switch in the ON orientation; both have the 












ON   OFF ON   OFF ON   OFF ON   OFF ON   OFF 
Isolate:####1##############2#############3##############4############5#









Figure 2.18. Mutation of recV results in phase-locked motility and toxin production. (A,B) 
C. difficile strains were assayed for motility in BHIS-0.3% agar. (A) Photographs were taken 
every 24 hours, and a representative image from 48 hours is shown. (B) Measurements of the 
diameters of motility were taken at 24, 48 and 72 hours. Shown are means and standard 
deviations from six biological replicates. ** p < 0.01, *** p < 0.001, by two-way ANOVA and 
Tukey’s multiple comparison test, comparing to flg ON/pPtet. (C) TcdA protein levels in cell 
lysates were evaluated by western blot. Shown is a representative image of three independent 





Figure 2.19. Isolation of motile recV flg OFF* suppressor mutants. (A) Representative image 
of a motility assay after 72 hours, with flg ON/pPtet (RT1615), flg OFF/pPtet (RT1617), sigD/pPtet 
(RT1690), recV flg ON*/pPtet (RT1715), recV flg ON*/pPtet::recV (RT1716), recV flg OFF*/pPtet 
(RT1691), and recV flg OFF*/pPtet::recV (RT1697). Strain numbers are listed in parentheses. 
The recV flg OFF*/pPtet::recV (RT1691) showed motility upon this prolonged incubation. (B) 
Orientation-specific PCR assay of the flagellar switch from recV flg ON*, recV flg OFF*, and 
three motile suppressor (MS) mutants of recV flg OFF* (pRT1719 – RT1724). Image 
representative of two independent experiments with eight biological replicates of motile 
suppressor mutants of recV flg OFF*. 
  


























Figure 2.20. Sequence alignment of the flagellar switch and inverted repeat sequences from 
NCBI accessible genomes of C. difficile. The following C. difficile genomes were used in a 
sequence alignment for the flagellar switch: 630, BI9, M68, CF5, R20291, CD196, BI1, and 
2007855. 
  
630          AAGTTACTATTTTACAAAAA-  GAGCAACTTTTCGAAGAAATATTTAAATACATATTAAAATTTTT  64 
BI9          AAGTTACTATTTTACAAAAAA  GAGCAACTTTTCGAAGAAATATTTAAATACATATTAAAATTTTT  65 
M68          AAGTTACTATTTTACAAAAAA  GAGCAACTTTTTGAAGAAATATTTAAATACATATTAAAATTTTT  65 
CF5 Inverse  AAGTTACTATTTTACAAAAAA  GAGCAACTTTTTGAAGAAATATTTAAATACATATTAAAATTTTT  65 
R20291       AAGTTACTATTTTACAAAAAA  AGGCAACTTTATAAAGAAATATTTAAATTTATATTAAAATATTT  65 
CD196        AAGTTACTATTTTACAAAAAA  AGGCAACTTTATAAAGAAATATTTAAATTTATATTAAAATATTT  65 
BI1 Inverse  AAGTTACTATTTTACAAAAAA  AGGCAACTTTATAAAGAAATATTTAAATTTATATTAAAATATTT  65 
2007855      AAGTTACTATTTTACAAAAAA  AGGCAACTTTATAAAGAAATATTTAAATTTATATTAAAATATTT  65 
 
 
630          TTATATTTTCATGGGACTTCATTAAAAAAATATTAGTTTTCTTACTAAATTGATACATTATTGTATT  131 
BI9          TTATATTTTCATGGGACTTCATTGAAAAAATATTAGTTTTCTTACTAAAATGATACATTATTGTATT  132 
M68          TTATATTTTCATGGGACTTCATTGAAAAAATATTAGTTTTCTTACTAAAATGATACATTATTGTATT  132 
CF5 Inverse  TTATATTTTCATGGGACTTCATTGAAAAAATATTAGTTTTCTTACTAAAATGATACATTATTGTATT  132 
R20291       TTATATTTTTATTAGGATTTACGAAAATAATATTAGTTTTCTTACCAAAGTGATACATTATTATATT  132 
CD196        TTATATTTTTATTAGGATTTACGAAAATAATATTAGTTTTCTTACCAAAGTGATACATTATTATATT  132 
BI1 Inverse  TTATATTTTTATTAGGATTTACGAAAATAATATTAGTTTTCTTACCAAAGTGATACATTATTATATT  132 
2007855      TTATATTTTTATTAGGATTTACGAAAATAATATTAGTTTTCTTACCAAAGTGATACATTATTATATT  132 
 
 
630          AATGTAATGGAAATGCGATTAATTTAAATAAATAAAGAAGTCA  TT-TTTGTAATATAGCAACTT   195 
BI9          AATGTAATGGAAATGCGATTAATTTAAATGAATAAAGAAGTCA  TTTTTTGTAATATAGCAACTT   196 
M68          AATGTAATGGAAATGCGATTAATTTAAATGAATAAAGAAGTCA  TTTTTTGTAATATAGCAACTT   196 
CF5 Inverse  AATGTAATGGAAATGCGATTAATTTAAATGAATAAAGAAGTCA  TTTTTTGTAATATAGCAACTT   196 
R20291       AATGTAATAGAAATGTAATTAATTTGGATGAATAAAGAAGTCA  TTTTTTGTAATATAGCAACTT   196 
CD196        AATGTAATAGAAATGTAATTAATTTGGATGAATAAAGAAGTCA  TTTTTTGTAATATAGCAACTT   196 
BI1 Inverse  AATGTAATAGAAATGTAATTAATTTGGATGAATAAAGAAGTCA  TTTTTTGTAATATAGCAACTT   196 
2007855      AATGTAATAGAAATGTAATTAATTTGGATGAATAAAGAAGTCA  TTTTTTGTAATATAGCAACTT   196 
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Table 2.1: Strains and plasmids used in this study. 
Strain/Plasmid Description/Purpose Reference 
Plasmids   
pMC123 E. coli – C. difficile shuttle vector; AmpR, CmR/TmR (117) 
pMC358 pMC123 with Enterococcus faecalis phoZ, including native phoZ 
promoter 
(77) 
pRT1323 pMC123::PflgB-5’UTR(FSON)-flgB::phoZ pMC123 with flgB operon 
promoter, 5’ UTR with the flagellar switch in the ON orientation, and 
flgB, fused to phoZ  
This work 
pRT1324 pMC123::PflgB-5’UTR(FSOFF)-flgB::phoZ pMC123 with flgB operon 
promoter, 5’ UTR with the flagellar switch in the OFF orientation, and 
flgB, fused to phoZ  
This work 
pSMB47 Tn916 integrational vector ErmR/CmR (118) 
pRT1532  pSMB47::slpATT;  pSMB47 with the C. difficile 630 slpA Rho-
independent terminator  
This work 
pRT1346 Promoterless phoZ in pRT1532 (::phoZ) This work 
pRT1345 C. difficile R20291 flgB operon promoter fused to phoZ in pRT1532 
(PflgB::phoZ) 
This work 
pRT1326 C. difficile R20291 flgB operon promoter, 5’ UTR with the flagellar 
switch in the ON orientation, and flgB, fused to phoZ in pRT1532 
(PflgB-5’UTR(FSON)-flgB::phoZ) 
This work 
pRT1344 C. difficile R20291 flgB operon promoter, 5’ UTR with the flagellar 
switch in the OFF orientation, and flgB, fused to phoZ in pRT1532 
(PflgB-5’UTR(FSOFF)-flgB::phoZ) 
This work 
pRT1254 C. difficile R20291 flagellar switch in the ON orientation and flgB, 
fused to phoZ in pRT1532 (FSON-flgB::phoZ) 
This work 
pRT1286 C. difficile R20291 flagellar switch in the OFF orientation and flgB 
gene, fused to phoZ in pRT1532 (FSOFF-flgB::phoZ) 
This work 
pMWO-074 Low copy anhydrotetracycline inducible expression vector, KanR (85) 
pRT1164 pMWO-074::recV (CDR20291_1004)  This work 
pRT1165 pMWO-074::xerD1 (CDR20291_1060)  This work 
pRT1166 pMWO-074::CDR20291_1068  This work 
pRT1167 pMWO-074::xerD2 (CDR20291_1174)  This work 
pRT1221 pMWO-074::CDR20291_1826  This work 
pRT1222 pMWO-074::CDR20291_1855  This work 
pRT1223 pMWO-074::CDR20291_1973  This work 
pRT1224 pMWO-074::CDR20291_3416  This work 
pRPF185 Anhydrotetracycline (ATc) inducible expression vector; CmR/Tm10 (87) 
pRT1611 β-glucuronidase gene, gusA, removed to generate reporterless 
derivative of pRPF185 
This work 
pRT1529 pRPF185::recV (CDR20291_1004)  This work 
pBL100 Targetron vector containing untargeted group II intron; AmpR (119) 
pRT1073 pBL100::sigD, for Targetron integration at nucleotide position 228 of 
sigD (CDR20291_0270), sense orientation 
(23, 60) 
pDSW1728 mCherryOpt; gene in MCS downstream of anhydrotetracycline-
inducible promoter system derivative of pRPF185 (RT1685) 
(72) 
pRPF144 E. coli-C. difficile shuttle vector with Pcwp2::gusA cassette; CmR/TmR (87) 
pRT1676 pRPF144::PflgM::mCherryOpt (replaces Pcwp2::gusA in pRPF144 with 
PflgM) 
This work 
pRT1483 pRPF144::mCherryOpt (promoterless) This work 
pRT1719 E. coli DH5α pCR4-TOPO: PflgB-5'UTR(FSON)-flgB cloned from   C. 
difficile R20291 RT1702 
This work 
pRT1720 E. coli DH5α pCR4-TOPO: PflgB-5'UTR(FSOFF)-flgB cloned from   C. This work 
! 115!
difficile R20291 RT1693 
pRT1721 E. coli DH5α pCR4-TOPO: PflgB-5'UTR(FSOFF)-flgB cloned from   C. 
difficile R20291 RT1704 
This work 
pRT1722 E. coli DH5α pCR4-TOPO: PflgB-5'UTR(FSOFF)-flgB cloned from   C. 
difficile R20291 RT1705 
This work 
pRT1723 E. coli DH5α pCR4-TOPO: PflgB-5'UTR(FSOFF)-flgB cloned from   C. 
difficile R20291 RT1706 
This work 
pRT1724 E. coli DH5α pCR4-TOPO: PflgB-5'UTR(FSOFF)-flgB cloned from   C. 
difficile R20291 RT1707 
This work 
   




DH5α F- Φ80lacZ Δ M15 (lacZYA-argF)U169 recA1 endA1 hsdR17(rκ -, 
mκ +) phoA supE44 thi-1 gyrA96 relA1 λ - tonA 
Invitrogen, (120) 
HB101(pRK24) F- mcrB mrr hsdS20(rB-mB)recA13 leuB6 ara-14 proA2 lacY1 galK2 
xyl-5 mtl-1 rpsL20 (pRK24) 
(117) 
RT1246 E. coli DH5α co-transformed with pRT1323 and pRT1164 This work 
RT1247 E. coli DH5α co-transformed with pRT1323 and pRT1165 This work 
RT1248 E. coli DH5α co-transformed with pRT1323 and pRT1166 This work 
RT1249 E. coli DH5α co-transformed with pRT1323 and pRT1167 This work 
RT1250 E. coli DH5α co-transformed with pRT1323 and pRT1221 This work 
RT1251 E. coli DH5α co-transformed with pRT1323 and pRT1222 This work 
RT1252 E. coli DH5α co-transformed with pRT1323 and pRT1223 This work 
RT1253 E. coli DH5α co-transformed with pRT1323 and pRT1224 This work 
RT1310 E. coli DH5α co-transformed with pRT1324 and pRT1164 This work 
RT1311 E. coli DH5α co-transformed with pRT1324 and pRT1165  This work 
RT1312 E. coli DH5α co-transformed with pRT1324 and pRT1166  This work 
RT1313 E. coli DH5α co-transformed with pRT1324 and pRT1167 This work 
RT1314 E. coli DH5α co-transformed with pRT1324 and pRT1221 This work 
RT1315 E. coli DH5α co-transformed with pRT1324 and pRT1222  This work 
RT1316 E. coli DH5α co-transformed with pRT1324 and pRT1223 This work 
RT1317 E. coli DH5α co-transformed with pRT1324 and pRT1224 This work 
   




BS49 CU2189::Tn916 for conjugation into C. difficile; TetR (121) (122) 
RT1392 BS49 transformed with pRT1346 (promoterless phoZ)  This work 
RT1393 BS49 transformed with pRT1345 (PflgB::phoZ) This work 
RT1394 BS49 transformed with pRT1326 (PflgB-5’UTR(FSON)-flgB::phoZ) This work 
RT1395 BS49 transformed with pRT1344 (PflgB-5’UTR(FSOFF)-flgB::phoZ) This work 
RT1331 BS49 transformed with pRT1254 (FSON-flgB::phoZ) This work 
RT1332 BS49 transformed with pRT1286 (FSOFF-flgB::phoZ) This work 
   
   




630Δerm Ribotype 012, erythromycin susceptible derivative of C. difficile 630 (123) 
ATCC 43598 Ribotype 017, gift from Shonna McBride ATCC 
R20291 Ribotype 027, epidemic isolate (19) 
RT1566 C. difficile R20291 with a Targetron insertion at nucleotide position 
228 of sigD, sense orientation (sigD::erm) 
This work 
RT1536  C. difficile R20291 flg ON isolate with  promoterless phoZ fusion This work 
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integrated on the chromosome via Tn916 (RT1392)  
RT1537  C. difficile R20291 flg OFF isolate with promoterless phoZ fusion 
integrated on the chromosome via Tn916 (RT1392)  
This work 
RT1538  C. difficile R20291 flg ON isolate with PflgB::phoZ fusion integrated 
on the chromosome via Tn916 (RT1393)  
This work 
RT1539  C. difficile R20291 flg OFF isolate with PflgB::phoZ fusion integrated 
on the chromosome via Tn916 (RT1393)  
This work 
RT1540 C. difficile R20291 flg ON isolate with PflgB-5’UTR(FSON)-
flgB::phoZ fusion integrated on the chromosome via Tn916 (RT1394) 
This work 
RT1541 C. difficile R20291 flg OFF isolate with PflgB-5’UTR(FSON)-
flgB::phoZ fusion integrated on the chromosome via Tn916 (RT1394) 
This work 
RT1542 C. difficile R20291 flg ON isolate with PflgB-5’UTR(FSOFF)-
flgB::phoZ fusion integrated on the chromosome via Tn916 (RT1395) 
This work 
RT1543 C. difficile R20291 flg OFF isolate with PflgB-5’UTR(FSOFF)-
flgB::phoZ fusion integrated on the chromosome via Tn916 (RT1395) 
This work 
RT1544 C. difficile R20291 flg ON isolate with FSON-flgB::phoZ fusion 
integrated on the chromosome via Tn916 (RT1331) 
This work 
RT1545 C. difficile R20291 flg OFF isolate with FSON-flgB::phoZ fusion 
integrated on the chromosome via Tn916 (RT1331) 
This work 
RT1546 C. difficile R20291 flg ON isolate with FSOFF-flgB::phoZ fusion 
integrated on the chromosome via Tn916 (RT1332) 
This work 
RT1547 C. difficile R20291 flg OFF isolate with FSOFF-flgB::phoZ fusion 
integrated on the chromosome via Tn916 (RT1332) 
This work 
RT1615 C. difficile R20291 flg ON isolate with pRT1611 This work 
RT1616 C. difficile R20291 flg ON isolate with pRT1529 This work 
RT1617 C. difficile R20291 flg OFF isolate with pRT1611 This work 
RT1618 C. difficile R20291 flg OFF isolate with pRT1529 This work 
RT1690 C. difficile R20291 sigD::ermB with pRT1611  This work 
RT1689 C. difficile R20291 sigD::ermB with pRT1676 This work 
RT1695 C. difficile R20291 flg ON isolate with pRT1676  This work 
RT1696 C. difficile R20291 flg OFF isolate with pRT1676  This work 
RT1698 C. difficile R20291 flg ON isolate with pDSW1728  This work 
RT1699 C. difficile R20291 flg OFF isolate with pDSW1728  This work 
RT1712 C. difficile R20291 flg ON isolate with pRT1483  This work 
RT1713 C. difficile R20291 flg OFF isolate with pRT1483  This work  
RT1714 C. difficile R20291 sigD::ermB with pRT1483  This work 
RT1693 C. difficile R20291 recV::ermB (cwpV OFF; flg OFF)a (84) 
RT1694 C. difficile R20291 recV::ermB (cwpV ON; flg OFF)a (84) 
RT1691 C. difficile R20291 recV::ermB (cwpV OFF; flg OFF)a with pRT1611  This work 
RT1697 C. difficile R20291 recV::ermB  (cwpV OFF; flg OFF)a with pRT1529  This work 
RT1702 C. difficile R20291 recV::ermB (cwpV OFF; flg ON)a This work 
RT1715 C. difficile R20291 recV::ermB (cwpV OFF; flg ON)a with pRT1611 This work 
RT1716 C. difficile R20291 recV::ermB (cwpV OFF; flg ON)a with pRT1529 This work 
RT1705 C. difficile R20291 recV::ermB flg OFF motile suppressor mutant #1 This work 
RT1706 C. difficile R20291 recV::ermB flg OFF motile suppressor mutant #2 This work 
RT1707 C. difficile R20291 recV::ermB flg OFF motile suppressor mutant #3 This work 
RT1708 C. difficile R20291 recV::ermB flg OFF motile suppressor mutant #4 This work 
 aGenotype in parentheses reflects starting orientations of the indicated switches. 
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Table 2.2. Primers used in this study. 
Primer Namea Sequence (5’ ! 3’)b Lab 
Annotati
on 
flgRibo012_Pub GAGCAACTTTTCGAAGAAATATTTAAATAC R1751 
flgRibo012_Inv GTATTTAAATATTTCTTCGAAAAGTTGCTC R1752 
flgRibo017_Pub GAGCAACTTTTTGAAGAAATATTTAAATAC R1622 







flgBConserv_Rev AGGCATAGCATCATTTAGTGTTTCTTC R857 
flgUTR5’end_For CGAATTCGTATACTTAAGTTAAAACTAAATAGGCAAATC (EcoRI) R591 
EF2973_phoZRBS
F 
GTTGAATTCAGGAGGAAACAAGGAAATGAAG (EcoRI) R1609 
EF2973_phoZCD
SR 












slpATerm_F GCGCACCGGATCCTATAAGT (BamHI) R1848 
slpATerm_R TGACTCAAGCTTCATCTTTTTATTTAGG (HindIII) R1849 
EF2973_phoZRBS
F 
GTTCAAGCATGCAGGAGGAAACAAGGAAATGAAG (SphI) R1632 
CDR20291_0248P
R 
GTTGAATTCAACTTAAGTATACAATAAATAAC (EcoRI) R1608 
CDR20291_5'flgL
IR 
GTCAAGCATGCCACCTATAATAACATATTATACC (SphI) R1673 
phoZ_AsymR GAATGTTAATAAGGTAACCCCTAGCAAAGCTCTTTTCTTC R1706 
CDR20291_0249R GCTGTTAATCCACTAGCAGATATTCTC R1704 
CDR20291_1004F 
(recV) 
GTCAAGGTACCGCAACAAGACCTATAGAAATAG (KpnI) R1675 
CDR20291_1004R 
(recV) 
CAGTTAAGCTTTTAACCAATAAAGAAATTTTCAC (HindIII) R1676 
CDR20291_1060F GTCAAGGTACCGATATTATAGAGGGATATATAGATTAC (KpnI) R1677 
CDR20291_1060R CAGTTAAGCTTCTATTTAGCTTCTGCTTTTTGTAATTCTAC (HindIII) R1678 
CDR20291_1068F GTCAAGGTACCAAAGACCAAGGTATCATATTAGAAAC (KpnI) R1679 
CDR20291_1068R CAGTTAAGCTTTTACTGGTCTTCATGTAATTTCAAATGAAC (HindIII) R1680 
CDR20291_1174F GTCAAGGTACCAAAAGGAAAGGAGTTATTATG (KpnI) R1681 
CDR20291_1174R CAGTTAAGCTTCTATTTTTTATTTATATCCAAATTATC (HindIII) R1682 
CDR20291_1826F GTCAAGGTACCAAAGCTGCAATTTATTCAAG (KpnI) R1683 
CDR20291_1826R CAGTTGGATCCCTAATTGCTTAAAGAAACAGAATTATCCA (BamHI) R1684 
CDR20291_1855F GTCAAGGTACCAATAATGATAAGAAAATTATAAAAGTAC (KpnI) R1685 
CDR20291_1855R CAGTTAAGCTTTTAATCGTCCTCAATCCATTCAAAATTC (HindIII) R1686 
CDR20291_1973F GTCAAGGTACCTATAAAATTTTGATTGGTGGGTTATATATG (KpnI) R1687 
CDR20291_1973R CAGTTGGATCCTTAATTAGCATTAAATAAACTTTCAG (BamHI) R1688 
CDR20291_3416F GTCAAGGTACCATTATTATATATGGATATTGC (KpnI) R1689 




CDR20291_1115q TTGAACTACAGCTTTCTTTCTCATTT R911 
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Cd1Ribo_NorthF GCAAATCTAGAGAAATCTAGTGACG R1791 
Cd1Ribo_NorthR CGTATACAATATACCTAGAACTCTT R1792 
recV_RT709F GAGTCAGAGCTCCAAATCAAACTAAGAGGAGTGGTTGAAA (SacI) R1853 
recV_RT709R TGACTCGGATCCACGTTATAATTAACCAATAAAG (BamHI) R1854 
CDR20291_0270F GTAGTTAATGAATAGAGAAGAATTAAT R1887 
CDR20291_0270R TCACCATCTATATAGAATATTTAAG R1888 
EBSuniv CGAAATTAGAAACTTGCGTTCAGTAAAC R991 
PflgM_F_NheI  CAATGCTAGCTATGCGTGAATTATAT (NheI) R2117 
R202flgMpromo_
R 
CTAACGAGCTCTAATTTAATTATCGCTC (SacI) R2046 
CwpVIS_R202F CAAAACCATGTTTTTTATAACAATTCATTAAC R1920 
CwpVIS_R202R GTTAATGAATTGTTATAAAAAACATGGTTTTG R1921 

















a Where locus tags are used in the primer name, the corresponding gene name is noted in parentheses 
b Restriction site sequences are highlighted with bold text; the corresponding enzyme is listed in parentheses. 
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CHAPTER 3: CHARACTERIZATION OF FLAGELLAR AND TOXIN PHASE 




Clostridium difficile produces flagella that enhance bacterial motility, and secretes toxins 
that promote diarrheal disease symptoms. Previously, we found that production of flagella and 
toxins are co-regulated via a flippable DNA element termed the “flagellar switch”, which 
mediates the phase variable production of these factors. Here we evaluate multiple isolates of C. 
difficile ribotype 012 strains and find them to be primarily flg OFF. Some, but not all, of these 
isolates showed the ability to switch between flg ON and OFF states. These findings suggest 
heterogeneity in the ability of C. difficile ribotype 012 strains to phase vary flagellum and toxin 
production, which may broadly apply to pathogenic C. difficile.  
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The obligate anaerobe Clostridium difficile is a leading cause of nosocomial intestinal 
infections. C. difficile associated infections (CDI) are most common in individuals who have 
undergone antibiotic therapy, which disrupts the usually protective microbiota and creates a 
niche for C. difficile outgrowth (1). Virulence of C. difficile is largely mediated by two 
glucosylating toxins, TcdA and TcdB, which target and inactivate Rho and Rac GTPases in the 
intestinal epithelium, resulting in depolymerization of the actin cytoskeleton and eventually host 
cell death (2). Toxin-mediated damage to the epithelium leads to disruption of the intestinal 
barrier, diarrheal symptoms, and a robust inflammatory response (2).  
C. difficile produces peritrichous flagella that are essential for swimming motility and 
contribute to host cell adherence (3-6). As in other bacterial species, the expression of flagellar 
genes occurs in a hierarchical manner (7). In C. difficile, at least four different operons encode 
flagellar genes. The early stage flagellar genes (flgB operon) are transcribed first, and they 
encode the basal body, motor, and rod of the flagella. The flgB operon also encodes the 
alternative sigma factor SigD (σD, also known as FliA or σ28). In addition to activating late stage 
flagellar gene expression, SigD also positively regulates the expression of tcdR, which encodes a 
sigma factor that activates transcription of tcdA and tcdB (7-10). Therefore, the regulation of 
flagellar genes also impacts virulence by affecting toxin gene expression.  
The expression of flagellum and toxin genes is subject to complex regulation (6, 7, 11-
13). Recently, we demonstrated that flagellum and toxin biosynthesis is phase variable via site-
specific recombination that inverts a DNA element termed the “flagellar switch” (14). The 
flagellar switch consists of a 154 bp invertible DNA sequence flanked by 21 bp inverted repeats 
(left inverted repeat (LIR) and right inverted repeat (RIR)) and lies upstream of the flgB operon. 
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The orientation of the flagellar switch controls expression of the flgB operon, and therefore sigD 
and the toxin genes, through an unidentified mechanism occurring post-transcription initiation 
(14). Bacteria with the flagellar switch in an orientation resulting in flagellum production, 
swimming motility, and high toxin production were termed flagellar phase ON (flg ON). In 
contrast, bacteria with the flagellar switch in the opposite orientation resulting in the absence of 
flagella, sessility, and reduced toxin production were termed flagellar phase OFF (flg OFF). 
RecV, a site-specific tyrosine recombinase previously shown to mediate inversion of the cwpV 
switch (15, 16), also mediates inversion of the flagellar switch (14). The phase variable 
production of flagella and toxins was proposed to allow C. difficile to balance the benefits of 
swimming motility and toxinogenesis with the cost of producing these immunogenic factors (17-
20).  
Flagellum and toxin phase variation in Clostridium difficile appears to vary across 
ribotypes (14). For C. difficile strains R20291, a ribotype 027 strain, and ATCC 43598, a 
ribotype 017 strain, both the flg ON and OFF orientations were apparent under multiple 
conditions tested. However, only the flg ON orientation was detectable in 630, a ribotype 012 
strain originally isolated from a patient with C. difficile infection (21). However, recent work 
from Collery et al. suggests the flagellar switch is capable of inversion in 630 (22), suggesting 
this strain is not phase-locked. JIR8094 (also named 630E) was isolated through serial passage of 
630 to obtain erythromycin-sensitive isolates amenable to genetic manipulation with tools 
relying on an erythromycin resistance cassette (23). Comparison of the genome sequence of 
JIR8094 to 630 revealed numerous secondary mutations that arose during and since isolation 
(22). One polymorphism identified was an inversion of the flagellar switch to the OFF 
orientation in JIR8094 compared to 630, which is flg ON. The JIR8094 genotype explains the 
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non-motile phenotype and reduced flagellum and toxin gene expression previously reported for 
JIR8094 (7), and indicates an ability to invert the flagellar switch in this strain lineage. In 
contrast, the 630∆erm strain was similarly derived from 630 through serial passaging, but it 
remains motile and toxinogenic (24). 
In this study, we examined multiple ribotype 012 strains, including laboratory-adapted, 
clinical, and environmental isolates, to assess their ability to invert the flagellar switch and to 
phase vary flagellum and toxin production. Analysis of these strains and their motile derivatives 
indicates that flagellum and toxin phase variation is conserved in ribotype 012 C. difficile, and 





The laboratory-adapted C. difficile strain JIR8094 is flg OFF  
The C. difficile strain JIR8094 is a non-motile, toxin-attenuated derivative of the ribotype 
012 strain 630 (7, 22, 23). In C. difficile, expression of the flgB operon is controlled by multiple 
cis-acting mechanisms, including a σA-dependent promoter (31), a c-di-GMP riboswitch in the 
5’UTR (27, 31, 32), and the flagellar switch (14). Sequencing of the flgB operon regulatory 
region from C. difficile 630 and JIR8094 revealed no differences in the promoter region or the c-
di-GMP riboswitch sequences. However, while the LIR and RIR were identical in the two 
strains, the intervening 154 bp was inverted in JIR8094 relative to 630 (Figure 3.1A). Alignment 
of the flagellar switch sequence using the reverse-complement of the sequence obtained for 
JIR8094 restored sequence identity to 100% with 630 (Figure 3.1A). Inversion of the flagellar 
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switch in JIR8094 relative to 630 was confirmed by orientation-specific PCR (Figure 3.1B). For 
this assay, a common reverse primer (Rv) is used in combination with a primer (Fw1) that leads 
to amplification when the template is in the ON orientation, or with a primer (Fw2) that 
amplifies when the template is in the OFF orientation  (Figure 3.1B) (14). As shown previously, 
C. difficile R20291 cultures contain a mixture of flg ON and OFF bacteria (Figure 3.1C) (14). In 
contrast, only the flg ON orientation was detected for strain 630, and only the flg OFF orientation 
was detected for JIR8094 (Figure 3.1C). In addition, strain 630 demonstrated swimming through 
motility medium, while JIR8094 was non-motile after 72 hours (Figure 3.1D). These 
observations are consistent with a recent report identifying the sequence inversion in JIR8094 
(22), and with phenotypes corresponding to the flg OFF state (7). 
 
The flagellar switch undergoes inversion at low frequency in JIR8094 
Throughout our experimentation, we did not observe motility or motile flares from 
JIR8094 in standard assays (data not shown), and Collery et al. similarly reported an inability to 
recover motile bacteria from this strain (22). These findings suggested that JIR8094 is phase-
locked OFF or undergoes inversion of the flagellar switch at a low rate. To distinguish between 
these possibilities, we modified the motility assay to accommodate higher density inoculums. 
Rather than inoculating motility agar with 2 µL of saturated broth culture, we first concentrated 
the culture 30-fold, reasoning that this would increase the odds of detecting rare flg ON bacteria. 
Over 48-72 hours, we were able to detect motility from a subset of JIR8094 inoculums (Figure 
3.2A).  
To determine whether motility was restored as a result of flagellar switch inversion to ON 
or due to extragenic suppressor mutations, we used orientation-specific PCR (Figure 3.1B) to 
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assess the orientation of the flagellar switch. Three motile derivatives of JIR8094 (MD #1-3) 
were arbitrarily chosen after recovery from the edge of the motile colony for further analysis. 
The term “motile derivatives” was chosen over “flg ON” for JIR8094 derivatives since, as 
described later in the text, these strains remain attenuated for flg ON phenotypes compared to 
strain 630. All three MDs yielded PCR products indicative of the flg ON orientation, but not the 
flg OFF orientation, as seen in the parental strain 630 (Figure 3.2B). Sequencing of the flagellar 
switch confirmed the flg ON orientation of the switch in JIR8094 MD #1-3 (Figure 3.2C). These 
results indicate that the flagellar switch remains reversible in JIR8094, though the frequency of 
inversion appears to be lower than previously observed for R20291 (14).  
To estimate the frequency of flg ON bacteria in JIR8094, a range of bacterial densities 
were assayed for swimming motility. As controls, we used the motile 630 strain, the non-motile 
630 ∆erm sigD mutant (33), and an isolate of C. difficile R20291 flg OFF which contains ~3 % 
flg ON bacteria (14). This small population of flg ON bacteria spatially segregates from non-
motile flg OFF bacteria in motility medium, leading to a motile phenotype that is readily 
apparent within 24 hours (14). Whereas R20291 appeared motile at all inoculums tested, motility 
of JIR8094 was only observed at the highest density, suggesting that flagellar switch inversion 
occurs at a low frequency in this strain (Figure 3.3).  
 
Characterization of JIR8094 motile derivatives 
We predicted that restoration of the flagellar switch to the ON orientation would restore 
flagellar motility and toxin production of the JIR8094 MDs to levels observed in the original 630 
parental strain. To test this, we assayed swimming motility using standard (not concentrated) 
inoculums, with C. difficile 630 and JIR8094 strains included as positive and negative controls, 
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respectively. The JIR8094 MD #1-3 were motile at all time points tested, unlike JIR8094 (Figure 
3.4A), but motility was not fully restored to the level seen for 630 (Figure 3.4B). We also 
observed that JIR8094 MD #1-3 produced fewer flagella than motile and peritrichous 630, while 
JIR8094 remained aflagellate (Figure 3.4C). 
 The intermediate motility of JIR8094 MD #1-3 could be due to either partial recovery of 
flagellar gene transcription and/or of flagellum biosynthesis, both of which could be due to 
additional mutations in JIR8094. Using quantitative reverse transcriptase PCR (qRT-PCR), we 
measured the transcript abundance for three flagellar genes, flgB, sigD, and fliC. Both flgB and 
sigD are in the operon directly controlled by the flagellar switch (early stage flagellar genes), and 
fliC serves as a representative sigD-regulated late stage flagellar gene. As previously reported, 
the flgB, sigD, and fliC transcripts were significantly lower in JIR8094 compared to 630 (Figure 
3.4D) (7). In MD #1-3, flgB, sigD, and fliC transcript levels were higher than in JIR8094, but 
were not restored to the levels in 630 (Figure 3.4D).  Nonetheless, the intermediate level of 
flagellar gene expression and number of flagella on the JIR8094 MDs were sufficient to confer 
some motility.  
Similar intermediate phenotypes were observed with regards to toxin production. 
Analysis of tcdR, tcdA, and tcdB transcripts in stationary phase cultures (favoring toxin gene 
expression) by qRT-PCR showed that all three transcripts were less abundant in JIR8094 than in 
630, as seen previously (7), although only tcdA was significantly lower (Figure 3.5A). The 
transcripts trended higher in MD #1-3 than in their JIR8094 parent, but the differences were not 
statistically significant (Figure 3.5A). Consistent with this, the amounts of TcdA protein 
produced by MD #1-3 appeared more similar to the JIR8094 parent than 630 (Figure 3.5B). 
Together, these data indicate that JIR8094 MD #1-3 have restored the ability to transcribe 
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flagellar and toxin genes, and thus motility and toxinogenesis, but suggest that other mutations in 
JIR8094 also affect flagellum and toxin gene expression in this strain.  
 
Topoisomerase activity in JIR8094 motile derivatives impacts motility 
Comparison of the genome sequences of C. difficile 630 and its 630∆erm and JIR8094 
derivatives revealed multiple single nucleotide polymorphisms, including 11 found in JIR8094 
but not the other two strains (one of which is the flagellar switch inversion) (22). We speculated 
that one or more of these polymorphisms is responsible for the difference in flagellar gene 
expression between 630 and the JIR8094 MD #1-3. Of interest was a nonsense mutation in a 
topA orthologue that introduced a stop codon at amino acid 386, while the full-length protein is 
695 amino acids. Because topA encodes DNA topoisomerase I, which controls DNA negative 
supercoiling, we postulated that the mutation in topA could result in changes to the flgB operon 
promoter and/or coding sequence that impair gene transcription in JIR8094 and its derivatives, 
compared to 630, which encodes the full length TopA. If so, expressing topA in the JIR8094 MD 
#1-3 is expected to restore motility and toxin production to the levels in 630. 
To test this, we ectopically expressed topA from an ATc-inducible promoter in 630, JIR8094, 
and the MD #1-3 and compared the motility of these strains to vector controls. A 630Δerm sigD 
mutant bearing vector or the topA expression plasmid (pTopA) was included as a non-motile 
control. After 72 hours, expression of topA did not significantly alter the motility of 630 or the 
sigD mutant as expected (Figure 3.6A and 3.6B). Expression of topA alone is not sufficient to 
augment motility in flg OFF bacteria, as JIR8094 + pTopA remained non-motile (Figure 3.6A 
and 3.6B). However, expression of topA in JIR8094 MD #1-3 significantly enhanced motility, 
restoring it to 630 levels (Figures 3.6A and 3.6B). Presumably TcdA levels would concomitantly 
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increase upon restoration of TopA activity, but western blot analysis indicated TcdA levels were 
unchanged in the JIR8094 MD #1-3 + pTopA derivatives compared to parent JIR8094 + pTopA 
(Figure 3.6C). These results suggest that the flagellar switch must be in the ON orientation to 
allow flagellar gene expression and motility, and DNA supercoiling affects flagellar gene 
expression. Moreover, additional mutations in JIR8094 may interfere with the link between toxin 
and flagellar gene expression.  
 
Clinical and environmental Isolates of C. difficile ribotype 012 are flg OFF 
 Both flagellar switch orientations were readily detected in C. difficile strains R20291, a 
ribotype 027, and ATCC 43598, a ribotype 017, but only the flg ON was detected in 630 (14). 
The 630 strain was isolated in 1982 (21), so passaging within and between labs could have led to 
accumulation of mutations that reduced the frequency of flagellar phase variation in 630. We 
thus asked whether the lack of (or very low frequency of) flagellar switch inversion in 630 is 
unique to this strain and its derivatives, or a broader attribute of currently circulating ribotype 
012 C. difficile isolates. To test this, we evaluated flagellar phase variation in six riboype 012 
isolates: SS235, a community environmental isolate; SE838, a hospital environmental isolate; 
and MAM30, MT4768, MT5065, and MT5066, isolates from patients with CDI (kindly gifted by 
Dr. Kevin Garey). Sequencing of the flagellar switches revealed that all six isolates contain the 
flagellar switch in the same OFF orientation as JIR8094, and opposite that of strain 630 (Figure 
3.7) (22). The flagellar switches of two isolates also contained polymorphisms within the 
inverted repeats (Figure 3.7). MT4768 had one nucleotide (nt) substitution in the LIR and an 
additional nucleotide in the RIR. SE838 contained an additional 3 nt in the LIR and 2 nt in the 
RIR. In addition, MT4768 possessed three single nucleotide substitutions within the flagellar 
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switch (Figure 3.7). SS235, MAM30, MT5065, and MT5066 had flagellar switches identical to 
that in JIR8094.  
Sequencing results indicate the conservation of the regulatory flagellar switch element, 
but they did not reveal if it is functional. It is also possible that the sequencing results reflect the 
most abundant switch orientation in a population, masking the presence of a lower abundance 
orientation. Therefore, we used PCR with orientation-specific primer sets that discriminate 
between the two DNA orientations (Figure 3.8A) (14). As a control we included 630, for which 
only the flg ON orientation is detectable (Figure 3.8A) (14). For all six isolates only the flg OFF 
orientation of the flagellar switch was detectable (Figure 3.8A). 
Given that flg OFF bacteria in R20291 are phenotypically aflagellate and non-motile 
(14), we predicted that the six isolates with the flagellar switch in the OFF orientation would be 
similarly non-motile. The six riboype 012 isolates were examined for the ability to swim through 
motility medium. Strain 630 and a 630Δerm sigD mutant were used as motile and non-motile 
controls, respectively. After 24 hours incubation, all six ribotype 012 isolates showed a non-
motile phenotype in comparison to the motile 630, which migrated outward from the original 
inoculation site (Figure 3.8B). Collectively, these data indicate that the flagellar switch is 
conserved in ribotype 012 clinical and environmental isolates and appear to be “phase-locked” in 
an flg OFF state or undergo flagellar switch inversion at a low frequency in vitro. 
 
Isolation and phenotypic characterization of flg ON derivatives of clinical and environmental 
ribotype 012 isolates 
 While examining the motility of the ribotype 012 isolates, we observed that a subset of 
replicates showed motile flares extending from the stab sites for some isolates (Figure 3.9A). 
! 140!
This is in contrast with R20291, for which we previously found that clonal flg OFF populations 
yielded a motile phenotype within 24 hours in 100% of replicates (14). To determine the 
frequency at which motile flares arise in the ribotype 012 isolates, we increased the number of 
biological replicates (n = 32 over 2 experiments) and monitored motility every 24 hours for 3 
days. A small proportion of colonies of three of the isolates developed motile flares by 24 hours 
(MT5066, 6.3%; SE838, 9.4%; SS235, 3.1%), and a fourth isolate showed motile flares by 48 
hours (MT5065, 18.9 %) (Figure 3.9B). The number of colonies with motile flares for these four 
isolates increased and then remained relatively stable between 48 and 72 hours (48 hours: 
MT5066, 71.9%; SE838, 100%; SS235, 59.4%; MT5065, 18.8%) (Figure 3.9B). The remaining 
two isolates, MAM30 and MT5065, failed to develop motile flares throughout the course of the 
experiments.  
To confirm that the bacteria from the edge of the flares regained motility through 
inversion of the flagellar switch to the ON orientation, we arbitrarily chose and isolated bacteria 
from three motile flares each for MT5066, SE838, and SS235 and subjected them to orientation-
specific PCR and sequenced the flagellar switch (Figure 3.1B). All nine motile isolates yielded a 
product for the flg ON orientation, indicating that DNA inversion occurred in these strains, yet a 
flg OFF product was also observed (Figure 3.10) (Figure 3.9C). This result is in contrast to the 
JIR8094 MD #1-3, for which only the flg ON orientation was detected (Figure 3.2B). In almost 
all cases, the intensity of the flg ON band was greater than the flg OFF, suggesting the majority 
of the population was flg ON. Sequencing results confirmed flagellar switch inversion to the ON 
orientation for all nine flg ON derivatives and 100% sequence identity with the strain 630 
flagellar switch. We noted that in all three flg ON derivatives of parent SE828, the RIR length 
increased from 22 bp to 23 bp (Figure 3.10).   
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 To determine whether flagellar switch inversion to the ON orientation was sufficient to 
restore flg ON phenotypes in these strains, we assayed the original ribotype 012 isolates and their 
flg ON derivatives for swimming motility and toxin production (14). As expected, all three flg 
ON derivatives of each strain showed motility compared to their respective non-motile parent 
strains (MT5066, SE838, and SS235) (Figure 3.11A). TcdA protein levels were visibly higher in 
cell lysates of the flg ON derivatives relative to the flg ON MT5066, SE838, and SS235 strains 
(Figure 3.11B). These results demonstrate that the flagellar switch is capable of inversion in 
some but not all clinical and environmental ribotype 012 isolates, and reiterate the regulatory 
link between toxin and flagellar gene expression via SigD. In addition, the ribotype 012 strains 
exhibit heterogeneity in their ability to phase vary, which may be attributed to differences in the 
sequences of the inverted repeats flanking the flagellar switch.  
 
Discussion 
Our prior study characterizing flagellum and toxin phase variation in C. difficile focused 
on the epidemic-associated 027 isolate R20291. In this strain, phase variation occurred readily in 
vitro, and the strain consisted of a mixture of flg ON and OFF bacteria. However, we noted that 
the ribotype 012 strain 630, which was originally isolated from a patient with C. difficile 
infection, existed primarily as flg ON bacteria. Here, we asked whether the 630 lineage is 
unusual, or whether reduced phase variation is a broader attribute of ribotype 012 strains. Strain 
630’s non-motile JIR8094 derivative primarily exists as flg OFF bacteria, and phase variation to 
flg ON occurs with low frequency. Our survey of six clinical and environmental ribotype 012 
isolates of C. difficile indicates that within the 012 ribotype there exists a range of abilities to 
phase vary flagellum and toxin production, at least from the flg OFF to ON states. This work 
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represents the first examination of flagellar and toxin phase variation within a ribotype family, 
and our results indicate potentially diverse patterns of phase variation across C. difficile strains. 
We found that the laboratory-adapted strain JIR8094 contains the flagellar switch in the 
OFF orientation, which is consistent with its non-motile and toxin-attenuated phenotypes. We 
were able to isolate rare motile derivatives of JIR8094. These were determined to have inverted 
the flagellar switch to the ON orientation, suggesting the recovery of motility was attributable to 
flagellar switch inversion. However, phenotypic characterization of these motile derivatives of 
JIR8094 indicated that motility and toxin production were only partially recovered compared to 
the original 630 strain (JIR8094 parent). However, JIR8094 contains 11 polymorphisms 
compared to 630 (22), and we found that restoring expression of one of the affected genes, topA, 
was sufficient to fully restore motility. This finding indicates that both loss of topA and inversion 
of the flagellar switch from ON to OFF negatively affected flagellar gene expression in JIR8094, 
and underscores previously stated cautions in using and interpreting results from research done 
with JIR8094. For example, one study using strain JIR8094 indicated that TcdA is dispensable 
for virulence in the hamster model (34), while another using 630Δerm showed that both TcdA 
and TcdB are sufficient for eliciting disease in hamsters (35). The initial studies suggesting TcdA 
was dispensable for infection may have been due to the flg OFF status of JIR8094. A tcdA 
mutation in the background of a motile derivative of JIR8094 could be attenuated for virulence 
in the hamster model supporting a role for TcdA in diarrheal disease development.  
The conditions that favor inversion from flg ON to OFF in 630 may be gleaned from how 
JIR8094 was generated, specifically through serial passage on solid medium (23). In our studies 
with R20291, we observed a bias toward the flg OFF orientation during growth on nutrient rich 
solid medium over several days, while switch orientation appeared stable during growth in the 
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same liquid medium (14). In contrast to JIR8094, strain 630Δerm was generated by passaging 
630 in non-selective liquid medium until a spontaneous erythromycin sensitive isolate was 
identified, and the flagellar switch remained in the flg ON orientation, unlike 630E (24). The 
ability to bias a phase variable genetic switch in one orientation over another is common in other 
mucosal bacterial pathogens. For example, incubation in human urine biases the Type I fimbrial 
switch to the OFF orientation in uropathogenic Escherichia coli (36). Anoxic conditions bias the 
fimbrial switch to the ON orientation in both uropathogenic Proteus mirabilis and E. coli (37). 
For C. difficile, factors that bias the flagellar switch orientation could be host factors sensed by 
gene products that influence recombination.  
All six of the original ribotype 012 isolates, both clinical and environmental, existed 
primarily, and perhaps exclusively, in a flg OFF state, both genotypically and phenotypically. 
Two strains, MAM30 and MT4768, appeared to be phase-locked, as we were unable to recover 
flg ON bacteria upon growth in motility medium, which selects for outgrowth of motile bacteria. 
The remaining four strains varied in their propensity to switch to flg ON. One of these, SE838, 
readily switched from flg OFF to ON, similar to R20291. A limitation of our study is that it is 
uncertain whether the isolates were flg OFF at the time of collection, or whether the strains 
switched during outgrowth in the laboratory. However, the fact that all six isolates from different 
patients and environments were flg OFF argues that our findings are not an artifact of in vitro 
work, but a common feature in the C. difficile ribotype 012 family. Recent work found that in a 
patient simultaneously infected with three C. difficile isolates, the ribotype isolate 012 was flg 
ON, providing evidence that not all ribotype 012 isolates are biased to flg OFF, or the isolate 
may have arisen from a stage of infection favoring flg ON bacteria (38). It is also possible that 
most ribotypes show a strong flg OFF bias and lower inversion frequency, similar to the ribotype 
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012, and the ribotype 027 and 017 strains examined previously are outliers (14). A 
comprehensive analysis of strains representing a variety of ribotypes both in vitro and during 
infection will help determine the population dynamics of flagellum and toxin phase variation in 
C. difficile.  
Inverted repeat length may affect recombination of the flagellar switch in the 012 
ribotype strains. Our previous analysis of the flagellar switch with publically available sequenced 
genomes of C. difficile indicated 21 bp inverted repeats in all strains. Interestingly, all of the 
clinical and environmental 012 ribotype isolates had both inverted repeats less than or greater 
than, but not equal to 21 bp (Figure 3.3). In addition, the SE838 isolate had flagellar switch IRs 
of 23 and 22 bp, but its flg ON derivatives had a RIR of 23 bp, suggesting some flexibility in the 
ability of the recombinase RecV to interact with these inverted repeats. It is also possible that a 
recombination directionality factor (RDF) is required for flagellar switch inversion in C. difficile 
strains that harbor non-ideal inverted repeats, and that the RDF is only produced under certain 
environmental conditions (39). The involvement of an RDF may allow precise control over when 
to promote recombination at the flagellar switch, similar to the contribution of an RDF that 
contributes to the excision of a DNA element and promotes sporulation (40). Alternatively, 
changes to repeat length could reduce affinity for RecV, and perhaps allow recombination by 
another recombinase. Current work seeks to identify a role for inverted repeat sequence and 
length in affecting flagellar switch inversion frequency in both directions in all ribotypes.  
Flagellar and toxin phase variation in C. difficile creates population heterogeneity that has 
the potential to influence diagnosis, disease progression, and transmission. Characterization of 
flagellar and toxin phase variation in multiple ribotypes of C. difficile could provide insight into 
factors that influence flagellar switch inversion and find correlations between diarrheal disease 
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symptoms and switch orientation. Identifying surface and exported proteins in C. difficile that are 
consistently produced and not subject to phase variable expression could serve as better 
diagnostic and therapeutic targets to ensure targeting of the entire population.  
 
Materials and Methods 
 
Bacterial strains and growth conditions 
All bacterial strains used in this study are listed in Table 3.1. C. difficile strains were 
cultivated statically at 37°C in brain heart infusion medium (BD, Beckton Dickinson) 
supplemented with 5% yeast extract (BHIS) or tryptone yeast (TY) medium, as specified. All C. 
difficile growth was done anaerobically in a Coy anaerobic chamber with an atmosphere of (90% 
N2, 5% CO2, 5% H2). Unless otherwise indicated, E. coli was cultured at 37°C under aerobic 
conditions in Luria Bertani (LB) medium. For selection of plasmids in E. coli, 100 µg/mL 
ampicillin (Amp) and/or 10 µg/mL chloramphenicol (Cm) was used, as indicated. Kanamycin 
(Kan) 100 µg/ml was used to select against E. coli in conjugations. For maintenance of plasmids 
in C. difficile, 10 µg/mL thiamphenicol (Tm) was used.  
 
Characterization of C. difficile ribotype 012 clinical and environmental isolates 
Clinical and environmental isolates of C. difficile used are part of the F ribotype database 
(25). The strains were ribotyped by fluorescent PCR and sequencing of ribosomal RNA genes as 
previously described (25). The flagellar switch orientation was determined by PCR amplification 
of the region and sequencing of the products using primers R591 and R857. 
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Orientation-specific PCR  
The flagellar switch orientation was determined by PCR using two primer sets that 
distinguish the orientation of the switch (14, 26). Primers were designed using the published 
genomes sequences for strains 630 (Accession No. FN688375.1) and R20291 (Accession No. 
FN545816.1). Primer sequences are listed in Table 3.2. For the 630 lineage and other ribotype 
012 isolates, R1751 and R857 were used to detect the ON orientation, and R1752 and R857 were 
used to detect the OFF. For R20291, R1614 and R857 were used to detect the ON orientation, 
and R1615 and R857 were used to detect the OFF. PCR products were separated on a 2% 




Swimming motility was assayed as described previously (14, 27). Briefly, individual 
colonies of the indicated strains were grown in TY broth overnight, then diluted 1:50 in fresh 
BHIS and grown to an OD600 ~ 1.0. In standard assays, 2 µL of culture were inoculated into 
anaerobic motility medium (0.5X BHIS-0.3% agar, autoclaved for 30 minutes). In experiments 
aimed at identifying JIR8094 motile revertants, a range of volumes of overnight bacterial 
cultures were centrifuged to collect and concentrate bacterial cells. The cells were suspended in 
100 µL of phosphate buffered saline (PBS), and 2 µL were stabbed into soft agar plates. 
Swimming motility was assayed by measuring the swim diameter after 24, 48, and 72 hours 
incubation as indicated. Two perpendicular measurements were averaged for each colony. 
Photographs shown were taken with the G:Box imaging system (Syngene). To measure the 
frequency of motile recovery in the ribotype 012 isolates, motility assays were performed as 
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described above with 32 independent colonies in two independent experiments. A stab site 
positive for motility was identified by the presence of a motile flare.  
 
Recovery of motile derivatives of parent JIR8094 and select ribotype 012 isolates 
After incubation in motility agar as described above, motile bacteria were collected from 
the edge of an expanded colony using a sterile loop and passaged onto BHIS agar for recovery. 
All isolates were confirmed to be motile by independently assaying swimming through motility 
medium, and the orientation of the flagellar switch was determined by PCR as described. 
 
Microscopy 
For transmission electron microscopy, colonies of C. difficile were grown in BHIS 
medium overnight, diluted into fresh BHIS medium, and grown to an OD600 of ~1.0.  Bacteria 
were washed in Dulbecco’s PBS (Sigma) prior to suspension in PBS-4 % paraformaldehyde for 
fixation for 1 hour in the anaerobic chamber. Cell suspensions were adsorbed onto 
Formvar/copper grids, washed with water, and stained for 30 seconds in two sequential drops of 
aqueous uranyl acetate (1.5%). Cells were viewed on a LEO EM 910 Transmission Electron 
Microscope (Carl Zeiss Microscopy, LLC, Thornword, NY). Documentation was done with a 
Gatan Orius SC1000 digital camera and Digital Micrograph 3.11.0 software (Gatan, Inc., 
Pleaston, CA).  
 
Detection of TcdA production by western blot 
Overnight cultures were grown in TY broth and then diluted 1:50 in fresh medium. 
Strains were grown until late stationary phase (OD600 1.8-2.0) for 24 hours, normalized to the 
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same density, and then cells were collected by centrifugation. Bacteria were lysed by suspension 
in SDS-PAGE buffer and heating to 100oC for 10 minutes. Samples were electrophoresed on 4-
15 % TGX gels (Bio-Rad), then transferred to nitrocellulose membranes. Membranes were 
stained with Ponceau S (Sigma) to determine equal loading and imaged using the G:Box Chemi 
imaging system. TcdA was detected using mouse anti-TcdA primary antibodies (Novus 
Biologicals) followed by goat anti-mouse IgG secondary antibody conjugated to DyLight 800 4X 
PEG (Invitrogen). Blots were imaged using the Odyssey imaging system (LI-COR). All strains 
were assayed in at least 3 independent experiments. 
  
RNA extraction, cDNA synthesis and quantitative reverse transcriptase–PCR 
C. difficile was grown in TY medium overnight, diluted in fresh medium, and grown until 
mid-exponential phase (OD600 ~1.0) or stationary phase (OD600 1.8-2.0) as indicated. Cells 
were collected by centrifugation, and RNA was isolated as described previously (14, 27). RNA 
was treated with DNase I (Ambion), and cDNA was then synthesized using the High-Capacity 
cDNA Reverse Transcription Kit (Thermo Fisher). qRT-PCR was done using SensiMix SYBR 
and Fluorescein Kit reagents (Bioline). The primers used were named following the convention 
gene-qF and gene-qR (Table 3.2). Data were normalized using the !!Ct method, with rpoC 
serving as the reference gene. At least four independent samples were included. 
 
Generation of topA expression strains 
The topA gene was amplified from 630 genomic DNA using primers R2302 and R2303, 
which introduced SacI and BamHI restriction sites, respectively. After digestion with these 
enzymes, the topA fragment was ligated into similarly digested pRPF185, which allows for ATc-
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inducible expression of the cloned gene (28). Ligation products were transformed into E. coli 
DH5α. Chloramphenicol-resistant clones were collected and screened by PCR with R2302 and 
R2303. Clones were confirmed by sequencing of the insert. The resulting pRPF185::topA was 
introduced into C. difficile 630, JIR8094, and the motile derivatives of JIR8094 by conjugation 
via HB101(pRK24) as previously described (27, 29, 30). Transconjugants were selected on agar 
media with Tm and Kan and confirmed by PCR with plasmid-specific primers R1832 and 
R1833. To induce expression of topA, anhydrotetracycline was added at a final concentration of 
20 ng/mL to motility medium to assay swimming motility and broth medium for assaying TcdA 





Figure 3.1. C. difficile JIR8094 has the flagellar switch in the OFF orientation. (A) Multiple 
sequence alignment of the flagellar switch sequences from C. difficile 630, its JIR8094 
derivative, and JIR8094-inv in which the 154 bp sequence between the imperfect inverted 
repeats was replaced with the reverse-complement. Blue shading indicates identical nucleotides. 
(B) Schematic for the orientation specific PCR assay used to determine the orientation of the 
flagellar switch. The Rv primer (R857) is used with either Fw1/ON (R1751) or Fw2/OFF 
(R1752) to detect the ON or OFF orientation of the flagellar switch, respectively. In the 630 
lineage, Fw1/ON + Rv yield a 374 bp product; Fw2/OFF + Rv yield a 250 bp product. Diagram 
not drawn to scale. (C) Orientation-specific PCR products using template DNA from C. difficile 
R20291, 630 and JIR8094. (D) Motility of 630 and JIR8094 in motility medium (0.5X BHIS-





Figure 3.2. The flagellar switch undergoes inversion at a low frequency in JIR8094. (A) 
Concentrated liquid cultures of JIR8094 were inoculated into motility medium along with 
standard (i.e., not concentrated) inoculums of 630 (motile) and 630Δerm sigD (non-motile) as 
controls. Shown is a representative experiment in which a JIR8094 culture was concentrated 30-
fold (9 replicates). After 48 hours growth at 37oC, motility or motile flares was detected for three 
concentrated inoculums with JIR8094. Data is representative of 3 independent experiments. (B) 
Orientation-specific PCR products for three motile flg ON derivatives of JIR8094 (MD #1-3). C. 
difficile R20291, 630, and JIR8094 were included as controls for both PCR primer sets. (C) 
Multiple sequence alignment of the flagellar switch of JIR8094, 630, and three flg ON 





Figure 3.3. Motile derivatives of JIR8094 arise at a low frequency. JIR8094 and R20291 
cultures were concentrated, and then serial dilutions were assayed for motility in motility 





Figure 3.4. JIR8094 motile derivatives have partial recovery of flagellar gene expression, 
flagellum biosynthesis, and motility. (A) Motility assay for 630, JIR8094, and JIR8094 MD 
#1-3. Image is representative of 3 biological replicates. (B) Quantification of motility after 24, 
48, and 72 hours. Shown are the means and standard deviations of the swim diameters from 3 
independent experiments. At both 48 and 72 hours, *** p < 0.001 compared to JIR8094, and # p 
< 0.05 compared to 630, by one way ANOVA and Tukey’s multiple comparisons test. The 
motilities of the JIR8094 MD #1-3 were not significantly different from each other. (C) 
Transmission electron microscopy (TEM) images for 630, JIR8094, and JIR8094 MD #1 
showing the presence or absence of flagella. (D) The abundance of flagellar gene transcripts 
flgB, sigD, and fliC in logarithmic phase BHIS cultures of 630, JIR8094, and JIR8094 MD #1-3 
isolates. The data were analyzed using the ∆∆Ct method with rpoC as the control gene and 630 
as the reference strain. Shown are the means and standard deviations. * p < 0.05, ** p < 0.01, 
*** p < 0.001 compared to the 630 reference by one-way ANOVA and Tukey’s multiple 




Figure 3.5. JIR8094 motile derivatives show intermediate toxin gene expression and toxin 
production. (A) qRT-PCR analysis of tcdR, tcdA, and tcdB transcript abundance in stationary 
phase cultures of 630, JIR8094, and JIR8094 MD #1-3. The data were analyzed using the ∆∆Ct 
method with rpoC as the control gene and 630 as the reference strain. Shown are the means and 
standard deviations. * p < 0.05 compared to 630 by one-way ANOVA and Tukey’s multiple 
comparisons test. None of the differences between JIR8094 and MD #1-3 values met p < 0.05. 
(B) Western blot detection of TcdA production by 630, JIR8094, and JIR8094 MD #1-3. A 




Figure 3.6. Ectopic expression of topA restores motility of JIR8094 motile derivatives to 630 
levels. (A,B) Motility of 630, JIR8094, JIR8094 MD #2, and a sigD mutant, each bearing vector 
(V) or pTopA, after 72 hours growth. (A) Image is representative of two independent 
experiments with six biological replicates of each strain. Equivalent results were obtained for 
JIR8094 MD #1 and MD #2. (B) Quantification of motility in the above strains after 72 hours, 
with the data for JIR8094 MD #1-3 combined. Two independent experiments with six biological 
replicates were done. *** p < 0.001 by one-way ANOVA and Tukey’s multiple comparisons 
test. (C) Detection of TcdA in the indicated strains by western blot. Data are representative of 






Figure 3.7. Sequence alignment of flagellar switch and inverted repeat sequences from the 
clinical and environmental ribotype 012 C. difficile isolates. A multiple sequence alignment 
generated using Clustal Omega with the flagellar switch and inverted repeats from the C. difficile 
strains 630, JIR8094, MAM30, MT4768, MT5065, SE838, and SS235. 
  
    630 AAGTTACTATTTT-ACAAA--AA GAGCAACTTTTCGAAGAAATATTTAAATACATAT  54 
JIR8094 AAGTTACTATTTT-ACAAA--AA TGACTTCTTTATTTATTTAAATTAATCGCATTTC  54 
  MAM30 AAGTTACTATTTT-ACAAA--AA TGACTTCTTTATTTATTTAAATTAATCGCATTTC  54 
 MT4768 AAGTTACTATTT--ACAAAA-AA TGACTTCTTTATTCATTTAAATTAATCGCATTTC  54 
 MT5065 AAGTTACTATTTT-ACAAA--AA TGACTTCTTTATTTATTTAAATTAATCGCATTTC  54 
 MT5066 AAGTTACTATTTT-ACAAA--AA TGACTTCTTTATTTATTTAAATTAATCGCATTTC  54 
  SE838 AAGTTACTATTTTTACAAAAAAA TGACTTCTTTATTTATTTAAATTAATCGCATTTC  57 
  SS235 AAGTTACTATTTT-ACAAA--AA TGACTTCTTTATTTATTTAAATTAATCGCATTTC  54 
 
    630 TAAAATTTTTTTATATTTTCATGGGACTTCATTAAAAAAATATTAGTTTTCTTACTAA 112 
JIR8094 CATTACATTAATACAATAATGTATCAATTTAGTAAGAAAACTAATATTTTTTTAATGA 112 
  MAM30 CATTACATTAATACAATAATGTATCAATTTAGTAAGAAAACTAATATTTTTTTAATGA 112 
 MT4768 CATTACATTAATACAATAATGTATCATTTTAGTAAGAAAACTAATATTTTTTCAATGA 112 
 MT5065 CATTACATTAATACAATAATGTATCAATTTAGTAAGAAAACTAATATTTTTTTAATGA 112 
 MT5066 CATTACATTAATACAATAATGTATCAATTTAGTAAGAAAACTAATATTTTTTTAATGA 112 
  SE838 CATTACATTAATACAATAATGTATCAATTTAGTAAGAAAACTAATATTTTTTTAATGA 115 
  SS235 CATTACATTAATACAATAATGTATCAATTTAGTAAGAAAACTAATATTTTTTTAATGA 112 
 
    630 ATTGATACATTATTGTATTAATGTAATGGAAATGCGATTAATTTAAATAAATAAAGAA 170 
JIR8094 AGTCCCATGAAAATATAAAAAAATTTTAATATGTATTTAAATATTTCTTCGAAAAGTT 170 
  MAM30 AGTCCCATGAAAATATAAAAAAATTTTAATATGTATTTAAATATTTCTTCGAAAAGTT 170 
 MT4768 AGTCCCATGAAAATATAAAAAAATTTTAATATGTATTTAAATATTTCTTCGAAAAGTT 170 
 MT5065 AGTCCCATGAAAATATAAAAAAATTTTAATATGTATTTAAATATTTCTTCGAAAAGTT 170 
 MT5066 AGTCCCATGAAAATATAAAAAAATTTTAATATGTATTTAAATATTTCTTCGAAAAGTT 170 
  SE838 AGTCCCATGAAAATATAAAAAAATTTTAATATGTATTTAAATATTTCTTCGAAAAGTT 173 
  SS235 AGTCCCATGAAAATATAAAAAAATTTTAATATGTATTTAAATATTTCTTCGAAAAGTT 170 
 
    630 GTCA TT--TTTGTAATATAGCAACTT 194 
JIR8094 GCTC TT--TTTGTAATATAGCAACTT 194 
  MAM30 GCTC TT--TTTGTAATATAGCAACTT 194 
 MT4768 GCTC TTT-TTTGTAATATAGCAACTT 195 
 MT5065 GCTC TT--TTTGTAATATAGCAACTT 194 
 MT5066 GCTC TT--TTTGTAATATAGCAACTT 194 
  SE838 GCTC TTTTTTTGTAATATAGCAACTT 199 




Figure 3.8. Clinical and environmental ribotype 012 isolates are flg OFF. (A) Orientation-
specific PCR products using the indicated strains as template. Template from 630 is included as a 
control to detect the flg ON orientation. Image is representative of four biological replicates. (B) 
Swimming motility after 24 hours. Data are representative of three independent experiments with 




Figure 3.9. Low frequency recovery of flg ON bacteria from select ribotype 012 isolates. (A) 
Swimming motility after 24 hours. A representative image with a motile flare (white arrow) is 
shown. (B) The isolates differ in the frequency of recovery of motile revertants. Shown are 
pooled data from two independent experiments, each examining 16 biological replicates (n = 32). 
Frequency of motile flares cumulative for each time point, with those detected at 72 hours 
including those from 48 hours. (C) Orientation-specific PCR products using the indicated strains 
as template. All nine recovered flg ON isolates derived from flg OFF MT5066, SE838, and 
SS235 yielded PCR products indicating both flg ON and flg OFF populations. Data are 




Figure 3.10. Sequence alignment of flagellar switch and inverted repeat sequences from the 
motile derivatives of clinical and environmental ribotype 012 C. difficile isolates. A multiple 
sequence alignment generated using Clustal Omega with the flagellar switch and inverted repeats 
from the C. difficile strains 630 and flg ON isolates of MT5066, SE838 and SS235. 
  
          630 AAGTTACTATTTT-ACAA--AAA GAGCAACTTTTCGAAGAAATATTTAAAT 48 
MT5066 flg ON AAGTTACTATTTT-ACAA--AAA GAGCAACTTTTCGAAGAAATATTTAAAT 48 
 SE838 flg ON AAGTTACTATTTTTACAAAAAAA GAGCAACTTTTCGAAGAAATATTTAAAT 51 
 SS235 flg ON AAGTTACTATTTT-ACAA--AAA GAGCAACTTTTCGAAGAAATATTTAAAT 48 
 
          630 ACATATTAAAATTTTTTTATATTTTCATGGGACTTCATTAAAAAAATATTAG 100 
MT5066 flg ON ACATATTAAAATTTTTTTATATTTTCATGGGACTTCATTAAAAAAATATTAG 100 
 SE838 flg ON ACATATTAAAATTTTTTTATATTTTCATGGGACTTCATTAAAAAAATATTAG 103 
 SS235 flg ON ACATATTAAAATTTTTTTATATTTTCATGGGACTTCATTAAAAAAATATTAG 100 
 
          630 TTTTCTTACTAAATTGATACATTATTGTATTAATGTAATGGAAATGCGATTA 152!
MT5066 flg ON TTTTCTTACTAAATTGATACATTATTGTATTAATGTAATGGAAATGCGATTA 152!
 SE838 flg ON TTTTCTTACTAAATTGATACATTATTGTATTAATGTAATGGAAATGCGATTA 155!
 SS235 flg ON TTTTCTTACTAAATTGATACATTATTGTATTAATGTAATGGAAATGCGATTA 152!
 
          630 ATTTAAATAAATAAAGAAGTCA TT--TTTGTAA-TATAGCAACTT       194!
MT5066 flg ON ATTTAAATAAATAAAGAAGTCA TT--TTTGTAA-TATAGCAACTT       194!
 SS235 flg ON ATTTAAATAAATAAAGAAGTCA TTTTTTTGTAAATATAGCAACTT       200!




Figure 3.11. Characterization of select flg ON ribotype 012 isolates. (A) Swimming motility 
assay after 24 hours. All nine recovered flg ON isolates were motile at 24 hours compared to 
their non-motile flg OFF MT5066, SE838, and SS235 parents. Data are representative of three 
independent experiments with five biological replicates for each strain. (B) Detection of TcdA in 
the indicated strains by western blot. Data are representative of three independent experiments. 
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Table 3.1. Strains and plasmids used in this study. 
Strain/Plasmid Description/Purpose Reference 
Plasmids   
pRPF185 Anhydrotetracycline (ATc) inducible expression vector; 
CmR/Tm10 
(28)  
pRT1611 pRPF185 with gusA removed (vector control) (14) 
pRT1830 pRPF185::topA (CD630_12740) This work 




DH5α F- Φ80lacZ Δ M15 (lacZYA-argF)U169 recA1 endA1 
hsdR17(rκ -, mκ +) phoA supE44 thi-1 gyrA96 relA1 λ - tonA 
Invitrogen, (41) 
HB101(pRK24) F- mcrB mrr hsdS20(rB-mB)recA13 leuB6 ara-14 proA2 lacY1 
galK2 xyl-5 mtl-1 rpsL20 (pRK24) 
(30) 




630 Ribotype 012 (21, 42) 
630Δerm Ribotype 012, erythromycin susceptible derivative of C. 
difficile 630 
(24) 
JIR8094 (630E) Ribotype 012, erythromycin susceptible derivative of C. 
difficile 630 
(23) 
R20291 Ribotype 027, epidemic isolate (43) 
MAM30 Ribotype 012, clinical isolate from hospitalized patient Gift from KW Garey 
MT4768 Ribotype 012, clinical isolate from hospitalized patient Gift from KW Garey 
MT5065 Ribotype 012, clinical isolate from hospitalized patient Gift from KW Garey 
MT5066 Ribotype 012, clinical isolate from hospitalized patient Gift from KW Garey 
SE838 Ribotype 012, hospital environmental isolate Gift from KW Garey 
SS235 Ribotype 012, community environmental isolate Gift from KW Garey 
RT1931 MT5066 flg ON #1 This work 
RT1946 MT5066 flg ON #2 This work 
RT1947 MT5066 flg ON #3 This work 
RT1932 SE838 flg ON #1 This work 
RT1933 SE838 flg ON #2 This work 
RT1948 SE838 flg ON #3 This work 
RT1934 SS235 flg ON #1 This work 
RT1935 SS235 flg ON #2 This work 
RT1949 SS235 flg ON #3 This work 
RT1566 R20291 sigD::erm (Targetron insertion at nucleotide position 
228 of sigD, sense orientation) 
(14) 
RT782 JIR8094 motile derivative #1 This work 
RT783 JIR8094 motile derivative #2 This work 
RT784 JIR8094 motile derivative #3 This work 
RT1609 JIR8094 motile derivative #1 + pRT1611 This work 
RT1860 JIR8094 motile r derivative #1 + pRT1830 This work 
RT1613 JIR8094 motile derivative #2 + pRT1611 This work 
RT1861 JIR8094 motile derivative #2 + pRT1830 This work 
RT1631 JIR8094 motile derivative #3 + pRT1611 This work 
RT1862 JIR8094 motile derivative #3 + pRT1830 This work 
RT1863 630 ∆erm sigD::erm + pRT1611 This work 
RT1864 630 ∆erm sigD::erm + pRT1830 This work 
RT1576 630 + pRT1611 This work 
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RT1858 630 + pRT1830 This work 
RT1578 JIR8094 + pRT1611 This work 




Table 3.2. Oligonucleotides used in this study. 
Primer Namea Sequence (5’ ! 3’)b Lab 
Annotat
ion 
flgRibo012_Pub GAGCAACTTTTCGAAGAAATATTTAAATAC R1751 














































CD630_topA_F CAAGAGCTCGATTAGGTAGTGGGGGTGTAT (SacI) R2302 







a Where locus tags are used in the primer name, the corresponding gene name is noted in parentheses 
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CHAPTER 4: RHO FACTOR IS REQUIRED FOR PHASE VARIATION OF 
FLAGELLA IN CLOSTRIDIUM DIFFICILE3 
 
Summary 
 Clostridium difficile is a bacterial pathogen that causes an antibiotic-associated diarrheal 
disease. C. difficile produces flagella that aid in bacterial motility and secretes toxins that are 
necessary for diarrheal disease symptoms. Both flagella and toxins are co-regulated in C. difficile 
via a genetic ON/OFF switch in a process called phase variation. Motile and toxigenic bacteria 
are phase ON, whereas non-motile and non-toxigenic bacteria are phase OFF. Herein, we 
identified Rho factor as a requirement for the ON/OFF production of flagella and toxins in C. 
difficile.  Mutations in Rho factor that are predicted to inactivate essential features of Rho 
activity restore motility to phase OFF bacteria. Normally, Rho factor terminates messages for 
production of proteins near the end. We predict that Rho factor directly terminates the message 
for production of flagella and toxins in phase OFF bacteria early. Our findings add to an 
emerging paradigm that Rho factor can terminate messages early and late in their expression. 
Introduction 
 Clostridium difficile is a Gram-positive, spore-forming anaerobe and the leading cause of 
antibiotic-associated diarrheal disease. Antibiotic treatment for a preexisting infection increases 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
3 I performed the experiments for Figures 4.1-4.6 and Tables 4.1-4.2, except Dr. Rita Tamayo 
isolated seven motile suppressors of recV flg OFF* listed in Table 4.3 (RT1939-RT1945). I 
wrote an original draft of Chapter 4 and Dr. Tamayo and I revised the final version herein. 
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susceptibility to C. difficile colonization (1). Antibiotic use disrupts the gastrointestinal microbial 
community that normally affords resistance to C. difficile infection. Diarrheal disease symptoms 
are most attributable to the glucosylating toxins TcdA and TcdB (2-5). In host cells, TcdA and 
TcdB glucosylate the regulatory regions of Rho family GTPases to prevent interaction with 
downstream effectors (6, 7). As a consequence, Rho GTPases can no longer interact with cellular 
factors controlling the actin cytoskeleton. In cell culture, phenotypically this results in a 
disruption of tight junctions and loss of epithelial cell integrity (8, 9), and downstream cell death 
through diverse mechanisms. Toxin activity during infection results in the disruption of the 
intestinal barrier and immune cell recruit with inflammation.  
The expression of both toxin genes is subject to diverse regulatory mechanisms to 
precisely control production of these energetically costly toxins (10). For example, in stationary 
phase conditions where amino acids and carbohydrates are low, the nutrient sensing 
transcriptional regulators CodY and CcpA derepress transcription of the genes encoding the 
toxin genes and their positive regulator TcdR (11-14). However, the toxins are dispensable for 
initial colonization in small animal models of disease (2-5). C. difficile encodes various surface 
bound appendages that enable bacterial colonization in the intestine, albeit with some 
redundancy to ensure survival (15, 16). Flagella in C. difficile contribute not only to swimming 
motility (17, 18), but also adherence to intestinal epithelial cells, colonization, and virulence in 
animal models of infection (19-21). Similar to Bacillus subtilis, the flagellar gene operons are 
arranged in discrete loci and expressed in a hierarchical manner to ensure assembly of the right 
complexes at the appropriate time (22). The early stage flagellar operon (flgB) encodes an 
alternative sigma factor, SigD, that is essential for expression of late stage flagellar genes (23, 
24). In addition, SigD contributes to expression of the toxin genes by activating transcription of 
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tcdR (20, 23, 24). Thus, factors that regulate expression of the flgB operon can also impact toxin 
production via SigD. Numerous regulators, such as Agr quorum sensing (25), SinR (26), RstA 
(27), and cyclic diguanylate (23) have been shown to affect both flagellar and toxin production in 
C. difficile. However, the exact regulatory mechanisms for many remain undefined. 
Recently we demonstrated that C. difficile flagella and toxin production is phase variable 
in both ribotypes 027 and 012 (28, 29). Phase variation is a process in bacteria allowing 
stochastic control of the production of cell surface or secreted proteins to generate phenotypic 
diversity (30). Diverse genetic mechanisms are at play in phase variation (30). In C. difficile, 
conservative site-specific recombination of a genetic switch termed the “flagellar switch” 
upstream of the flgB operon is responsible for phase variation of flagella and toxins (28). The 
flagellar switch is an invertible 154 bp element and flanked by 21 bp imperfect inverted repeats. 
In flagellar phase ON (flg ON) bacteria, the switch is in an orientation permissive for 
downstream gene expression, and therefore C. difficile produces flagella, is motile, and secretes 
the glucosylating toxins. In flagellar phase OFF (flg OFF) bacteria, the switch restricts gene 
expression, and C. difficile is aflagellate, non-motile, and attenuated for toxin production. The 
canonical regulatory mechanism inherent to genetic switches relies on an invertible promoter 
element. In one orientation, the promoter is positioned to control transcription of a downstream 
gene by RNA polymerase. However, inversion of the switch disrupts the orientation-specific 
nature of the -10 and -35 elements such that RNA polymerase can no longer transcribe the target 
gene. The fimbrial switch in Escherichia coli contains a promoter element for fimA operon 
expression (31). In Salmonella, a flagellar switch encodes the Hin recombinase necessary for 
inversion as well as a promoter to control expression of fljBA operon (32).  
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In C. difficile, the flagellar switch lies between the previously identified, upstream σA-
dependent promoter and the flgB coding sequence. Thus, the σA-dependent promoter drives 
transcription through the 5’ untranslated region (UTR) including the flagellar switch (33). We 
showed the mechanism of regulation via the flagellar switch occurs post-transcription initiation 
and involves an unidentified trans-acting posttranscriptional regulator specific to C. difficile 
(28). The only other genetic switch functionally characterized in C. difficile is 5’ of the cwpV 
gene (34-36). The cwpV switch results in the formation of an intrinsic terminator in the mRNA 
of cwpV OFF bacteria, but allows transcriptional readthrough in cwpV ON bacteria (34). The 
flagellar switch in C. difficile does not contain an intrinsic terminator (28). Therefore, we sought 
to identify the regulatory mechanism by which the flagellar switch controls downstream flgB 
operon expression. 
 The tyrosine recombinase RecV is both necessary and sufficient to mediate inversion of 
the flagellar switch in both direction in C. difficile strain R20291 (28). Mutation of recV in 
R20291 locks the flagellar switch in either orientation. We denote the phase-locked mutants with 
an asterisk to differentiate them from phase variable states: phase-locked recV::erm flg ON (recV 
flg ON*) or phase-locked recV::erm flg OFF (recV flg OFF*) (28). The genotype of the flagellar 
switch predicts the phenotype in these mutants: recV flg ON* produce flagella, are motile, and 
secrete toxins, whereas recV flg OFF* are aflagellate, non-motile, and attenuated for toxin 
production (28). We previously observed that extended incubation of the recV flg OFF* mutant 
in motility medium can infrequently give rise to “motile flares” in which motile bacteria migrate 
from the stab site of non-motile bacteria (Figure 2.19A). We hypothesized that the motile recV 
flg OFF* bacteria were suppressors with mutations in a gene(s) responsible for inhibiting gene 
expression in flg OFF bacteria (28, 37). In this body of work, we sequenced the suppressors, 
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identified the mutations, and characterized the suppressor mutants in motility and toxin assays. 
Mutations were identified in the rho gene, suggesting that Rho factor is responsible for 
termination of gene expression in flg OFF bacteria. Rho factor is an ATP-dependent RNA 
helicase that mediates transcription termination at the 3’ end of a gene or operon (38). Emerging 
evidence shows Rho factor can mediate termination in the leader RNA as a regulatory 
mechanism due to changes in RNA structure (39, 40). Based on our results, we propose models 
in which Rho factor either directly or indirectly mediates transcription termination in the flgB 




Frequency in detection of motile suppressors  
We previously described four motile suppressors (MS) from a recV flg OFF* mutant. 
Despite recovering swimming motility, the MS strains retained the flagellar switch in the OFF 
orientation. These data suggest that under the conditions tested RecV is the sole recombinase 
responsible for inversion of the flagellar switch. No mutations were present in the flgB operon 
promoter and leader sequence in the recV flg OFF* MS compared to the parental strain (data not 
shown). We hypothesized that the recV flg OFF* MS have either (1) extragenic gain-of-function 
mutations in positive regulators of flgB operon expression to override the flg OFF regulatory 
mechanism, or (2) extragenic loss-of-function mutations in an unidentified C. difficile-specific, 
trans-acting regulatory factor responsible for transcription termination in flg OFF bacteria. 
Motility assays were performed with 64 biological replicates of recV flg OFF* over two 
independent experiments to calculate the frequency of MS by counting motile flares. The recV 
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flg ON* mutant served as a motile control, and a sigD::erm (sigD) mutant served as a non-motile 
control. Motility was monitored every 24 hours for three days. Only 3.1% of recV flg OFF* 
colonies stabbed into the motility medium developed motile flares at 24 hours (Figure 4.1). The 
percentage of colonies showing motility increased from 10.9% at 48 hours to 21.9% at 72 hours 
(Figure 4.1). Based on these data, we conclude that recovery of motility in the non-motile recV 
flg OFF* mutant is an infrequent event.  
 
The motile suppressors display restored motility  
  Based on the presence of motile flares, we predicted the MS would have restored 
swimming motility. We isolated fourteen MS from motility medium and assayed for swimming 
motility compared to motile recV flg ON*, non-motile recV flg OFF*, and a non-motile sigD 
mutant control strains. All 14 MS were motile at 24 and 48 hours compared to the non-motile 
recV flg OFF* and sigD mutants (Figure 4.2A & 4.2B). In addition, MS #8-14 had a significant 
increase in motility compared to recV flg ON* at 48 hours (p < 0.05 *) (Figure 4.2B). From these 
data, we concluded that the infrequent motile flares detected in the motility medium (Figure 4.1) 
from the parental recV flg OFF* mutant represent a motile suppressor population with recovered 
swimming motility.  
 
Identification of the mutations in motile suppressors 
To identify the genes involved in recovery of swimming motility in the recV flg OFF* 
motile suppressors, whole genome sequencing and variant analysis was performed on seven 
independent MS and the parental recV flg OFF* mutant. A minimum threshold of 50% of 
sequencing reads with an allelic variant relative to the reference genome was arbitrarily set to 
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identify mutations present in the MS, but absent from the parental strain (Materials & Methods). 
Only one gene, CDR20291_33240, which encodes an orthologue of Rho factor from E. coli (38), 
was altered in all seven MS; MS #1-7 contained a frameshift, missense, or nonsense mutation in 
rho (Table 4.1). Additional polymorphisms were identified in a subset of these strains. In 5/7 
strains (MS #2-6), we identified a single nucleotide polymorphism (SNP) in the intergenic region 
between two convergent genes: a gene coding a prophage site-specific recombinase and the ilvB 
gene, coding for the acetolactate synthase large subunit. In the same 5 MS, we identified two 
additional mutations upstream of a gene annotated to encode a manganese-containing catalase. In 
MS #7, we identified a SNP in a gene coding for a predicted transposase-like protein B element.  
Seven additional MS of the recV flg OFF* mutant (MS #8-14) were isolated from motile 
flares for sequencing of the rho gene, and 6/7 contained a mutation in rho (Table 4.1). MS #11 
did not contain a mutation in rho, but was included for comparison in most assays since it had a 
mild growth defect unlike most of the suppressors (discussed later). Based on these results, we 
focused on evaluating Rho factor as the lead candidate gene product required for termination of 
transcription in the flgB operon leader RNA of flg OFF bacteria 
 
Predicted functional consequences of rho mutations 
 Rho factor is an homohexamer that functions as an ATP-dependent RNA helicase that 
mediates transcription termination at the 3’ end of a gene or operon (38). Domains and amino 
acid residues important for Rho factor function have been delineated in great detail in the model 
organism E. coli. In this section, we briefly review the functional domains in E. coli Rho 
compared to C. difficile Rho, and we predict the functional consequence of most mutations 
(Figure 4.3A and 4.3B). C. difficile Rho monomer can be divided into two domains, C-terminal 
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and N-terminal, each with distinct subdomains that contribute to function (Figure 4.1). The N-
terminal domain (NTD) has three subdomains: an N-terminal Helix Bundle (NHB), an Insertion 
Domain, and a Primary Binding Site (PBS). The NHB consists of amino acids 11-51 and helps 
recruit nascent RNA to the PBS. The PBS consists of amino acids 171 to 223 and, in E. coli, lies 
in the outer leaflet of the hexamer, and binds RNA rich in pyrimidine bases, specifically 
cytosines. The sequence recognized by the PBS is called the rho utilization (rut) site and lies 60-
70 nucleotides or bases upstream of the termination zone. Rho factor remains tethered to the rut 
site via the PBS, and nascent RNA is thread through the interior channel of the hexamer. 
Mutations in the PBS affect termination efficiency. The Insertion Domain varies in length and 
amino acid composition and is present in some bacteria and contributes to various functions. The 
CTD consists of several features that contribute to ATP binding, hydrolysis, and RNA binding. 
The CTD has Walker A (AA 288-295) and B (AA 371-375) motifs that are present in many 
proteins that use ATP binding and hydrolysis for energy. ATPase activity is required for both 
RNA-DNA helicase function of Rho in separating the nascent mRNA from the template DNA 
out of the transcription elongation complex of RNAP, and the termination activity. The Q-loop 
(AA 390-402) and R-loop (AA 431-436) consist of the Secondary Binding Site (SBS), which 
contributes to RNA binding along the interior of the hexamer during translocation. Mutations in 
the SBS affect the termination site. RNA binding by SBS induces conformation changes to allow 
for ATP binding and hydrolysis and translocation of Rho along the transcript.     
Although our suppressor screen was not saturating, we identified several mutants 
presumably defective in key functions of Rho. Several mutants have missense mutations in 
domains that contribute to RNA binding in either the PBS and the Q-loop of the SBS – MS #7 
(R201M) and MS #9 (L404P) (Figure 4.3B). The proline likely introduces conformational 
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rigidity due to the cyclic structure and prevents conformational changes in the Q-loop. Several 
mutants have missense mutations in the CTD likely affecting interdomain interactions, ATP 
binding and hydrolysis, and structural transitions: MS #2 (G474V), MS#3 (G279E), MS #8 
(S473F), MS #12 (R322I), and MS #13 (D320A) (Figure 4.3B). The MS #12 (R322I) is the 
critical arginine valve residue necessary for ATP ! ADP transitions. Several mutants have 
nonsense mutations resulting in truncated Rho proteins of various sizes and lacking critical 
domains: MS #4 (E444Stop), MS #5 (AA 70 frameshift), MS #6 (E255Stop), MS #10 
(E108Stop), and MS #14 (E247Stop) (Figure 4.3B). The MS #1 (N528S) remains to be 
determined since it is the second to last amino acid. The mutation in MS #11 has not been 
identified and may be upstream of rho affecting expression or in another gene that contributes to 
termination in flg OFF bacteria. Collectively, these mutants can be used to probe specific 
domains in C. difficile, specifically the ATP binding and hydrolysis, interdomain interactions, 
and RNA binding domains PBS and SBS.   
 
Putative inactivating rho mutations attenuate planktonic growth  
Inactivation of rho in E. coli is lethal (41), but rho mutants in B. subtilis and 
Staphylococcus aureus are viable with negligible growth defects (42, 43). Some of the MS 
developed smaller colonies on nutrient rich agar medium, and as detailed above, some of the 
observed mutations are predicted to abolish critical features for Rho activity, such as ATP 
binding and hydrolysis. Therefore, we evaluated the growth kinetics of the 14 MS relative to the 
recV flg ON* mutant and the parental recV flg OFF* mutant. We found that 4/14 MS (i.e., MS 
#1, MS #7, MS #8, and MS #11) had reproducible growth kinetics comparable to the recV flg 
OFF* and recV flg ON* mutants in rich medium (Figure 4.4A). Growth rates were calculated 
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using exponential phase time points at 4 hours and 5.5 hours. All motile suppressors exhibited 
variable growth rates compared to the parent recV flg OFF* mutant in exponential phase (Figure 
4.4B). That all the MS grew in vitro is consistent with previous work showing that the rho gene 
is not essential for growth in C. difficile strain R20291 (44). Targeted mutation of the rho gene in 
R20291 is currently underway.  
   
Rho factor is dispensable for regulation of toxin production 
 The flagellar switch orientation affects expression of sigD in the flgB operon (28, 29). 
Moreover, a recV flg ON* mutant produces high concentrations of TcdA, whereas the recV flg 
OFF* mutant is attenuated for TcdA production (28). SigD, the flagellar alternative sigma factor, 
is required for expression of late stage flagellar genes and contributes to expression of the toxin 
genes. In a hierarchy, SigD activates tcdR expression, and TcdR activates tcdA and tcdB 
expression (20, 23, 24). Therefore, we predicted that TcdA levels would increase in the MS 
relative to the parental strain. TcdA levels were assessed by western blot in strains grown for 12 
hours in TY and BHIS medium. MS #1, #7, #8, and #11 were used since their growth curves 
were most similar to the recV flg OFF* mutant (Figure 4.4A and 4.4B). The recV flg ON* 
mutant served as a positive control, and both the recV flg OFF* and sigD mutants served as 
negative controls. In TY medium, we found that TcdA levels were indistinguishable among the 
recV flg OFF*, recV flg ON*, MS #1, MS #7, MS #8, MS #11, and sigD mutants (Figure 4.5A). 
Although peptide-rich TY medium is ideal for assessing toxin production (45), SigD activity 
may be higher in glucose-rich media, such as BHIS, which is used in the motility medium. In 
BHIS, we found that TcdA levels, as previously published (28), were significantly reduced in the 
recV flg OFF* mutant compared to the recV flg ON* mutant, and the MS #1, #7, #8, and #11 had 
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variable recovery in TcdA production between independent experiments (Figure 4.5B). Loss of 
function mutations in Rho factor may have pleotropic effects on the expression and production of 
other positive and negative regulators of toxin production that confound the role of the flagellar 
switch and SigD.   
 
Rho mutant alleles exhibit dominant negative effects 
 To load onto a nascent RNA and mediate transcription termination, Rho factor must 
assemble into a hexamer to function (38). Mutant monomers expressed in trans to a wildtype 
allele could be antagonistic to the wildtype multimeric protein rendering the protein non-
functional. To determine if the mutations in the rho gene of the motile suppressors are dominant 
negative, we cloned each of the 13 rho mutant alleles downstream of the anhydrotetracycline 
(ATc)-inducible promoter (46). The wildtype allele of rho from the recV flg OFF* mutant served 
as a negative control for the assay. The plasmids were transformed into the recV flg OFF* 
mutant, and resulting strains were assayed for the frequency of motile flares in motility medium 
every 24 hours for two days to determine whether the rho mutant alleles could exert a dominant 
negative effect (47). Frequency of motile reversion was determined with and without ATc 
inducer since the Ptet promoter is known to be leaky (47). As expected, expression of the 
wildtype rho allele resulted in the lowest frequency of motile stab sites regardless of ATc 
concentration. Less than 25% of stab sites had motile flares for strains expressing the G279E, 
AA70!FS!Stop79, L404P, or D320A rho allele at 24 hours; by 48 hours the strains expressing 
the G279E, L40P, and D320A alleles yielded motile flares in 100% of stab sites without ATc 
(Table 4.2). Leaky expression of the remaining mutant rho alleles exerted a dominant negative 
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effect with greater than 25% of stab sites positive for motile flares by 24 hours and 100% 
positive by 48 hours (Table 4.2).  
Dominant negative mutants should exhibit a dose-dependent effect over the wildtype 
gene product. Interestingly, we found that the addition of ATc to motility medium reduced the 
frequency of motile conversion for all the Rho mutants at 24 hours compared to uninduced, 
except the R322I allele increased from 75% to 100% (Table 4.2). By 48 hours, motility medium 
with ATc had at least 75% of stab sites positive for motile flares with all the Rho mutants (Table 
4.2). These data demonstrate that Rho mutant alleles can exert a dominant negative effect over 
the wildtype Rho homohexamer. We propose that this occurs through generation of 
heterohexamers of wildtype and mutant Rho, resulting in loss of Rho-mediated inhibition of 
expression in flg OFF* bacteria. The reciprocal experiments with Rho mutant overexpression in 
the recV flg ON* mutant had no effect on motility with or without ATc inducer (Table 4.3). 
Motile flares detected for expression of the wildtype Rho in the recV flg OFF* background were 
isolated for future characterization.  
 
Rho-dependent regulation occurs after transcription initiation of flgB operon 
Rho inactivation can affect gene expression by direct, indirect cis, or indirect trans 
effects (48). Direct regulation is the canonical mechanism involving Rho factor binding, 
translocating, and terminating transcription by paused RNAP at specific sites. Indirect regulation 
in cis can be due to continued transcription into a neighboring gene or operon if an upstream 
terminator is Rho dependent. Indirect regulation in trans can be due to the production of a factor 
encoded elsewhere that impacts gene expression at the promoter or post-transcription initiation. 
To determine whether Rho factor affects flgB operon expression at the promoter level (indirect 
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trans) or post-transcription initiation (direct or indirect trans), we used alkaline phosphatase 
(AP) gene reporters. The same AP reporter constructs described previously were used (28), 
except cloned into a low-copy plasmid for higher overall AP activity. Briefly, the native flgB 
promoter (σA-dependent), the full 498 bp 5’ UTR with the flagellar switch (FS) in either the 
phase ON or OFF orientation, and flgB (first gene of the flgB operon) were placed upstream of 
the phoZ reporter gene (PflgB-5’UTR(FSON/OFF)-flgB::phoZ; ON or OFF). A transcriptional fusion 
of phoZ to the flgB promoter (PflgB::phoZ; Promoter) served as a positive control for the assay, 
and a promoterless construct (::phoZ; Promoterless) was included as a negative control. The four 
reporters were transformed into the following mutants: recV flg OFF*, recV flg ON*, MS #1 
(N528S), MS #7 (R201M), MS #8 (S473F), and MS #11 (suppressor mutation undetermined). 
These MS were chosen because they have growth kinetics most similar to the recV flg ON* and 
OFF* strains. As anticipated, the Promoterless reporter control showed no AP activity, and the 
presence of the Promoter reporter significantly increased activity in all strains tested (Figure 4.6). 
AP activity was detectable and comparable for the ON reporter in the recV flg OFF* and recV flg 
ON* mutants, indicating that the flg ON leader RNA is resistant to Rho-dependent termination 
(Figure 4.6). However, AP activity was higher for the ON reporter in all four MS compared to 
recV flg ON*, which suggests that either Rho factor affects gene expression in the flg ON 
background to a minor degree, or a regulator of transcription elongation or RNA stability is 
highly expressed or more active in rho mutants. These possibilities are not mutually exclusive. 
The OFF reporter had negligible AP activity and was indiscernible between the recV flgB ON* 
and recV flgB OFF* mutants, but was significantly higher in all four MS (Figure 4.6). Proficient 
gene expression with the OFF reporter in MS is consistent with the phenotypic recovery of 
motility observed in these strains. Collectively, these data eliminate the possibility that Rho 
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factor exerts an indirect trans effect at the promoter of the flgB operon. Moreover, we predict 
Rho factor mediates transcription termination at the flgB operon leader RNA either through a 
direct or indirect trans mechanism. 
 
Discussion 
  Based on these studies, our data suggest that flagellar phase variation in Clostridium 
difficile strain R20291 requires the activity of Rho factor. In summary, a flagellar switch 
upstream of the flgB operon mediates the ON/OFF expression of flagellar and toxin genes (28, 
29). Phase-locked non-motile bacteria infrequently give rise to motile suppressors with mutations 
in rho, implicating Rho factor in flagellar and toxin phase variation. The identified Rho mutant 
alleles are predicted to be non-functional since their overexpression restores motility to phase-
locked non-motile bacteria.  
We isolated a constellation of missense Rho mutants predicted to affect mRNA binding, 
translocation, and termination – all essential steps in Rho-dependent transcription termination. 
These results, particularly the isolation of multiple isolates with nonsense mutations in Rho, 
suggest that rho is not essential for growth. The motile suppressors have growth defects in 
nutrient rich medium suggesting that rho inactivation does attenuate expression or activity of 
important processes in C. difficile. In contrast, rho inactivation in B. subtilis and S. aureus have 
negligible effects on growth (42, 43). In a saturating transposon screen in C. difficile R20291 
(44), Rho was absent from the list of essential genes, which supports our findings. Interestingly, 
nusA and nusG mutants were not recovered in that screen. NusA associates with RNAP to help 
fold and stabilize hairpin-dependent pauses and terminators in bacteria (49), but also antagonizes 
Rho factor activity through direct competition for specific sites on transcripts (38, 50). NusG 
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interacts with RNAP to stimulate transcription elongation (51), and also stabilizes the Rho 
secondary binding site interaction with RNA to promote termination (38, 52).  
 Rho factor is required for phase variation of fimbriae in E. coli and capsule in Neisseria 
meningitidis (53, 54). In E. coli, the FimE recombinase controls inversion of the fimbrial switch 
(fimS), which contains a promoter, in the ON to OFF direction to prevent transcription of the 
fimA structural gene. The fimE gene is located immediately 5’ of fimS. Joyce et al. demonstrated 
that fimE mRNA half-life is differentially regulated based on fimS orientation. In the fimS ON 
orientation, the transcript for fimE extends across the switch into fimA, whereas the OFF 
transcript terminates in fimS. Rho inactivation restored fimE mRNA stability in fimS OFF 
bacteria. The fimS mRNA contains a boxA sequence, a sequence associated with Rho-mediated 
termination (55), exclusively when in the OFF orientation to facilitate Rho-dependent 
transcription termination. In N. meningitidis, slip-strand mispairing of a repeat sequence within 
the coding sequence of a polysialyltransferase gene reveals a cryptic Rho-dependent 
transcription termination site in capsule-OFF bacteria (54). We propose that in C. difficile, the 
change in mRNA sequence due to DNA switch inversion reveals either a rut sequence or a 
strong RNAP pause site in flg OFF bacteria. The strand specific determinant of Rho factor 
binding or RNAP pausing determines the outcome of Rho-dependent flagellum phase variation 
in C. difficile.  
 Rho inactivation in B. subtilis results in hypersporulation due to loss of an internal kinB 
gene Rho-dependent terminator (48). KinB is a histidine kinase that acts in a phosphorelay to 
activate Spo0A, the master regulator of sporulation initiation in B. subtilis (56). A mechanism 
involving an indirect effect of Rho via inappropriate readthrough of upstream genes can be 
eliminated since the genes 5’ to the flgB operon are σD-dependent (24). Interestingly, the 
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flagellar glycosylation genes 5’ of the flgB operon may require Rho-factor for transcription 
termination since 7/14 motile suppressors were hypermotile relative to recV flg ON*. Loss of 
Rho-dependent termination in the hypothetical gene 5’ of the flgB operon would lead to 
transcriptional read-through into the flgB operon promoting a positive feedback loop. However, 
overexpression of Rho mutants in the recV flg ON* had negligible effects on motility. Our 
working model is that Rho factor mediates direct transcription termination in the leader RNA of 
the flgB operon in flg OFF bacteria. The OFF reporter had significantly higher activity in the MS 
compared to either phase locked mutant. These data are supported by the recovery of swimming 
motility observed in the MS. The high activity of the ON reporter in MS strains could be due to 
increased expression and/or activity of positive regulators of flagellar gene expression. 
Specifically, we speculate that AgrA and/or SinR, which regulate expression of c-di-GMP 
diguanylate cyclases and phosphodiesterases (25, 26), indirectly control flagellar gene expression 
in flg ON and OFF bacteria.  
Multiple in vitro and in vivo approaches are underway to distinguish between direct and 
indirect mechanisms of flagellar phase variation via Rho factor. Targeted mutagenesis of Rho is 
needed to confirm that Rho relieves inhibition of motility in flg OFF bacteria. Treatment with 
bicyclomycin, a Rho-specific antibiotic (57), or heterologous expression of Psu, a Phage-Derived 
Rho Inhibitor (58, 59), can resolve any doubts of the contribution of Rho to flagellar phase 
variation. Transcription termination assays using the leader sequence for the flgB operon with the 
switch in the ON and OFF orientation will help discern a direct role for Rho factor in 
termination. Should such studies indicate that Rho factor does not directly terminate transcription 
in the leader RNA of the flgB operon, then whole transcriptome studies could identify gene 
networks dysregulated in a rho mutant due to global loss of transcription termination. In 
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addition, one motile suppressor lacking mutations in rho had growth kinetics comparable to 
either phase-locked mutant. Identifying the gene(s) mutated in this motile suppressor is of high 
priority, because it may reveal the factor that mediates indirect control of flagellar gene 
expression by Rho.  
   
Materials and Methods 
 
Bacterial strains and growth conditions 
 All bacterial strains used in this study are listed in Table 4.3. C. difficile was cultured at 
37ºC in anaerobic conditions with a gas atmosphere of 90% N2, 5% CO2, and 5% H2 in a Coy 
chamber. Brain Heart Infusion with 5% yeast extract (BHIS) or Tryptone Yeast (TY) media were 
used for cultivation of C. difficile where indicated. Unless otherwise indicated, E. coli was 
cultured at 37°C under aerobic conditions in Luria Bertani (LB) medium. For selection of 
plasmids in E. coli, 100 µg/mL ampicillin (Amp) and/or 10 µg/mL chloramphenicol (Cm) was 
used, as indicated. Kanamycin (Kan) 100 µg/ml was used to select against E. coli in conjugations 




 The recV flg OFF* mutant was used to isolate motile suppressors. Motility assays were 
set-up as previously described (28, 29, 60). Briefly, bacteria were cultured overnight in TY 
media and diluted 1:50 into fresh BHIS media for growth until reaching an Optical Density (OD) 
of ~1.0 at 600nm. A 1.5 µL volume of bacterial culture was used to stab inoculate anaerobic 
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0.3% 0.5X BHIS agar medium. Motility plates were incubated at 37 ̊C and motile flares were 
visually detected and enumerated, for frequency estimates, every 24 hours for three days. An 
asymmetric motile flare coming from the non-motile stab site was indicative of a potential motile 
suppressor. Using inoculating loops, motile suppressors were recovered from the lead the edge of 
the swim site and passaged on BHIS agar to isolate single colonies. Individual colonies were 
used to confirm motility in soft agar plates. For characterization of motile suppressors, the same 
conditions mentioned previously were used. For strains with plasmids, motility medium 
contained thiamphenicol at a final concentration of 10 µg/mLSwim diameters were measured 
every 24 hours as indicated, averaging the diameters from the narrowest and widest edges of the 
colony.  For experiments determining whether a specific rho mutant allele could exert a 
dominant negative effect in recV flg OFF* and recV flg ON*, motile flares were enumerated 
every 24 hours for two days. Single colonies were suspended in 100 µL of 1X PBS and 1.5 µL 
was used to stab inoculate motility medium.  
 
Whole Genome Sequencing 
 Genomic DNA was extracted from seven motile suppressors (RT1705 to RT1711 in 
Table 4.3) and the parental strain recV flg OFF* (RT1693) as previously described (61). 
Genomic DNA was prepared using the KAPA HyperPrep Kit (Roche) and sequenced using an 
Illumina HiSeq 2500 Rapid Run platform with paired ends and 100X coverage by the UNC-CH 
High Throughput Genomic Sequencing Facility. Data was processed and sequencing reads were 
mapped to the reference C. difficile R20291 genome (Accession No. FN545816.1) using CLC 
Genomics Workbench software with default settings. Mutations present exclusively in 
suppressors, but absent from the reference recV flg OFF* strain are presented in Table 4.1. 
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Western Blots for TcdA 
Overnight cultures were grown in TY broth and then diluted 1:50 in fresh TY or BHIS, 
where indicated. Strains were grown until late stationary phase (OD600 1.8-2.0) for 12 hours, 
normalized to the same density, and then cells were collected by centrifugation. Bacteria were 
lysed by suspension in SDS-PAGE buffer and heating to 100oC for 10 minutes. Samples were 
electrophoresed on 4-15 % TGX gels (Bio-Rad), then transferred to nitrocellulose membranes. 
Membranes were stained with Ponceau S (Sigma) to determine equal loading and imaged using 
the G:Box Chemi imaging system. TcdA was detected using mouse anti-TcdA primary 
antibodies (Novus Biologicals) followed by goat anti-mouse IgG secondary antibody conjugated 
to DyLight 800 4X PEG (Invitrogen). Blots were imaged using the Odyssey imaging system (LI-
COR). All strains were assayed in at least 2 independent experiments in TY and BHIS media. 
 
Alkaline phosphatase reporter assays 
 Strains were passaged from glycerol stock and single colonies were used to inoculate TY 
medium. Overnight cultures were diluted 1:50 into BHIS medium and grown until OD600 ~1.0-
1.5. One milliliter of culture was collected by centrifugation, supernatant discarded, and the 
pellet was stored in -20 ̊C freezer until ready to perform the assay. The AP assay was performed 
as previously described (28, 62).   
 
 
Generation of strains 
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 Alkaline phosphatase reporters were cloned from previously described templates using 
R2282 and R1706 described in Table 4.3 (28). Products for promoterless phoZ, PflgB::phoZ,  
PflgB-5’UTR(FSON)-flgB::phoZ, and PflgB-5’UTR(FSOFF)-flgB::phoZ were digested with NheI and 
BamHI and ligated into similarly digested pRPF144 (46). E. coli transformants were screened 
with primers R2282 and R1706, and positive cloned were sequenced with the same primers to 
confirmation. Plasmids were transformed into E. coli HB101, which was used in conjugations 
with the indicated C. difficile strains in Table 4.3 after brief heat shock (63). C. difficile 
transconjugants were selected on BHIS with thiamphenicol and kanamycin. 
 For dominant negative motility assays, constructs bearing a mutated rho allele were 
cloned as described. Briefly, genomic DNA from the 13 motile suppressors with mutations in the 
rho was used as template in a PCR using primers R2308 and R2307 to amplify the rho gene 
(CDR20291_3324) (61). PCR products were digested with EcoRV and BamHI and ligated into 
pRPF185. pRPF185 was digested with SacI, Klenow treated to generate blunt ends, and digested 
with BamHI prior to ligation with insert. E. coli transformants were grown at 30 ̊C to hinder 
additional mutations in rho and were screened with R2308 and R2307. Sequence integrity was 
confirmed using primers R2308, R2307, R2366, and R2367. Plasmids were transformed into 
HB101 for conjugation with the C. difficile strains listed in Table 4.3 (63). C. difficile 






Figure 4.1: Low frequency recovery of motile suppressors from the recV flg ON* mutant. 
The recV flg OFF* mutant was inoculated into motility medium, and the presence of motile 
flares was recorded every 24 hours for three days. Data are expressed as a percentage of motile 
flares divided by the total number of replicates. Data are combined from two independent 






















Figure 4.2.: The motile suppressors display restored motility. (A) Representative image of a 
swimming motility plate at 48 hours with the recV flg ON*, recV flg OFF*, sigD, and MS #4 
mutants. (B) Quantification of swim diameter measured at 24 and 48 hours with the recV flg 
ON*, recV flg OFF*, sigD, and MS #1-14 mutants. Data were pooled from 2 independent 













































Figure 4.3. Schematic and amino acid alignment with features of C. difficile Rho factor. (A, 
B) Schematic of Rho factor with annotated and color-coded domains important for function. N-
terminal Helix Bundle (NHB) domain is colored blue and consists of amino acids (AA) 11-51. 
The Insertion Domain is colored grey and is AA 52-167. The Primary Binding Site (PBS) 
domain is colored green and is AA 171-223. The C-terminal domain (CTD) has a smaller region 
of AA 266-514. Walker motif A domain is orange (A) and bolded AA 288-295 in (B). Walker 
motif B domain is orange (A) and underlined and bolded AA 371-375 in (B). The Q loop domain 
is colored grey in (A) and is wavy underlined AA 390-402 in (B). The R loop domain is grey in 














LILDDKVLEG LGSKTLVELR EIAKELKIKS ITTYKKNELI EIINSKSKNE 50 
EKVNEETKEK NEDIKEDIKN RKENIERESI EKEVEYKSPT KSYNKKEIDT 100 
QNISQNQENR NQRNDYNKTT SVNDSNKSSN ISNRMVRNNN KNYYMPKQVD 150 
ESKIVDEFNT SKEDEVVGVL EILPDGFGFL RGSNYLSTEG DVYVSPSQIR 200 
RFNMKTGDKI KGITRHPKSG EKFRALLYVQ KINDENPDTA IQRNAFETLT 250 
PIFPEERLTL ETNRNEIATR IIDLISPIGK GQRGLIVAPP KAGKTVLLKS 300 
VANSIAKNHP NVELIVLLID ERPEEVTDMK ESIEGDVIYS TFDQVSSHHV 350 
KVAEMVLNRA QRLVEHGKDV VILLDSITRL ARAYNLTISP TGRTLSGGID 400 
PGALHGPKKF FGAARNIRQG GSLTILGTAL VETGSRMDDV IFEEFKGTGN 450 




Figure 4.4. Growth curves and rates of motile suppressors. (A) Growth curves of the recV flg 
ON*, recV flg OFF*, and MS #1-14 strains in BHIS medium. Data are pooled from two 
independent experiments with 4-6 biological replicates of each mutant. (B) Growth rates of the 
recV flg ON*, recV flg OFF*, and MS #1-14 strains calculated from (A) using time points at 4 







































































Figure 4.5. Motile suppressors produce TcdA in variable levels depending on growth 
medium. (A, B) Western blots for TcdA from the cell lysates of the recV flg ON*, recV flg 
OFF*, MS #1, MS #7, MS #8, MS #11, and sigD mutants in (A) TY medium and (B) BHIS 



















Figure 4.6. Evaluation of alkaline phosphatase reporters in the motile suppressors. Alkaline 
phosphatase activity for promoterless phoZ (Promoterless), PflgB::phoZ (Promoter), PflgB-
5’UTR(FSON)-flgB::phoZ (ON), and PflgB-5’UTR(FSOFF)-flgB::phoZ (OFF) reporters in the recV 
flg OFF*, recV flg ON*, MS #1, MS #7, MS #8, and MS #11 mutants. Data are pooled from two 
independent experiments with four biological replicates of each strain.  
 






































Table 4.1. Mutations identified from whole genome sequencing of motile suppressors. 
Suppressor Strain Position on R20291 Chromosome 
Nucleotide Locus Tag in 
CDR20291 
Gene 
Annotation Notes Reference Alteration Frequency 
recV flg ON MS #1 3955138 T C 99.28 3324 rho N528S 
recV flg OFF* MS #2 
3955300 C A 99.13 3324 rho G474V 
1670842 G A 74.76 1414 – 1415   
1726838 A T 79.58 5’ of 1465   
1726842 T G 77.68 5’ of 1465   
recV flg OFF* MS #3 
3955885 C T 97.66 3324 rho G279E 
1670842 G A 57.32 1414 – 1415   
1726838 A T 55.11 5’ of 1465   
1726842 T G 51.76 5’ of 1465   
recV flg OFF* MS #4 
3955391 C A 99.05 3324 rho E444Stop 
1670842 G A 68.91 1414 – 1415   
1726838 A T 74.24 5’ of 1465   
1726842 T G 71.44 5’ of 1465   
recV flg OFF* MS #5 
3956539 T / 89.83 3324 rho Frameshift 
1670842 G A 70.43 1414 – 1415   
1726838 A T 73.19 5’ of 1465   
1726842 T G 71.26 5’ of 1465   
recV flg OFF* MS #6 
3955955 C A 99.22 3324 rho E255Stop 
1670842 G A 74.76 1414 – 1415   
1726838 A T 79.58 5’ of 1465   
1726842 T G 77.68 5’ of 1465   
recV flg OFF* MS #7 3956119 T C 99.02 3324 rho R201M 4128329 A G 90.91 5’ of 3478   
recV flg OFF* MS #8 1418 C T N/A 3324 rho S473F 
recV flg OFF* MS #9 1212 T C N/A 3324 rho L404P 
recV flg OFF* MS #10 322 G T N/A 3324 rho E108Stop 
recV flg OFF* MS #11 N/A N/A N/A N/A  rho N/A 
recV flg OFF* MS #12 965 G T N/A 3324 rho R322I 
recV flg OFF* MS #13 957 G A N/A 3324 rho D320A 






Table 4.2. Frequency estimates of dominant negative effects in a motility assay. 
rho alleles 
Frequency at 24 hoursa Frequency at 48 hoursa 
0 ATcb,c  15 ATcb,d  0 ATcb,c 15 ATcb,d 
Wildtype 0.00 0.00 29.17 0.00 
MS #1: N528S 91.67 0.00 100.00 100.00 
MS #2: G474V 45.83 0.00 100.00 75.00 
MS #3: G279E 16.67 0.00 100.00 100.00 
MS #4: E444Stop 95.83 16.67 100.00 100.00 
MS #5: Frameshift 8.33 0.00 70.83 75.00 
MS #6: E255Stop 66.67 0.00 100.00 100.00 
MS #7: S473F 87.50 25.00 100.00 100.00 
MS #8: L404P 41.67 0.00 100.00 100.00 
MS #9: E108Stop 8.33 0.00 100.00 100.00 
MS #10 41.67 0.00 100.00 91.67 
MS #11: R322I 75.00 100.00 100.00 100.00 
MS #12: D320A 16.67 0.00 100.00 100.00 
MS #13: 
E247Stop 91.67 0.00 100.00 100.00 
MS #14: S473F 16.67 0.00 100.00 100.00 
aFrequency is expressed as a percentage of number the motile flares divided by the number of 
biological replicates tested.  
bConcentration of ATc added in ng/mL. 
cFor uninduced conditions, wildtype and MS #1-7 frequency estimates were calculated from two 
independent experiments with 24 biological replicates whereas MS #8-14 was from a single 
experiment with 12 biological replicates.  





Table 4.3. Strains and plasmids used in this study. 
Strain/Plasmid Description/Purpose Reference 
Plasmids   
pRPF185 Anhydrotetracycline (ATc) inducible expression vector; 
CmR/Tm10 
(46) 
pRT1611 pRPF185 with gusA removed (vector control) (28) 
pRPF144 pMTL960 with gusA under the transcriptional control of the 
promoter for cwp2  
(46) 
pRT1824 pMTL960: ::phoZ (promoterless) This study 
pRT1825 pMTL960: PflgB::phoZ This study 
pRT1826 pMTL960: PflgB-5'UTR(FSON)-flgB::phoZ This study 
pRT1827 pMTL960: PflgB-5'UTR(FSOFF)-flgB::phoZ This study 
pRT1882 pRPF185: rho wildtype from RT1693 This study 
pRT1883 pRPF185: rho allele from RT1705 MS #1 This study 
pRT1884 pRPF185: rho allele from RT1706 MS #2 This study 
pRT1885 pRPF185: rho allele from RT1707 MS #3 This study 
pRT1886 pRPF185: rho allele from RT1708 MS #4 This study 
pRT1887 pRPF185: rho allele from RT1709 MS #5 This study 
pRT1888 pRPF185: rho allele from RT1710 MS #6 This study 
pRT1889 pRPF185: rho allele from RT1711 MS #7 This study 
pRT2099 pRPF185: rho allele from RT1939 MS #8 This study 
pRT2100 pRPF185: rho allele from RT1940 MS #9 This study 
pRT2101 pRPF185: rho allele from RT1941 MS #10 This study 
pRT2102 pRPF185: rho allele from RT1942 MS #11 This study 
pRT2103 pRPF185: rho allele from RT1943 MS #12 This study 
pRT2104 pRPF185: rho allele from RT1944 MS #13 This study 
pRT2105 pRPF185: rho allele from RT1945 MS #14 This study 




DH5α F- Φ80lacZ Δ M15 (lacZYA-argF)U169 recA1 endA1 
hsdR17(rκ -, mκ +) phoA supE44 thi-1 gyrA96 relA1 λ - tonA 
Invitrogen, (64) 
HB101(pRK24) F- mcrB mrr hsdS20(rB-mB)recA13 leuB6 ara-14 proA2 lacY1 
galK2 xyl-5 mtl-1 rpsL20 (pRK24) 
(65) 




RT1693 R20291 recV::erm cwpV OFF*; flg OFF*  (36) 
RT1694 R20291 recV::erm cwpV ON*; flg OFF*  (36) 
RT1702 R20291 recV::erm cwpV OFF*; flg ON*  (28) 
RT1705 MS #1 from RT1693 This study 
RT1706 MS #2 from RT1693 This study 
RT1707 MS #3 from RT1693 This study 
RT1708 MS #4 from RT1693 This study 
RT1709 MS #5 from RT1693 This study 
RT1710 MS #6 from RT1693 This study 
RT1711 MS #7 from RT1693 This study 
RT1939 MS #8 from RT1694 This study 
RT1940 MS #9 from RT1694 This study 
RT1941 MS #10 from RT1694 This study 
RT1942 MS #11 from RT1694 This study 
RT1943 MS #12 from RT1694 This study 
!
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RT1944 MS #13 from RT1694 This study 
RT1945 MS #14 from RT1694 This study 
RT1838 RT1693 + pRT1824 (::phoZ) This study 
RT1839 RT1693 + pRT1825 (PflgB::phoZ) This study 
RT1840 RT1693 + pRT1826 (PflgB-5'UTR(FSON)-flgB::phoZ) This study 
RT1841 RT1693 + pRT1827 (PflgB-5'UTR(FSOFF)-flgB::phoZ) This study 
RT1842 RT1702 + pRT1824 (::phoZ) This study 
RT1843 RT1702 + pRT1825 (PflgB::phoZ) This study 
RT1844 RT1702 + pRT1826 (PflgB-5'UTR(FSON)-flgB::phoZ) This study 
RT1845 RT1702 + pRT1827 (PflgB-5'UTR(FSOFF)-flgB::phoZ) This study 
RT1846 RT1705 + pRT1824 (::phoZ) This study 
RT1847 RT1705 + pRT1825 (PflgB::phoZ) This study 
RT1848 RT1705 + pRT1826 (PflgB-5'UTR(FSON)-flgB::phoZ) This study 
RT1849 RT1705 + pRT1827 (PflgB-5'UTR(FSOFF)-flgB::phoZ) This study 
RT1850 RT1711 + pRT1824 (::phoZ) This study 
RT1851 RT1711 + pRT1825 (PflgB::phoZ) This study 
RT1852 RT1711 + pRT1826 (PflgB-5'UTR(FSON)-flgB::phoZ) This study 
RT1853 RT1711 + pRT1827 (PflgB-5'UTR(FSOFF)-flgB::phoZ) This study 
RT1981 RT1939 + pRT1824 (::phoZ) This study 
RT1982 RT1939 + pRT1825 (PflgB::phoZ) This study 
RT1983 RT1939 + pRT1826 (PflgB-5'UTR(FSON)-flgB::phoZ) This study 
RT1984 RT1939 + pRT1827 (PflgB-5'UTR(FSOFF)-flgB::phoZ) This study 
RT1985 RT1942 + pRT1824 (::phoZ) This study 
RT1986 RT1942 + pRT1825 (PflgB::phoZ) This study 
RT1987 RT1942 + pRT1826 (PflgB-5'UTR(FSON)-flgB::phoZ) This study 
RT1988 RT1942 + pRT1827 (PflgB-5'UTR(FSOFF)-flgB::phoZ) This study 
RT1904 RT1693 + pRT1882 This study 
RT1905 RT1693 + pRT1883 This study 
RT1906 RT1693 + pRT1884 This study 
RT1907 RT1693 + pRT1885 This study 
RT1908 RT1693 + pRT1886 This study 
RT1909 RT1693 + pRT1887 This study 
RT1910 RT1693 + pRT1888 This study 
RT1911 RT1693 + pRT1889 This study 
RT1912 RT1702 + pRT1882 This study 
RT1913 RT1702 + pRT1883 This study 
RT1914 RT1702 + pRT1884 This study 
RT1915 RT1702 + pRT1885 This study 
RT1916 RT1702 + pRT1886 This study 
RT1917 RT1702 + pRT1887 This study 
RT1918 RT1702 + pRT1888 This study 





Table 4.4. Primers used in this study. 
Primer Namea Sequence (5’ ! 3’)b Lab 
Annotation 
PhoZ_RPF144_F GAATGCTAGCGAGCTGACTGGGTTGAAG R2282 
phoZ_AsymR GAATGTTAATAAGGTAACCCCTAGCAAAGCTCTTTTCTTC R1706 
R202_rho_F2 CAAGATATCCATGCCTTCAATTTCCAAAATAAG R2308 
R202_rho_R CAAGGATCCTCCATATTTGCATTTGTATTATTGATT R2307 
CDR20291_3324intF GGAAACTAATAGAAATGAAATAGCT R2366 
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CHAPTER 5: DISCUSSION4 
 
Discovery of flagellum and toxin phase variation in C. difficile 
Clostridium difficile infections (CDI) are a cause of significant morbidity and mortality in 
industrialized countries. Diarrheal disease caused by CDI ranges from mild inflammatory 
diarrhea to pseudomembranous colitis, a severe condition characterized by pathologic lesions on 
the mucosal surface of colonic tissue. Antibiotic treatment is the leading risk factor for CDI, 
because the antibiotics disrupt the intestinal microbial community that is usually protective 
against CDI (1). In response to certain bile salts in the intestine, C. difficile spores germinate into 
actively growing vegetative cells (2, 3). The vegetative bacteria secrete the protein toxins TcdA 
and TcdB, which are largely responsible for the inflammation, intestinal pathology, and diarrheal 
disease symptoms seen in CDI (4).  
C. difficile surface proteins mediate adherence to other microbial species, mucus, and 
intestinal cells within the colon for colonization (5). The peritrichous flagella produced by C. 
difficile aid in motility and modulate colonization in an animal model of infection (6). In 
addition, TcdA and TcdB production is linked to flagellum biosynthesis (7-10). SigD (σD), an 
alternative sigma factor encoded within the early stage flagellar gene operon (flgB operon), is 
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essential for transcription of late stage flagellar genes, and also positively regulates transcription 
of the toxin genes (Fig. 5.1) (11, 12). Therefore, factors that regulate expression of the flgB 
operon not only control bacterial motility, they are also likely to impact toxin production and 
therefore virulence of C. difficile. The 5’ untranslated region (UTR) of the flgB operon mRNA 
contains a riboswitch (Cd1) specific to the nucleotide second messenger cyclic diguanylate (c-di-
GMP) (13, 14). C-di-GMP binding to Cd1 causes premature transcription termination within the 
first 160 nucleotides of the 5’ UTR of the flgB operon mRNA, inhibiting flagellar gene 
expression, motility, and toxin production. Because the flgB 5’ UTR is 498 nucleotides, we 
postulated that an additional cis-acting regulatory element downstream of Cd1 could control 
flagellar and toxin gene expression.   
In Chapter 2, we determined that flagellum and toxin production is subject to phase 
variation via DNA inversion in C. difficile R20291, a representative 027 strain isolated in 2006 
from an epidemic of CDI in the U.K (15, 16). Between Cd1 and the first open reading frame of 
the flgB operon lies a 154 bp invertible DNA element flanked by 21 bp imperfect inverted 
repeats (Fig. 5.1). We termed the invertible element the “flagellar switch.” Based on genomes 
currently available on public databases, the flagellar switch sequence and flanking inverted 
repeats are conserved in all C. difficile genomes with flagellar biosynthesis genes. The flagellar 
switch is capable of inversion in at least three ribotypes (i.e., 027, 017, and 012), under the 
conditions tested.  
Our study in Chapter 2 showed that C. difficile with the flagellar switch oriented 
according to the R20291 published genome (FN545816.1) expresses and produces peritrichous 
flagella, engages in swimming motility, and secretes the glucosylating toxins, and is thus 
flagellar phase ON (“flg ON”). Conversely, bacteria with the sequence oriented in the inverse 
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orientation are non-flagellated, non-motile, and attenuated for toxin secretion, and are thus 
flagellar phase OFF (“flg OFF”). The tyrosine recombinase RecV was determined to catalyze 
inversion of the flagellar switch, and mutation of recV in C. difficile showed that RecV is 
required for flagellar switch inversion. RecV was previously shown to control inversion of a 
genetic switch upstream of cwpV, which encodes a cell wall protein involved in autoaggregation 
and resistance to certain bacteriophage (17-19). Interestingly, the flagellar and cwpV switches 
have seemingly disparate sequences in the inverted repeats and surrounding DNA.  
 
Strain Dependent Differences in Flagellar Phase Variation 
The C. difficile strain 630 (ribotype 012) was isolated in 1982 from a patient with severe 
CDI in Switzerland (20). Erythromycin-sensitive derivatives of 630, 630Δerm and 630E, are 
more amenable to currently available genetic tools and used most often to study C. difficile 
physiology and virulence (21, 22). However, unlike the R20291 strain in which we could detect 
the flagellar switch in both ON and OFF orientations, only the ON orientation was detected in 
630Δerm and in the 630 parent  (15). These results suggest that the flagellar switch is locked in 
these strains. The inability of the flagellar switch to invert to the flg OFF orientation in 630 and 
630Δerm could be due to the shorter inverted repeats flanking the flagellar switches in these 
strains, with 20 bp instead of the 21 bp evident in all of the other available published genomes of 
C. difficile strains with a flagellar switch. Inverted repeat length has been demonstrated to affect 
recombination at the cwpV switch in several C. difficile strains (17). Reduced inverted repeat 
length could similarly prevent inversion of the flagellar switch in 630 and 630Δerm.  
Recent work suggests that the flagellar switch in 630 is capable of inversion from flg ON 
to OFF in some condition(s). Collery et al. found the flagellar switch in the OFF orientation in 
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JIR8094 (also referred to as 630E), another derivative of 630 (23). To obtain JIR8094, C. 
difficile 630 was serially passaged an undisclosed number of times on non-selective agar medium 
(22). In the process, JIR8094 acquired a non-motile and less toxigenic phenotype. We previously 
reported that ectopic expression of sigD in JIR8094 was sufficient to rescue toxin production, 
consistent with mutations that affect expression of sigD in the flgB operon (11). Collery et al. 
inverted the flagellar switch in JIR8094 to that in 630 and 630Δerm, which would presumably 
restore flagellar motility and toxin production (23, 24). However, the JIR8094 mutant strain 
remained non-motile and attenuated for production of both toxins (23). The lack of restored 
motility and toxinogenesis may be due to inversion of only 150 bp of the flagellar switch, 
whereas we experimentally determined that 154 bp comprise the flagellar switch (15). 
Alternatively, several other genetic differences between 630E and its 630 parent have been 
identified and may account for abrogated motility and toxin production in 630E strain.  
In Chapter 3, we assessed the frequency and phenotypic outcomes of flagellar switch 
inversion in multiple C. difficile ribotype 012 isolates (16). The laboratory-adapted strain 
JIR8094 and six clinical and environmental isolates were all found to be flg OFF: non-motile and 
attenuated for toxin production. We isolated low frequency motile derivatives of JIR8094 with 
partial recovery of motility and toxin production. We speculated that an additional accumulated 
mutation in JIR8094 accounted for the partial restoration. Indeed, overexpression of a 
topoisomerase gene that was mutated in JIR8094 fully restored motility to 630 levels in the 
JIR8094 motile derivatives. However, TcdA levels were unchanged in JIR8094 motile 
derivatives overexpressing the topoisomerase relative to a vector control strain. Repairing the 
additional identified genetic polymorphisms in JIR8094 (23), such as those in genes encoding an 
RNA helicase or oligopeptide transporter, may fully restore toxin biosynthesis.  
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The clinical and environmental isolates varied considerably in the frequency in which flg 
ON derivatives arose, and these derivatives showed full restoration of motility and toxin 
production. We observed heterogeneity in the size of inverted repeats flanking the flagellar 
switch among clinical and environmental isolates. However, there was no correlation between 
inverted repeat size and frequency of flg ON derivatives, suggesting that inverted repeat size 
does not influence recombination. Ultimately, studying the differences between 630 and JIR8094 
may help reveal the mechanism by which the orientation of the flagellar switch modulates 
downstream gene expression. In subsequent sections we discuss additional implications of our 
findings based on this study. 
 
Wildtype strains: Fake News or False Alarms? 
 An overarching approach used in basic research of bacterial pathogens is linking 
genotype to phenotype. Does a bacterial gene product contribute to fitness under these 
conditions, and will genetic complementation of a mutant in trans restore fitness? Mucosal 
bacterial pathogens that use diverse mechanism to mediate the ON/OFF production of surface or 
secreted virulence factors can hamper research progress. As presented in Chapter 3, laboratory 
passage of C. difficile strain 630 lead to the isolation of not only a genetically amenable 
derivative named JIR8094, but a flagellar and toxin phase OFF isolate. Given its amenability to 
mutagenesis, JIR8094 has been used in many studies to identify and characterize virulence gene 
regulators (25, 26), sporulation genes (27, 28), and cell wall modifications genes (29). Early 
work using JIR8094 suggested that TcdA was dispensable for diarrheal disease in hamsters (30), 
but this outcome was most likely because the flagellar switch orientation (flg OFF) masked the 
contribution of TcdA. However, not all studies that used JIR8094 revealed phenotypes that were 
!
! 209!
significantly different than when studied in 630∆erm. For example, two major studies co-
released in PLOS Genetics assessed the contribution of predicted sporulation-specific sigma 
factors to each stage in sporulation (27, 28). Both independent studies yielded overwhelmingly 
similar results with one paper using JIR8094 (27) and the other 630∆erm (28).  
Misattribution of a phenotype or over/underestimation of a virulence factor has been 
demonstrated previously in other mucosal pathogens. Anderson et al. initially attributed 
NGO0322, a hydrogen peroxide induced gene based on microarray data, to gonococcal 
resistance to neutrophil phagocytosis and killing through mutation and complementation (31). 
However, 11 genes encoding Opa proteins in Neisseria gonorrhea are subject to stochastic 
expression by phase variation and contribute to gonococcal survival in neutrophils (32). 
Immunoblots for Opa proteins revealed distinct differences in Opa profiles between the 
NGO0322 mutant and the parental strain. Ultimately, the Opa profile present in the NGO0322 
mutant, and not the function of NGO0322 itself, was responsible for gonococcal survival in 
neutrophils. Phenotypic diversity poses challenges for basic research in linking genotype to 
phenotype in bacteria that undergo high frequency phase variation of surface proteins that 
influence host-pathogen interactions.  
Genetically phase locked mutants in Streptococcus pneumoniae have helped clarify 
phenotypes, to a degree. Oliver et al. generated genetically colony phase-locked opaque and 
transparent mutants of Streptococcus pneumoniae (33). Opaque colonies are associated with 
higher capsule production, invasive disease, whereas transparent colonies are associated with 
asymptomatic colonization of the nasal cavity and less invasive disease. S. pneumoniae generates 
six different alleles of a methylase through site-specific recombination and Oliver et al. 
generated genetically locked mutants for all six. Four were phase locked transparent and two 
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phase locked opaque and exhibited differences in mortality and biofilm formation, but not 
adherence to epithelial cells (33). Alarmingly, their phase locked alleles generated colony types 
that were contradictory to previous work using the same strain background (34). The differences 
could be due to strain passage and SNPs throughout the genome between independent labs. 
Nonetheless, these studies shed light on the challenges poised when working with chameleon-
like pathogens.  Research is underway to generate genetically “phase-locked” strains of C. 
difficile to assess the contribution of individual phase variable gene products to virulence. 
Combinatorial mutants of recV with the various genetic switches locked would benefit the C. 
difficile community by clarifying the contribution of individual phase variable gene products to 
colonization, diarrheal disease symptoms, and transmission during host infection.   
 
Topoisomerase: A Flip & Twist for Phenotypic Diversity 
 In Chapter 3, we found that inversion of the flagellar switch to flg ON in JIR8094 only 
partially restored motility and toxin production, suggesting that other genetic variations in 
JIR8094 negatively impact these processes. JIR8094 and derivative strains carry a non-sense 
mutation in the topA gene that truncates the protein (23). Overexpression of topA, which encodes 
a type II topoisomerase, fully restored the motility of the JIR8094 motile derivatives. However, 
the JIR8094 parent remained non-motile upon overexpression of TopA, suggesting that DNA 
relaxation is not sufficient to recover motility in flg OFF bacteria. Although, under the conditions 
tested, DNA supercoiling and topoisomerase activity did not influence flagellar switch inversion, 
previous studies have specified roles for DNA topology and supercoiling in affecting fimS 
inversion in E. coli. In laboratory-adapted strains of E. coli, Insertion Sequence 2 elements 
inactivate fimE, a recombinase that favors the ON to OFF bias of fimS, which results in equal 
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efficiency of fimS inversion by FimB (35). Treatment of FimB-only strains with Novobiocin, a 
DNA gyrase-specific antibiotic that relaxes DNA (positive supercoiling), biases cells to be fimS 
ON (36). Leucine-responsive regulatory protein (Lrp) and Integration Host Factor (IHF) can now 
introduce additional bends and kinks into the fimS DNA making the switch an unfavorable 
substrate for FimB-mediated inversion, so cells are “trapped” in an ON state (37, 38). Mutations 
in Lrp and IHF binding sites in fimS restore FimB inversion, and cells become biased to OFF 
(37, 38). In the fimS OFF state, Histone-like nucleoid-structuring protein (H-NS) bends the DNA 
to restrict FimB-mediated inversion and additional mutations in H-NS binding sites restore 
inversion from OFF-to-ON and ON-to-OFF (38). Collectively, Lrp, IHF, and H-NS function as 
recombination directionality factors (RDF) to bias fimS in a given orientation for exclusively 
fimbrial phase ON and phase OFF bacteria. In the absence of antibiotics, DNA topology in 
stationary phase is relaxed and the aforementioned RDFs can affect fimS inversion frequency. 
Does DNA topology and supercoiling influence flagellar switch inversion in the ribotype 027 
and 017 strains? Treatment of cells with a DNA gyrase inhibitor such as a fluoroquinolone 
antibiotic, which would increase positive supercoiling as a result of DNA topoisomerase activity, 
would allow an assessment of the impact of topology on flagellar switch orientation.    
 
Mechanism of Phase Variable Gene Regulation 
 Phase variation occurs by multiple mechanisms in diverse mucosal bacterial pathogens, 
including site-specific recombination, general homologous recombination, slip strand mispairing, 
and DNA methylation (39). For site-specific recombination, a recombinase recognizes a specific 
DNA sequence and catalyzes strand exchange and DNA inversion. The orientation of the DNA 
sequence dictates whether a nearby gene is expressed. Classically, the invertible DNA element 
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contains a promoter to transcriptionally control an adjacent gene or operon. The best-studied 
example of this mechanism is the Type I fimbrial biosynthetic operon in E. coli. Here, the 
invertible element fimS lies upstream of the Type I fimbrial operon. Within fimS is a promoter 
that, when properly oriented, drives transcription of fimA (40). Using a series of transcriptional 
reporters and growth conditions known to be permissive for flagellar gene expression, we found 
that the flagellar switch in C. difficile does not contain a promoter, and expression of the flgB 
operon relies on the upstream σA-dependent promoter (15).  
 Phase variable expression of cwpV in C. difficile occurs through a post-transcriptional 
mechanism (17). In one orientation (ON) of the cwpV switch, the leader region of the cwpV 
mRNA adopts a structure allowing transcriptional elongation into the cwpV coding sequence. In 
the opposite orientation (OFF), the leader region forms an intrinsic terminator that causes 
premature termination of transcription, precluding transcription of the cwpV coding sequence and 
CwpV biosynthesis. To determine whether a similar cis-acting mechanism occurs via the 
flagellar switch, we evaluated the same transcriptional reporters in Bacillus subtilis, a spore-
forming obligate aerobe, where we postulated that C. difficile-specific trans-acting regulatory 
factors would be absent. In contrast with results from C. difficile, we found that the flg ON and 
OFF reporters yielded equivalent activity in B. subtilis, indicating that no intrinsic transcription 
terminator is present in the flagellar switch. Northern blotting failed to detect evidence of 
premature transcript termination, suggesting that factor-dependent termination also does not 
occur (15). However, the low sensitivity of northern blotting using a Digoxigenin-labeled probe 
does not allow us to eliminate the possibility of factor-dependent termination (15). 
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Interstate 5’: The Rho(d) Less Travelled 
 Data presented in Chapter 4 implicate Rho factor in mediating strand-specific 
transcription termination in flg OFF bacteria. Motile suppressor mutants were isolated from 
phase-locked flg OFF mutants in motility medium. All sequenced motile suppressors harbored 
missense or nonsense mutations in the rho gene resulting in non-functional, unstable, or severely 
truncated variants of Rho factor. Growth curves and calculated growth rates demonstrated that 
rho is not essential for growth, but does attenuate growth kinetics in nutrient rich media. Why is 
the Rho mutant attenuated? As demonstrated in other organisms, Rho factor could help resolve 
R-loops, terminate the timely expression of cryptic prophage genes, and prevent pervasive 
antisense transcription that is toxic (41). RNA sequencing and CHIP-seq experiments could 
illuminate a role for Rho factor in these processes in C. difficile. All motile suppressors had 
motility comparable to the phase locked flagellar OFF mutant. The results of gene reporter 
experiments suggest that Rho factor is constitutively expressed under the conditions tested, since 
a flg OFF reporter was inactive in a phase-locked flg ON* mutant. Gene reporter data suggest 
that Rho factor directly mediates strand-specific termination in the leader RNA of the flgB 
operon of OFF bacteria and/or controls the production of another factor to indirectly control 
flagellar gene expression in a phase-dependent manner. Experiments are ongoing to distinguish 
between these possibilities. 
  Because of the propensity of the phase-locked off strain to restore motility via suppressor 
mutations in Rho, we favor a model in which Rho factor directly impacts flgB operon expression. 
Based on the literature, we present three working models that coincide with the steps of Rho 
factor function: binding, translocation, and termination. In the first model, a cytosine-rich rut 
sequence is present exclusively in the flg OFF RNA and in the 5’ to 3’ orientation to recruit Rho 
!
! 214!
factor via the primary binding site (PBS). A limitation of this model is that the flagellar switch 
sequence is limited in cytosines and AT-rich. However, Rho function has not been studied in 
AT-rich species, so it is formally possible that rut sites have different sequence features in C. 
difficile. In the second model, the rut sequence is present in the cytosine-rich sequence 5’ of the 
flagellar switch, in the Cd1 riboswitch region. This model is predicated on the ability of Insertion 
Domain present in the NTD of Rho factor to unwind highly structured RNA. To allow phase-
specific control of flg gene expression, a Rho Antagonizing RNA Element (RARE) sequence 
present in the flg ON strand prevents Rho translocation by preventing closed complex formation. 
Sevostayanova et al. found that a RARE antagonizes Rho-dependent termination in the leader 
RNA of the mgtCBR operon in Salmonella enterica serovar Typhimurium (42). Alternative stem 
loop formation would dictate whether RARE is accessible to restrict Rho activity downstream of 
binding the rut sequence. Furthermore, in this model RARE would be absent from flg OFF RNA 
because the factor is strand-specific or inaccessible by alternate stem loop formation. In the third 
model, neither availability of the rut sequence nor Rho translocation are compromised, but 
instead a strand-specific pause site is present exclusively in the flg OFF state (and a weak or no 
pause site is present in the flg ON state). Either the 5’ to 3’ orientation of the sequence or the 
secondary structure would dictate RNAP polymerase accessibility to the pause site. In the leader 
RNA of corA in S. Typhimurium, one of two mutually exclusive stem loop conformations not 
only makes a rut sequence accessible, but stimulates a strong RNAP pause site normally 
repressed by the alternative stem loop conformation (43). These three models coincide with an 
emerging paradigm that Rho factor can serve not just as a constitutive terminator of transcription 
at the 3’ end of genes and operons, Rho can also mediate regulated termination within leader 
sequences of mRNAs to control gene expression in cis (44).  
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Numerous other questions remain. What features of the leader RNA of the flgB operon 
are required for Rho function? Does transcription termination require NusG at a weak pause site? 
Finally, is there a therapeutic benefit of targeting Rho factor to force all bacteria to produce 
immunostimulatory flagellin and toxins for clearance by immune system? The role of the 
insertion domain, the bases required for Rho interaction, and the usefulness of Rho as a 
therapeutic target are areas of future investigation 
 
Rho(llin’) on Highly Structured RNA: A Unique Insertion Domain of C. difficile Rho factor 
Rho factor in C. difficile contains the canonical domains present in E. coli Rho that 
contribute to transcription termination in the N- and C-terminal domains, plus one unique 
feature. In C. difficile, Rho factor contains an additional domain, the Insertional Domain, 
between the N-terminal Helix Bundle (NHB) and Primary Binding Site (PBS) (Figure 4.3). The 
better characterized Rho proteins from E. coli and B. subtilis lack an insertional domain, but a 
few Rho proteins with insertion domains from other species have been characterized (45-48). For 
example, in Clostridium botulinum, a Rho insertion domain forms prion-like proteins when 
overproduced in bacteria and permissive fungi (47). The function of the insertional domain in C. 
difficile Rho is unknown. Interestingly, an insertion domain in Micrococcus leutus Rho factor 
aids in unwinding of highly structure RNA immediately downstream of a promoter to mediate 
termination (46). We speculate that the insertion domain of C. difficile Rho similarly unwinds the 
secondary structure of the c-di-GMP sensing riboswitch to access a rut sequence. This 
hypothesis is consistent with our inability to detect termination or loss of gene expression of the 
flg OFF reporter in B. subtilis (15). B. subtilis Rho does not have the N-terminal insertion 
domain. Chimeras of B. subtilis Rho with the C. difficile insertion domain added could elucidate 
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if this domain is sufficient for rut sequence access both in vitro and in vivo. Mechanistic insight 
into the function of the Rho insertion domain in C. difficile could inform us of the functional 
contribution of this feature in many genetically intractable bacteria (48). 
 
Two Are Better Than One: c-di-GMP and DNA Inversion Regulate Flagellum Biosynthesis  
 Cyclic diguanylate and phase variation by DNA inversion control flagellum biosynthesis 
and toxin production in C. difficile (49, 50). C-di-GMP binds to the Cd1 riboswitch in the leader 
RNA of the flgB operon to cause premature transcription termination at the 160 nt. Mutation of a 
single base in the P2 domain of the Cd1 riboswitch renders the riboswitch unable to bind and 
respond to c-di-GMP resulting in robust reporter activity, as determined using a reporter fusion 
in B. subtilis (51). Low c-di-GMP concentrations are permissive for transcription through to the 
downstream flagellar switch and flagellar genes, but elevated c-di-GMP leads to termination 89 
nt before reaching the LIR of the flagellar switch. Notably, these findings indicate that c-di-GMP 
is epistatic to the phase variation mechanism, i.e., phase variation is only relevant under low 
intracellular c-di-GMP conditions. Thus, the proposed mechanism for phase variable gene 
regulation via Rho is similarly only relevant when c-di-GMP levels are sufficiently low to allow 
readthrough of the full leader sequence. Cooperation between a riboswitch and Rho factor within 
a leader sequence has been previously demonstrated in S. Typhimurium. Holland et al. 
demonstrated that under high Mg2+ concentrations, the Mg2+-sensing riboswitch in the leader 
sequence of the mgtA mRNA requires Rho factor for termination (52). Specifically, low Mg2+ 
promotes a secondary structure that favors transcription elongation into the mgtA coding 
sequence, which functions in Mg2+ import. However, in high Mg2+ the RNA adopts a relaxed 
conformation that exposes a rut sequence, allowing Rho to bind and terminate transcription 
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prematurely, and preventing the import of toxic levels of Mg2+. Treatment with the Rho-specific 
inhibitor Bicyclomycin abrogates Rho-dependent termination in permissive conditions (high 
Mg2+). The independent functions of a riboswitch and Rho factor in the same leader mRNA, as 
seen in the case of the C. difficile flgB leader, is new territory. 
Environmental signals that elevate intracellular c-di-GMP in C. difficile would repress the 
SigD regulon, which includes genes involved in flagellar motility, toxin production, various 
adhesins, and other factors (12). Yet increasing c-di-GMP is expected to have further pleotropic 
effects, such as increased Type IV pilus production and related phenotypes (13, 49, 53). McKee 
et al. found that mutation of the major pilin gene pilA1 or the pilus ATPase gene pilB1 reduces 
C. difficile persistence in a mouse infection model (54). Interestingly, pilA1 expression is 
positively regulated by a c-di-GMP “ON” riboswitch. These studies suggest that the intracellular 
concentration of c-di-GMP is elevated in bacterial cells at least transiently during infection. 
Accordingly, termination through the Cd1 riboswitch is also likely to occur during infection. 
Mutation of the Cd1 riboswitch and the flagellar switch individually and in combination would 
inform the individual contribution of these cis-acting regulators to flgB operon expression. These 
mutagenesis techniques remain challenging in C. difficile, but are feasible using newly available 
tools (55).   
 
RecV-Dependent Changes in C. difficile Colony Morphology 
Differences in the expression of cell surface structures can affect how bacteria assemble 
into a colony, and changes to gross colony morphology can provide insight into microbial 
physiology and virulence (56). Reynolds et al. reported that the phase variable expression of 
cwpV influences colony morphology (18). C. difficile recV mutants characterized as CwpV phase 
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ON (“cwpV ON”) colonies exhibited a densely packed morphology with smooth edges, whereas 
a recV mutant noted as cwpV phase OFF (“cwpV OFF”) bacteria yield dispersed, ruffled colonies 
(18). Other genes have also been implicated in colony morphology development (57, 58). In 
pursuit of obtaining enriched flagellar phase variant populations, we observed smooth, circular 
(SC) colonies and rough, filamentous (RF) colonies, but colony morphology was not strongly 
associated with flagellar switch orientation (15). To identify the genes responsible for the SC and 
RF colony morphologies, we evaluated a panel of C. difficile mutants. We noted that a C. 
difficile R20291 sigD mutant, which is aflagellate and non-motile, can form both SC and RF 
colonies, indicating that colony morphology is independent of flagellum biosynthesis and 
motility (Fig. 5.2A). Mutating recV resulted in SC colonies in both flagellar phase locked ON 
and OFF strains, indicating that the RF colony morphology is independent of flagellar switch 
orientation but dependent on RecV (Fig. 5.2B). In our work, in contradiction with the prior 
report, the RF colony morphology is independent of the cwpV switch orientation because recV 
mutants with the cwpV switch locked ON and OFF both yield SC colonies.  
Unpublished data indicates that RecV controls DNA inversion of another switch(es) 
controlling phase variable expression of genes mediating SC and RF colony morphology 
(personal communication, Ognjen Sekulovic, et al.). If so, generating independent recV mutants 
could give rise to exclusively SC colonies (as observed) or RF colonies depending on the 
orientation of such a switch at the time of recV inactivation. To determine if RecV modulates 
colony morphology, we transformed C. difficile from SC and RF colonies with a plasmid 
allowing expression of recV or the vector control (Figure 5.2C & 5.2D) (15, 59). Bacteria from 
SC and RF colonies bearing vector retained their respective colony morphologies, and bacteria 
from SC colonies expressing recV retained the SC colony morphology. In contrast, bacteria from 
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RF colonies expressing recV yielded SC colonies. From these data, we surmise that RecV 
mediates recombination at a genetic switch upstream of genes responsible for the RF colony 
morphology. RecV inactivation in a previous study suggested the cwpV ON is responsible for the 
RF colonies (18), but based on our findings we predict another RecV-dependent switch was 
locked in their strain and cwpV ON was misattributed to RF colonies. 
Few studies have evaluated the ultrastructure of C. difficile colonies (60). Our data 
suggest that the production of a surface protein or polysaccharides is subject to RecV-dependent 
phase variation and impacts colony morphology. There are three known extracellular 
polysaccharides that could influence colony morphology, named PSI-PSIII, and the export 
machinery and cell wall proteins that anchor these polysaccharides to the surface could be 
involved as well (61, 62). Alternatively, RecV may indirectly affect colony morphology by 
mediating phase variation of a protein controlling the transcription, translation, or localization of 
a surface protein or polysaccharide. As noted above, two other invertible DNA sequences have 
been predicted based on the comparison of genomes of multiple C. difficile strains (63). These 
are located upstream of CDR20291_15140 and CDR20291_06850, which encode functional c-
di-GMP phosphodiesterases (64, 65). The nucleotide second messenger c-di-GMP has been 
shown to affect colony morphology in multiple bacteria, and preliminary data suggests c-di-
GMP may do so in C. difficile (unpublished data, Garrett and Tamayo) (66, 67). The function 
and virulence contribution of the RecV-dependent phase variable surface proteins or 




Virulence contribution of RecV-dependent phase variation during host infection 
The role of phase variation of flagella and toxins during C. difficile infection remains to 
be determined. Ideally, such studies would use phase-locked mutants, so that the inability to 
switch between flg ON and OFF states can be assessed. A recV mutant is phase-locked, but we 
refrained from evaluating this mutant in animal models of C. difficile disease because of the 
likely pleiotropic effects of the mutation. RecV controls inversion of both the flagellar and cwpV 
switches (15, 17, 18), and impacts at least two other loci (personal communication, Ognjen 
Sekulovic, et al.). Thus, combinatorial genetic switch mutants through inactivation of recV 
would be required to assess the effect of each individual switch on C. difficile virulence. An 
alternative approach for generating phase-locked mutants is site-directed mutagenesis of the 
inverted repeats, a method successful for phase locking the fimbrial switch in E. coli (68), which 
would allow us to lock the flagellar switch without affecting inversion of other switches.  
Gunther et al. found that the ability of uropathogenic Escherichia coli (UPEC) to phase 
vary type I fimbriae biosynthesis affects colonization (68). A fimS phase-locked OFF mutant was 
attenuated for colonization in a mouse model of urinary tract infection compared to wild type 
and fimS phase-locked ON strains, consistent with a known role for these fimbriae in UPEC 
virulence (68). Flagellar filaments contribute to C. difficile R20291 colonization during infection 
of mice (9), so flagellar phase locked C. difficile similarly may display colonization phenotypes 
consistent with the ON/OFF status of the flagellar switch and flagellum biosynthesis. However, 
the fitness benefit of adherence comes at a cost to flg ON bacteria: both flagellin and the 
glucosylating toxins are immunostimulatory. C. difficile flagellin stimulates host Toll-like 
receptor 5 (TLR5), which activates signaling pathways leading to the secretion of IL-8, a 
neutrophil chemokine, in epithelial cells (69, 70). The link between flagellum and toxin 
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biosynthesis is also likely to impact C. difficile fitness in the intestine. The glucosylating toxins 
stimulate apoptosis, necrosis, or pyroptosis depending on the host cell type and model of 
infection (71-74). Batah et al. found that flagellin and the toxins synergistically elicit a robust 
inflammatory response from the intestinal epithelium during infection of mice with R20291, 
whereas the individual antigens alone were not sufficient for eliciting such a response (75). Thus, 
while the flg ON state may be advantageous for establishing a C. difficile infection and disease, 
the flg OFF state may be selected at later stages of infection because it allows avoidance of 
immune clearance.  
The role for CwpV in C. difficile in the context of the anaerobic host intestine must also 
be considered. CwpV promotes bacterial autoaggregation in vitro, which was proposed to 
suggest a role for CwpV in host colonization (18). CwpV also promotes resistance to 
bacteriophage predation by reducing phage adsorption and phage tail spike DNA injection (19). 
Thus, cwpV ON bacteria could resist phage attack in the intestine. Given the functional 
contributions of CwpV to C. difficile in vitro, the potential contribution of cwpV OFF bacteria to 
CDI is puzzling. Bacteria that are cwpV OFF may be less likely to generate an antibody response, 
and/or they could disperse from an unfavorable colonization site during infection.   
Because RecV mediates inversion of multiple sequences, it is tempting to speculate that 
RecV allows coordination of their production, resulting in synergism or antagonism between 
those factors. Considering flagella and CwpV together, these may have complementary roles in 
colonization, with a cwpV ON phenotype compensating for a lack of flagella in a flg OFF 
bacterium, and vice versa. One of the antigens may be more immunodominant such that patient 
infection with another strain could allow for growth of a phase OFF for that antigen. Although 
antibodies against CwpV can be recovered after infection, CwpV might still be less 
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immunostimulatory compared to flagellin and the toxins (76). In bacteria that are phase ON for 
both surface structures, the adherence of these bacteria could be greater than individually if they 
engage distinct receptors. However, in each case, the cost of immunogenicity will play a role in 
the overall survival of the respective bacteria. 
Several other issues complicate the ability to predict the virulence outcome during 
infection. CwpV could alter flagellar function, although results in C. difficile 630 contradict this 
assertion: motility and flagellin production are unchanged in bacteria overexpressing CwpV (18). 
The SigD regulon (under the control of the flagellar switch) includes several predicted and 
functionally characterized adhesins that may synergize with CwpV and/or flagella for 
colonization (12). Finally, additional RecV-dependent switch(es) may influence C. difficile 
virulence. Importantly, there is no evidence to date that RecV preferentially recognizes one 
switch orientation over the other for any of its targets, so presumably the abundance of phase ON 
and OFF of each target in a population relies on external selective pressures.  
 
Translational Impact: Diagnostics & Treatment 
Our findings have significant implications for CDI diagnosis and treatment. The methods 
used for the diagnosis of CDI are a point of contentious debate given the diversity in disease 
symptoms and tests (77, 78). C. difficile can be diagnosed using Nucleic Acid Amplification 
Tests (NAAT) to detect C. difficile rRNA, toxin, or metabolic genes. NAAT have high 
sensitivity with low specificity. Another approach relies on detection of a specific C. difficile 
product, namely glutamate dehydrogenase (GDH), an intracellular and secreted enzyme that 
contributes to virulence (79, 80), or the glucosylating toxins. Testing for specific products has 
relatively low sensitivity, but high specificity. Exclusively using NAAT for diagnosis can lead to 
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a false positive result for CDI: the patient can be asymptomatically colonized, or remnants of 
DNA from past exposure may confound the test results. Tests for GDH provide the advantage of 
stating the patient has an actively growing vegetative population of C. difficile, and the toxin 
immunoassay determines the presence of toxin producing strains. Patients presenting with 
diarrheal disease symptoms can be subjected to a testing algorithm for C. difficile involving 
detection GDH to denote active replication of the organism, and subsequent NAAT or toxin 
immunoassay to indicate the presence of virulent C. difficile. If negative by GDH, then no other 
tests are needed. A positive result for the GDH test is followed with a confirmatory toxin 
immunoassay or NAAT. In many cases, a negative result for the toxin immunoassay arises for a 
patient who is not currently experiencing diarrheal disease symptoms. We propose that such 
patients may be colonized with a flg OFF isolate. We obtained six ribotype 012 isolates and 
found that all were flg OFF and therefore poor producers of the glucosylating toxin TcdA. TcdA 
and TcdB levels in such strains could be below the level of sensitivity in a predominately flg 
OFF colonizing C. difficile. We suggest labs consider a NAAT evaluating the orientation of the 
flagellar switch as a prognostic marker of CDI. Conditions that bias the population to flg ON 
would result in increased toxin production, which would become readily detectable by toxin 
immunoassays and require immediate treatment with metronidazole or vancomycin. Patients 
with recurrent infection could be dealing with C. difficile undergoing switching between flg ON 
with fulminant disease and flg OFF with no disease.  
For CDI treatment, the new monoclonal antibodies targeting both toxins developed by 
Merck may be ineffective since the target is subject to phase variable production. Treatment with 
monoclonal antibodies to the toxins will improve diarrheal disease symptoms, but have no 
effects on colonization. Carter et al. demonstrated that toxin mutants of ribotype 027 strains 
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maintained colonization in mice at levels similar to parental toxin positive strains for at least 48 
hours post-infection. These data suggest that colonization will remain, and these patients could 
serve as asymptomatic carriers of C. difficile. Identifying surface and exported proteins in C. 
difficile that are consistently produced and not subject to phase variable production could serve 
as better diagnostic and therapeutic targets to ensure targeting of the entire population. 
 
Concluding Remarks 
 The discovery and characterization of flagellum and toxin phase variation in C. difficile 
has provided new knowledge of a cis-acting regulatory feature controlling the production of 
these virulence factors, but has also left many unanswered questions.  
1.! How does Rho factor mediate transcription termination in the leader RNA of the flgB 
operon? What features of the leader RNA impart Rho factor recognition? What is the 
functional contribution of the insertion domain of Rho in comparison to previously 
characterized Rho proteins? Does Rho factor contribute to regulation at other genetic 
switches?  
2.! RecV appears to control multiple switches. What is the phase variable surface protein or 
polysaccharide controlled by RecV and affecting colony morphology? What is the 
sequence that RecV recognizes among the switches? Is a single nucleotide deletion in the 
inverted repeats, as seen in 630E, sufficient to inhibit DNA inversion? Could an 
accessory factor(s) help RecV discriminate between its targets, leading to different rates 
of inversion? If so, what is the functional outcome to C. difficile physiology?  
3.! Lastly, the contribution of RecV-mediated phase variation of flagella, toxins, 
autoaggregation, and phage resistance to virulence in a host has yet to be examined. 
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Potential interactions between these phenotypes could substantially alter the course of 
CDI and transmission to a new host.  
Defining the mechanism controlling phase variation of virulence factors in C. difficile could 






Figure 5.1. Diagram of the regulatory scheme for flagellar and toxin phase variation in C. 
difficile. A DNA invertible element, which we termed the “flagellar switch,” is located in the 5’ 
UTR of the flgB operon and controls transcription of structural and regulatory genes necessary 
for flagellum biosynthesis and motility. One orientation of the flagellar switch, but not the other, 
is permissive for downstream gene expression. In addition, the flagellar switch regulates toxin 
production by controlling the expression of sigD, which located in the flgB operon and encodes a 
sigma factor, σD, that promotes toxin gene transcription. RecV, a tyrosine recombinase, catalyzes 
DNA inversion in both directions at the flagellar and cwpV switches, and also impacts one or 






Figure 5.2. RecV controls a genetic switch responsible for the RF morphology in a σD-
independent manner. Light microscopy images of C. difficile R20291 colonies grown on BHIS 
agar. (A) A R20291 sigD mutant develops smooth circular (SC) and rough filamentous (RF) 
colonies (B) All recV mutants yield SC colonies, regardless of flagellar and cwpV switch 
orientations. Switch genotypes are indicated in parentheses, with asterisks denoting phase-locked 
orientations. (C) Bacteria from SC colonies transformed with a plasmid for ectopic recV 
expression (pRecV, pRT1529) or the vector control (pRT1611) retain the SC colony morphology 
of the parent isolate. (D) Bacteria from RF colonies transformed with the vector control develop 
the parental RF colony morphology, while overexpression of recV (pRecV) results in conversion 
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